| 1 | 0,5 MG fingolimod | - | - | - | - | 1件: 13 13 💬
|
| 2 | 0.25 MG RPC1063 | - | - | - | - | 3件: 13 13, 96, 97 💬
|
| 3 | 0.25MG RPC1063 | - | - | - | - | 2件: 13 13, 97 💬
|
| 4 | 0.5 MG RPC1063 | - | - | - | - | 2件: 13 13, 97 💬
|
| 5 | 0.5MG RPC1063 | - | - | - | - | 1件: 13 13 💬
|
| 6 | 0.9% chloride injection sodium | - | - | - | - | 1件: 13 13 💬
|
| 7 | 1 - andrographis paniculata P/ST extract | - | - | - | - | 1件: 13 13 💬
|
| 8 | 1 MG RPC1063 | - | - | - | - | 2件: 13 13, 97 💬
|
| 9 | 1% steroid cream | - | - | - | - | 1件: 13 13 💬
|
| 10 | 1-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-YL)OXY]-3-pyridinyl}-2-pyrrolidinone | - | - | - | - | 1件: 13 13 💬
|
| 11 | 1.0MG RPC1063 | - | - | - | - | 1件: 13 13 💬
|
| 12 | 10000IU vitamin D | - | - | - | - | 1件: 13 13 💬
|
| 13 | 11C-acetate | 1件: Acetic acid C-11 Acetic acid C-11 | - | - | - | 3件: 13 13, 86, 88 💬
|
| 14 | 11C-BMS-986196 | - | - | - | - | 1件: 13 13 💬
|
| 15 | 11C-MC1 | - | - | - | - | 3件: 6 6, 13, 46 💬
|
| 16 | 11C-PBR28 | - | - | - | - | 2件: 6 6, 13 💬
|
| 17 | 11C-PIB | - | - | - | - | 5件: 5 5, 6, 7, 13, 17 💬
|
| 18 | 11C-PS13 | - | - | - | - | 2件: 6 6, 13 💬
|
| 19 | 13-PCV booster | - | - | - | - | 1件: 13 13 💬
|
| 20 | 18F-DPA-714 and 18F-FDG | - | - | - | - | 1件: 13 13 💬
|
| 21 | 18F-OP-801 | - | - | - | - | 3件: 2 2, 6, 13 💬
|
| 22 | 18F-PM-PBB3 | - | - | - | - | 1件: 13 13 💬
|
| 23 | 19 NOR vitamin D | - | - | - | - | 1件: 13 13 💬
|
| 24 | 2 - excipients | - | - | - | - | 1件: 13 13 💬
|
| 25 | 2 MA transcranial direct current stimulation | - | - | - | - | 1件: 13 13 💬
|
| 26 | 2-(2-(2-amino-9H-purin-9-YL)ethyl)-1,3-propanediol diacetate ester | 1件: Famciclovir Famciclovir | 1件: Famciclovir
Famciclovir
💬
| - | - | 1件: 13 13 💬
|
| 27 | 2-CDA | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 28 | 2-CDA, 2-chloro-2'-deoxy-ß-D-adenosine | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 29 | 2-CDA, 2-chloro-2?-deoxy-ß-D-adenosine | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 30 | 2-CDA, 2-chloro-2’-deoxy-ß-D-adenosine | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 31 | 2-chloro-2'-deoxyadenosine, 2CDA | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 32 | 2-chloro-2?-deoxy-ß-D-adenosine | - | - | - | - | 1件: 13 13 💬
|
| 33 | 2-chloro-2’-deoxy-ß-D-adenosine | - | - | - | - | 1件: 13 13 💬
|
| 34 | 20 MG GA | - | - | - | - | 1件: 13 13 💬
|
| 35 | 20 MG mitoq | - | - | - | - | 1件: 13 13 💬
|
| 36 | 200106 or EMD 28162 | - | - | - | - | 1件: 13 13 💬
|
| 37 | 20MG/0.5ML GA | - | - | - | - | 1件: 13 13 💬
|
| 38 | 20MG/0.5ML glatiramer acetate | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 39 | 23-PPV | - | - | - | - | 1件: 13 13 💬
|
| 40 | 23-valent pneumococcal polysaccharide vaccine | - | - | - | - | 3件: 13 13, 46, 53 💬
|
| 41 | 25(OH)D3 | - | - | - | - | 1件: 13 13 💬
|
| 42 | 25OH-vitamin D | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 13 13 💬
|
| 43 | 2b3-201 | - | - | - | - | 1件: 13 13 💬
|
| 44 | 3 MG melatonin | - | - | - | - | 1件: 13 13 💬
|
| 45 | 3,4-diaminopyridine | - | - | - | - | 2件: 12 12, 13 💬
|
| 46 | 4 MA transcranial direct current stimulation | - | - | - | - | 1件: 13 13 💬
|
| 47 | 4-aminopyridine | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 3 3, 13 💬
|
| 48 | 4-AP | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
| 49 | 4.5 MG naltrexone | 1件: Naltrexone Naltrexone | 2件: Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| 3件: OPRD1 OPRD1,
OPRK1,
OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 13 13 💬
|
| 50 | 40 MG GA | - | - | - | - | 2件: 2 2, 13 💬
|
| 51 | 40 MG glatiramer acetate | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 2件: 2 2, 13 💬
|
| 52 | 40 MG glatiramer acetato | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 53 | 40MG OF mitoq | - | - | - | - | 1件: 13 13 💬
|
| 54 | 5 MG melatonin | - | - | - | - | 1件: 13 13 💬
|
| 55 | 5000IU vitamin D | - | - | - | - | 1件: 13 13 💬
|
| 56 | 52069.00.01 | - | - | - | - | 1件: 13 13 💬
|
| 57 | 6 months weight resistance and balance program | - | - | - | - | 1件: 13 13 💬
|
| 58 | 89 ZR-DF-crefmirlimab | - | - | - | - | 2件: 13 13, 25 💬
|
| 59 | 9060X | - | - | - | - | 2件: 13 13, 149 💬
|
| 60 | 95% pure ecgc capsules 200MG | - | - | - | - | 1件: 13 13 💬
|
| 61 | A4I antagonist | - | - | - | - | 1件: 13 13 💬
|
| 62 | AB1010 | - | - | - | - | 6件: 2 2, 5, 6, 13, 46, 96 💬
|
| 63 | ABA-101 | - | - | - | - | 1件: 13 13 💬
|
| 64 | Abatacept | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80,
CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 26件: 2 2, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
|
| 65 | Abobotulinumtoxin A | - | - | - | - | 1件: 13 13 💬
|
| 66 | ABP 692 | - | - | - | - | 1件: 13 13 💬
|
| 67 | ABR-215062 | - | - | - | - | 1件: 13 13 💬
|
| 68 | ABR-215062 sodium salt | - | - | - | - | 2件: 13 13, 96 💬
|
| 69 | ABT-555 | - | - | - | - | 1件: 13 13 💬
|
| 70 | ABT-874/human monoclonal antibody against IL-12 | - | - | - | - | 1件: 13 13 💬
|
| 71 | ABX-1431 HCL | 1件: ABX-1431 ABX-1431 | - | - | - | 1件: 13 13 💬
|
| 72 | Acetaminophen tablet 650MG | 1件: Acetaminophen Acetaminophen | 1件: Acetaminophen
Acetaminophen
💬
| 2件: PTGS1 PTGS1,
PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 💬
|
| 73 | Acetazolamide | 1件: Acetazolamide Acetazolamide | 2件: Acetazolamide
Acetazolamide
,
Acetazolamide sodium
💬
| 13件: CA CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA,
CA2,
CA4 💬
| 6件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 5件: 13 13, 90, 115, 155, 230 💬
|
| 74 | Acetylsalicylic acid | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: Aspirin
Aspirin
💬
| 2件: PTGS1 PTGS1,
PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 4件: 13 13, 46, 51, 210 💬
|
| 75 | Aciclovir | 1件: Acyclovir Acyclovir | 2件: Acyclovir
Acyclovir
,
Acyclovir sodium
💬
| - | - | 3件: 13 13, 28, 60 💬
|
| 76 | Aclasta 5 MG infusionslösung | 1件: Zoledronic acid Zoledronic acid | 5件: Zoledronic acid
Zoledronic acid
,
Zoledronate disodium
,
Zoledronate trisodium
,
Zoledronic acid
,
Zoledronic acid hemipentahydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬
|
| 77 | Aclasta 5MG solution FOR infusion | - | - | - | - | 1件: 13 13 💬
|
| 78 | ACT | - | - | - | - | 1件: 13 13 💬
|
| 79 | ACT-1 | - | - | - | - | 1件: 13 13 💬
|
| 80 | ACT-128800 | - | - | - | - | 1件: 13 13 💬
|
| 81 | ACT-128800 dose 1 | - | - | - | - | 1件: 13 13 💬
|
| 82 | ACT-128800 dose 2 | - | - | - | - | 1件: 13 13 💬
|
| 83 | ACT-128800 dose 3 | - | - | - | - | 1件: 13 13 💬
|
| 84 | Acth | 1件: Corticotropin Corticotropin | 2件: Corticotropin
Corticotropin
,
Corticotropin, repository
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 3件: 13 13, 145, 222 💬
|
| 85 | Acthar | 1件: Corticotropin Corticotropin | 2件: Corticotropin
Corticotropin
,
Corticotropin, repository
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 6件: 2 2, 13, 46, 49, 50, 222 💬
|
| 86 | Acthar GEL | 1件: Corticotropin Corticotropin | 2件: Corticotropin
Corticotropin
,
Corticotropin, repository
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 5件: 13 13, 46, 49, 84, 222 💬
|
| 87 | Activated charcoal | 1件: Activated charcoal Activated charcoal | 1件: Charcoal, activated
Charcoal, activated
💬
| - | - | 2件: 13 13, 85 💬
|
| 88 | Active control | - | - | - | - | 1件: 13 13 💬
|
| 89 | Acyclovir | 1件: Acyclovir Acyclovir | 2件: Acyclovir
Acyclovir
,
Acyclovir sodium
💬
| - | - | 2件: 13 13, 28 💬
|
| 90 | AD26.COV2.S | - | - | - | - | 7件: 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 91 | Adderall XR | - | - | - | - | 1件: 13 13 💬
|
| 92 | Adderall XR 10 MG | - | - | - | - | 1件: 13 13 💬
|
| 93 | Adderall XR 5MG | - | - | - | - | 1件: 13 13 💬
|
| 94 | Adenosine | 1件: Adenosine Adenosine | 1件: Adenosine
Adenosine
💬
| 4件: ADORA1 ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬
| 13件: Alcoholism Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 13 13, 58, 65 💬
|
| 95 | Adezunap | - | - | - | - | 1件: 13 13 💬
|
| 96 | Adherence counseling | - | - | - | - | 1件: 13 13 💬
|
| 97 | Adipose tissue-derived mesenchymal stromal cells | - | - | - | - | 1件: 13 13 💬
|
| 98 | Adrenocorticotropic hormone | 1件: Corticotropin Corticotropin | 2件: Corticotropin
Corticotropin
,
Corticotropin, repository
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 2件: 13 13, 84 💬
|
| 99 | ADS-5102 | - | - | - | - | 2件: 6 6, 13 💬
|
| 100 | ADS-5102, 137 MG | - | - | - | - | 1件: 13 13 💬
|
| 101 | ADS-5102, 274 MG | - | - | - | - | 1件: 13 13 💬
|
| 102 | Aerobic training | - | - | - | - | 1件: 13 13 💬
|
| 103 | Aert, (R)-baclofen | - | - | - | - | 1件: 13 13 💬
|
| 104 | Agee cream | - | - | - | - | 1件: 13 13 💬
|
| 105 | Ahsc | - | - | - | - | 1件: 13 13 💬
|
| 106 | Aimspro | - | - | - | - | 2件: 13 13, 51 💬
|
| 107 | AIN | - | - | - | - | 1件: 13 13 💬
|
| 108 | AIN457 | - | - | - | - | 9件: 13 13, 37, 41, 46, 56, 96, 97, 107, 271 💬
|
| 109 | Albuterol | 1件: Albuterol Albuterol | 2件: Albuterol sulfate
Albuterol sulfate
,
Albuterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 12 12, 13, 86, 113, 231, 256, 299, 340 💬
|
| 110 | Alcohol wipes VS. NO alcohol wipes | 1件: Ethanol Ethanol | 3件: Alcohol
Alcohol
,
Isopropanol and methylated alcohol
,
Ethanol
💬
| - | - | 1件: 13 13 💬
|
| 111 | Alemtuzumab | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 18件: 13 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 65, 85, 96, 107, 283, 284, 285, 326 💬
|
| 112 | Alemtuzumab 12 MG | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 13 13 💬
|
| 113 | Alemtuzumab 24 MG | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 13 13 💬
|
| 114 | Alemtuzumab GZ402673 | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 13 13 💬
|
| 115 | Alemtuzumab immunotherapy | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 13 13 💬
|
| 116 | Alemtuzumab injection | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 13 13 💬
|
| 117 | Alfuzosin | 1件: Alfuzosin Alfuzosin | 2件: Alfuzosin hydrochloride
Alfuzosin hydrochloride
,
Alfuzosin
💬
| 1件: ADRA1A ADRA1A 💬
| 9件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 13 13 💬
|
| 118 | Alks 8700 | - | - | - | - | 1件: 13 13 💬
|
| 119 | Alks 8700 delayed release (DR) capsule | - | - | - | - | 1件: 13 13 💬
|
| 120 | ALL patients IN THE study will BE treated with ocrelizumab | - | - | - | - | 1件: 13 13 💬
|
| 121 | Allogeneic fecal microbiota | - | - | - | - | 1件: 13 13 💬
|
| 122 | Allogeneic human umbilical cord tissue-derived mesenchymal stem cells | - | - | - | - | 1件: 13 13 💬
|
| 123 | Allogeneic umbilical cord mesenchymal stem cells | 1件: Allogeneic umbilical cord mesenchymal stem cells Allogeneic umbilical cord mesenchymal stem cells | - | - | - | 1件: 13 13 💬
|
| 124 | Allogenic placenta derived mesenchymal stem cells | - | - | - | - | 1件: 13 13 💬
|
| 125 | Allorx | - | - | - | - | 8件: 2 2, 13, 46, 51, 85, 90, 97, 226 💬
|
| 126 | Alpha lipoic acid | - | - | - | - | 1件: 13 13 💬
|
| 127 | Alpha-lipoic acid | - | - | - | - | 2件: 2 2, 13 💬
|
| 128 | Alpha1-antitrypsin | - | - | - | - | 1件: 13 13 💬
|
| 129 | Altri farmaci DEL sistema nervoso | - | - | - | - | 1件: 13 13 💬
|
| 130 | ALXN1210 | - | - | - | - | 7件: 2 2, 11, 13, 50, 62, 66, 109 💬
|
| 131 | Amantadine | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 4件: 6 6, 8, 13, 127 💬
|
| 132 | Amantadine hydrochloride | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 6 6, 13 💬
|
| 133 | Amantadine hydrochloride 100 MG (milligrams) oral capsule | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 134 | Amantadine level | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 135 | American ginseng extract HT-1001 | 1件: Panax quinquefolius whole Panax quinquefolius whole | - | - | - | 1件: 13 13 💬
|
| 136 | Amiloride | 1件: Amiloride Amiloride | 2件: Amiloride hydrochloride
Amiloride hydrochloride
,
Amiloride
💬
| 3件: SCNN1A SCNN1A,
SCNN1B,
SCNN1G 💬
| 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 4件: 13 13, 67, 225, 299 💬
|
| 137 | Amiloride hydrochloride | 1件: Amiloride Amiloride | 2件: Amiloride hydrochloride
Amiloride hydrochloride
,
Amiloride
💬
| 3件: SCNN1A SCNN1A,
SCNN1B,
SCNN1G 💬
| 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 13 13 💬
|
| 138 | Amiloride hydrochloride, 2 H2O | 1件: Amiloride Amiloride | 2件: Amiloride hydrochloride
Amiloride hydrochloride
,
Amiloride
💬
| 3件: SCNN1A SCNN1A,
SCNN1B,
SCNN1G 💬
| 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 13 13 💬
|
| 139 | Amilostad HCT tablets | - | - | - | - | 1件: 13 13 💬
|
| 140 | Amniotic fluid or placental CD117 stem cells | - | - | - | - | 1件: 13 13 💬
|
| 141 | Ampyra | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
| 142 | Amyvid radiopharmaceutical | - | - | - | - | 1件: 13 13 💬
|
| 143 | AN100226 | - | - | - | - | 2件: 13 13, 96 💬
|
| 144 | AN100226, BG00002 | - | - | - | - | 1件: 13 13 💬
|
| 145 | Anakinra | 1件: Anakinra Anakinra | 1件: Anakinra
Anakinra
💬
| 2件: IL1R1 IL1R1,
IL1R2 💬
| 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 19件: 2 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬
|
| 146 | Androgel 1 % topical GEL | - | - | - | - | 1件: 13 13 💬
|
| 147 | Androgel 10 grams OF GEL containing 100 MG OF testosterone | 1件: Testosterone Testosterone | 1件: Testosterone
Testosterone
💬
| 1件: AR AR 💬
| 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 13 13 💬
|
| 148 | Andrographolides | - | - | - | - | 1件: 13 13 💬
|
| 149 | Anesthetic topical adhesive synera | - | - | - | - | 1件: 13 13 💬
|
| 150 | ANK-700 | - | - | - | - | 1件: 13 13 💬
|
| 151 | Anti LP40 antibody, subclass IGG4 LA294 | - | - | - | - | 2件: 13 13, 46 💬
|
| 152 | ANTI-aquaporin-4 antibody | - | - | - | - | 1件: 13 13 💬
|
| 153 | ANTI-baffr cart | - | - | - | - | 1件: 13 13 💬
|
| 154 | ANTI-CD20 antibody | - | - | - | - | 2件: 13 13, 64 💬
|
| 155 | ANTI-CD20 MAB | - | - | - | - | 1件: 13 13 💬
|
| 156 | ANTI-CD20 monoclonal antibody | - | - | - | - | 1件: 13 13 💬
|
| 157 | ANTI-CD20 MS treatment | - | - | - | - | 1件: 13 13 💬
|
| 158 | ANTI-CD25 humanized monoclonal antibody | - | - | - | - | 1件: 13 13 💬
|
| 159 | ANTI-CD52 monoclonal antibody | - | - | - | - | 1件: 13 13 💬
|
| 160 | ANTI-mullerian hormone (AMH) level | - | - | - | - | 1件: 13 13 💬
|
| 161 | ANTI-myelin oligodendrocyte glycoprotein | - | - | - | - | 1件: 13 13 💬
|
| 162 | ANTI-thymocyte globulin | - | - | - | - | 18件: 11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬
|
| 163 | Anticholinergic medication | - | - | - | - | 1件: 13 13 💬
|
| 164 | Anticuerpo monoclonal ANTI-lingo-1 humano | - | - | - | - | 1件: 13 13 💬
|
| 165 | Antihistamine | - | - | - | - | 3件: 13 13, 19, 46 💬
|
| 166 | Antimycotic | - | - | - | - | 1件: 13 13 💬
|
| 167 | Antithymocyte | - | - | - | - | 1件: 13 13 💬
|
| 168 | Antithymocyte immunoglobulin | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | 1件: Anti-human thymocyte immunoglobulin, rabbit
Anti-human thymocyte immunoglobulin, rabbit
💬
| 11件: CD2 CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬
| 31件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 2件: 13 13, 96 💬
|
| 169 | Anxiety | - | - | - | - | 1件: 13 13 💬
|
| 170 | Anxiety/depression and work and activities | - | - | - | - | 1件: 13 13 💬
|
| 171 | Apitox - pure honeybee toxin | - | - | - | - | 1件: 13 13 💬
|
| 172 | Arbaclofen | 1件: Arbaclofen Arbaclofen | 1件: Arbaclofen
Arbaclofen
💬
| 2件: GABBR GABBR,
GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 2件: 13 13, 206 💬
|
| 173 | Arbaclofen ER tablets | 1件: Arbaclofen Arbaclofen | 1件: Arbaclofen
Arbaclofen
💬
| 2件: GABBR GABBR,
GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 174 | Arbaclofen extended release tablets | 1件: Arbaclofen Arbaclofen | 1件: Arbaclofen
Arbaclofen
💬
| 2件: GABBR GABBR,
GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 175 | Arbaclofen placarbil | 2件: Arbaclofen Arbaclofen,
Arbaclofen Placarbil | 2件: Arbaclofen placarbil
Arbaclofen placarbil
,
Arbaclofen
💬
| 2件: GABBR GABBR,
GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 176 | Arbaclofen placarbil 15 MG BID | 2件: Arbaclofen Arbaclofen,
Arbaclofen Placarbil | 2件: Arbaclofen placarbil
Arbaclofen placarbil
,
Arbaclofen
💬
| 2件: GABBR GABBR,
GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 177 | Arbaclofen placarbil 30 MG BID | 2件: Arbaclofen Arbaclofen,
Arbaclofen Placarbil | 2件: Arbaclofen placarbil
Arbaclofen placarbil
,
Arbaclofen
💬
| 2件: GABBR GABBR,
GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 178 | Arbaclofen placarbil 45 MG BID | 2件: Arbaclofen Arbaclofen,
Arbaclofen Placarbil | 2件: Arbaclofen placarbil
Arbaclofen placarbil
,
Arbaclofen
💬
| 2件: GABBR GABBR,
GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 179 | Aricept | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 3件: 6 6, 13, 124 💬
|
| 180 | Aricept 10 MG filmdragerade tabletter | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 13 13 💬
|
| 181 | Aricept 5 MG filmdragerade tabletter | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 13 13 💬
|
| 182 | ARM 1 - GEH120714 (18F) injection | - | - | - | - | 1件: 13 13 💬
|
| 183 | Armodafinil | 1件: Armodafinil Armodafinil | 1件: Armodafinil
Armodafinil
💬
| 1件: SLC6A3 SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 3件: 6 6, 13, 84 💬
|
| 184 | ARN-6039 | - | - | - | - | 1件: 13 13 💬
|
| 185 | Arzerra | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 186 | Arzerra - 100 MG - concentrato PER soluzione PER infusione - USO endovenoso - flacone(vetro) - 5 ML(20MG/ML) 3 flaconi | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 187 | Arzerra - 1000 MG - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino (vetro) - 50 ML (20 MG/ML) 1 flaconcino + 2 KIT DI prolunga | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 188 | ASA | - | - | - | - | 1件: 13 13 💬
|
| 189 | ASB-683699 | - | - | - | - | 1件: 13 13 💬
|
| 190 | Aspirin | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: Aspirin
Aspirin
💬
| 2件: PTGS1 PTGS1,
PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 12件: 13 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231, 271 💬
|
| 191 | Aspirin 650MG oral capsule | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: Aspirin
Aspirin
💬
| 2件: PTGS1 PTGS1,
PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 💬
|
| 192 | Assessment OF disability | - | - | - | - | 1件: 13 13 💬
|
| 193 | Assessment OF impact OF MS ON cognition | - | - | - | - | 1件: 13 13 💬
|
| 194 | AT-home natalizumab treated MS patient | - | - | - | - | 1件: 13 13 💬
|
| 195 | ATA188 | - | - | - | - | 1件: 13 13 💬
|
| 196 | Atacicept | 1件: Atacicept Atacicept | 1件: Atacicept
Atacicept
💬
| 2件: TNFSF13 TNFSF13,
TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 5件: 13 13, 46, 49, 66, 222 💬
|
| 197 | Atacicept 150 MG | 1件: Atacicept Atacicept | 1件: Atacicept
Atacicept
💬
| 2件: TNFSF13 TNFSF13,
TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 3件: 13 13, 49, 66 💬
|
| 198 | Atacicept 25 MG | 1件: Atacicept Atacicept | 1件: Atacicept
Atacicept
💬
| 2件: TNFSF13 TNFSF13,
TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 2件: 13 13, 66 💬
|
| 199 | Atacicept 75 MG | 1件: Atacicept Atacicept | 1件: Atacicept
Atacicept
💬
| 2件: TNFSF13 TNFSF13,
TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 3件: 13 13, 49, 66 💬
|
| 200 | ATG | - | - | - | - | 6件: 13 13, 19, 60, 96, 222, 285 💬
|
| 201 | ATL1102 | 1件: ATL1102 ATL1102 | - | - | - | 2件: 13 13, 113 💬
|
| 202 | Atomoxetine | 1件: Atomoxetine Atomoxetine | 2件: Atomoxetine hydrochloride
Atomoxetine hydrochloride
,
Atomoxetine
💬
| 1件: SLC6A2 SLC6A2 💬
| 2件: Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle 💬 | 3件: 6 6, 8, 13 💬
|
| 203 | Atorvastatin | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 17件: 13 13, 22, 46, 49, 51, 58, 79, 84, 88, 93, 96, 97, 160, 225, 271, 297, 299 💬
|
| 204 | ATX-MS-1467 | - | - | - | - | 1件: 13 13 💬
|
| 205 | Aubagio | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 206 | Aubagio - 14 MG - compressa rivestita CON film - USO orale - bister (ALU/ALU) perforato monodose - 10 X 1 compressa | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 207 | Aubagio - 14 MG - compressa rivestita CON film - USO orale - blister (ALU/ALU) - 28 compresse | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 208 | Aubagio 14 MG FILM-coated tablets | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 209 | Aubagio 14MG TBL FLM | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 210 | Autologous adipose derived mesenchymal cells | - | - | - | - | 1件: 13 13 💬
|
| 211 | Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved | - | - | - | - | 1件: 13 13 💬
|
| 212 | Autologous bone marrow transplantation | - | - | - | - | 2件: 13 13, 28 💬
|
| 213 | Autologous bone marrow-derived mononuclear stem cells | - | - | - | - | 1件: 13 13 💬
|
| 214 | Autologous CD4+T cells stimulated and expanded EX vivo BY A MOG peptide modified BY THE introduction OF A thioreductase motif into THE flanking residues OF THE T cell epitope | - | - | - | - | 1件: 13 13 💬
|
| 215 | Autologous HB-admscs | - | - | - | - | 1件: 13 13 💬
|
| 216 | Autologous hematopoietic stem cell | - | - | - | - | 1件: 13 13 💬
|
| 217 | Autologous hematopoietic stem cell transplant | - | - | - | - | 1件: 13 13 💬
|
| 218 | Autologous hematopoietic stem cell transplantation | - | - | - | - | 7件: 11 11, 13, 14, 28, 49, 51, 84 💬
|
| 219 | Autologous hematopoietic stem cells | - | - | - | - | 1件: 13 13 💬
|
| 220 | Autologous mesenchymal cell product | - | - | - | - | 1件: 13 13 💬
|
| 221 | Autologous mesenchymal stem cell transplantation | - | - | - | - | 1件: 13 13 💬
|
| 222 | Autologous mesenchymal stem cells | - | - | - | - | 5件: 2 2, 6, 13, 17, 46 💬
|
| 223 | Autologous myelin-derived peptide-pulsed tolerogenic dendritic cells | - | - | - | - | 1件: 13 13 💬
|
| 224 | Autologous stem cell transplantation | - | - | - | - | 4件: 13 13, 28, 56, 96 💬
|
| 225 | Autologous stem cells | - | - | - | - | 2件: 13 13, 51 💬
|
| 226 | Autologous T-lymphocytes | - | - | - | - | 1件: 13 13 💬
|
| 227 | AV605 | - | - | - | - | 1件: 13 13 💬
|
| 228 | Avonex | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 2件: 13 13, 97 💬
|
| 229 | Avonex (interferon BETA-1A), biogen idec LTD | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 230 | Avonex - 30 MCG (6 milioni UI) polvere E solvente PER soluzione iniettabile 4 flaconi CON dispositivo bioset + 4 siringhe preriempite USO intramuscolare | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 231 | Avonex 30 microgram/0.5 ML solution FOR injection | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 232 | Avonex 30 microgramos/0,5 ML (interferóN beta - 1A) solucióN inyectable | - | - | - | - | 1件: 13 13 💬
|
| 233 | Avonex 30 microgramos/0.5 ML solucióN para inyeccióN | - | - | - | - | 1件: 13 13 💬
|
| 234 | Avonex 30 µG/0,5 ML solution FOR injection | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 235 | Avonex and topamax | - | - | - | - | 1件: 13 13 💬
|
| 236 | Avonex IM 4SIR 30MCG/0,5ML 4AG | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 237 | Avonex prefilled syringe VIA manual IM injection | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 238 | Avonex*IM 4SIR 30MCG/0,5ML+4AG | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 239 | Avonex/betaseron/copaxone/rebif | - | - | - | - | 1件: 13 13 💬
|
| 240 | Avonex/zocor | - | - | - | - | 1件: 13 13 💬
|
| 241 | AVP-923 | - | - | - | - | 3件: 2 2, 6, 13 💬
|
| 242 | Azathioprine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 22件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 63, 65, 66, 84, 85, 94, 95, 96, 97, 162 💬
|
| 243 | Azatioprina HEX. 50CPR 50MG BL | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 13 13 💬
|
| 244 | Azithromycin | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 6件: 13 13, 84, 85, 96, 228, 299 💬
|
| 245 | B001 | - | - | - | - | 1件: 13 13 💬
|
| 246 | B001 injection | - | - | - | - | 1件: 13 13 💬
|
| 247 | Bacille calmette-guerin vaccine | - | - | - | - | 1件: 13 13 💬
|
| 248 | Bacille OF calmette-guerin | - | - | - | - | 1件: 13 13 💬
|
| 249 | Baclofen | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR,
GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 7件: 2 2, 10, 13, 18, 65, 149, 206 💬
|
| 250 | Baclofen 20 MG | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR,
GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 251 | Baclofen ER capsules (GRS) 10 MG | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR,
GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 252 | Baclofen ER capsules (GRS) 20 MG | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR,
GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 253 | Baclofen ER capsules (GRS) 30MG | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR,
GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 254 | Baclofen ER capsules (GRS) 40MG | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR,
GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 255 | Baclofen ER capsules (GRS) 50 MG | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR,
GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 256 | Baclofen IR | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR,
GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 257 | Baclofen tablets USP 10 MG | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR,
GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 258 | BAF312 | - | - | - | - | 2件: 13 13, 50 💬
|
| 259 | BAF312 0,25 MG tablet | - | - | - | - | 1件: 13 13 💬
|
| 260 | BAF312 1 MG tablet | - | - | - | - | 2件: 13 13, 50 💬
|
| 261 | BAF312 4 MG tablet | - | - | - | - | 1件: 13 13 💬
|
| 262 | BAF312 hemifumarate | - | - | - | - | 2件: 13 13, 50 💬
|
| 263 | BAF312A | - | - | - | - | 1件: 13 13 💬
|
| 264 | Bafiertam | - | - | - | - | 1件: 13 13 💬
|
| 265 | BAL | - | - | - | - | 1件: 13 13 💬
|
| 266 | Balance exercise program using exoskeleton device | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 13 13 💬
|
| 267 | Balance exercises | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 13 13 💬
|
| 268 | Balance exercises with stroboscopic glasses | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 13 13 💬
|
| 269 | Balance exercises with virtual reality glasses | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 13 13 💬
|
| 270 | Balance exercises with visual-based metaphor training | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 13 13 💬
|
| 271 | Balance platform therapy | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 13 13 💬
|
| 272 | Balance targeted exercises | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 13 13 💬
|
| 273 | Balance trainer balance exercises | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 13 13 💬
|
| 274 | Balance training | 1件: Isoxaflutole Isoxaflutole | - | - | - | 2件: 6 6, 13 💬
|
| 275 | Baminercept | 1件: Baminercept Baminercept | 1件: Baminercept
Baminercept
💬
| 1件: LTB LTB 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 3件: 13 13, 53, 97 💬
|
| 276 | Baricitinib | 1件: Baricitinib Baricitinib | 1件: Baricitinib
Baricitinib
💬
| 2件: JAK1 JAK1,
JAK2 💬
| 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 19件: 2 2, 13, 41, 46, 49, 50, 51, 53, 54, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
|
| 277 | Baseline treatment | - | - | - | - | 1件: 13 13 💬
|
| 278 | BAT4406F | - | - | - | - | 1件: 13 13 💬
|
| 279 | BAT4406F injection | - | - | - | - | 1件: 13 13 💬
|
| 280 | BAY 79-4998 | - | - | - | - | 1件: 13 13 💬
|
| 281 | BAY86-5046 | - | - | - | - | 1件: 13 13 💬
|
| 282 | BAY86-5046_interferon-BETA-1B | - | - | - | - | 1件: 13 13 💬
|
| 283 | Bazedoxifene acetate | 1件: Bazedoxifene Bazedoxifene | 1件: Bazedoxifene acetate
Bazedoxifene acetate
💬
| 2件: ESR1 ESR1,
ESR2 💬
| 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 13 13 💬
|
| 284 | BBR 2778 | - | - | - | - | 2件: 11 11, 13 💬
|
| 285 | BCD-054 180 MCG | - | - | - | - | 1件: 13 13 💬
|
| 286 | BCD-054 240 MCG | - | - | - | - | 1件: 13 13 💬
|
| 287 | BCD-063 | - | - | - | - | 1件: 13 13 💬
|
| 288 | BCD-132 | - | - | - | - | 1件: 13 13 💬
|
| 289 | BCD-132, 125 MG | - | - | - | - | 1件: 13 13 💬
|
| 290 | BCD-132, 500 MG | - | - | - | - | 1件: 13 13 💬
|
| 291 | BCG20-0134 | - | - | - | - | 1件: 13 13 💬
|
| 292 | Beam regimen | - | - | - | - | 1件: 13 13 💬
|
| 293 | Beetainterferoni -1A | - | - | - | - | 1件: 13 13 💬
|
| 294 | Belimumab | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 13件: 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 95, 222, 296 💬
|
| 295 | Berg balance scale | - | - | - | - | 4件: 6 6, 13, 113, 149 💬
|
| 296 | BETA-1B interferoni | - | - | - | - | 1件: 13 13 💬
|
| 297 | BETA-alanine | 1件: beta-Alanine beta-Alanine | 1件: beta-Alanine
beta-Alanine
💬
| - | - | 1件: 13 13 💬
|
| 298 | BETA-alanine supplementation | 1件: beta-Alanine beta-Alanine | 1件: beta-Alanine
beta-Alanine
💬
| - | - | 1件: 13 13 💬
|
| 299 | BETA-carotene | 1件: Beta carotene Beta carotene | 1件: beta Carotene
beta Carotene
💬
| - | - | 1件: 13 13 💬
|
| 300 | BETA-interferon | - | - | - | - | 1件: 13 13 💬
|
| 301 | Betacarotene | 1件: Beta carotene Beta carotene | 1件: beta Carotene
beta Carotene
💬
| - | - | 1件: 13 13 💬
|
| 302 | Betaconnect | - | - | - | - | 1件: 13 13 💬
|
| 303 | Betaconnect AUTO-injector | - | - | - | - | 1件: 13 13 💬
|
| 304 | Betaconnect autoinjector | - | - | - | - | 1件: 13 13 💬
|
| 305 | Betaconnect device | - | - | - | - | 1件: 13 13 💬
|
| 306 | Betaferon | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 307 | Betaferon - 15 flaconcini 0.25 MG + 15 flaconcini 2 ML | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 308 | Betaferon 250 MCG | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 309 | Betaferon 250 microgram/ML | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 310 | Betaferon 250 microgram/ML, powder and solvent FOR solution FOR injection | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 311 | Betaferon 250 microgramos | - | - | - | - | 1件: 13 13 💬
|
| 312 | Betaferon 250MCG | - | - | - | - | 1件: 13 13 💬
|
| 313 | Betaferon 250µG | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 314 | Betaferon 500 MCG | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 315 | Betaferon 500 µG | - | - | - | - | 1件: 13 13 💬
|
| 316 | Betaferon 500MCG | - | - | - | - | 1件: 13 13 💬
|
| 317 | Betaferon 500µG | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 318 | Betaferon SC 15F 0,25MG 15SIR | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 319 | Betaferon, BAY86-5046 | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 320 | Betaferon/betaseron | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 321 | Betaseron | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 322 | Betaseron (interferon BETA-1B, BAY86-5046), bayer healthcare AG | 2件: Human interferon beta Human interferon beta,
Interferon beta-1b | 2件: Interferon beta-1b
Interferon beta-1b
,
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 323 | Bevacizumab | 1件: Bevacizumab Bevacizumab | 1件: Bevacizumab
Bevacizumab
💬
| 1件: VEGFA VEGFA 💬
| 23件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 8件: 13 13, 34, 85, 87, 89, 227, 280, 331 💬
|
| 324 | Bexarotene | 1件: Bexarotene Bexarotene | 1件: Bexarotene
Bexarotene
💬
| 3件: RXRA RXRA,
RXRB,
RXRG 💬
| 18件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Efferocytosis, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬 | 2件: 13 13, 75 💬
|
| 325 | Bexsero | - | - | - | - | 4件: 11 11, 13, 62, 222 💬
|
| 326 | BG-12 120 | - | - | - | - | 1件: 13 13 💬
|
| 327 | BG00002 | - | - | - | - | 1件: 13 13 💬
|
| 328 | BG00012 | - | - | - | - | 2件: 13 13, 46 💬
|
| 329 | BG9418 | - | - | - | - | 1件: 13 13 💬
|
| 330 | BGC20-0134 | - | - | - | - | 1件: 13 13 💬
|
| 331 | BGG492 | - | - | - | - | 1件: 13 13 💬
|
| 332 | BHT-3009 | - | - | - | - | 1件: 13 13 💬
|
| 333 | BHT-3009 0.5 MG | - | - | - | - | 1件: 13 13 💬
|
| 334 | BHT-3009 1.5 MG | - | - | - | - | 1件: 13 13 💬
|
| 335 | BHT-3009-01 | - | - | - | - | 1件: 13 13 💬
|
| 336 | BIIB017 | - | - | - | - | 1件: 13 13 💬
|
| 337 | BIIB017 (peginterferon BETA-1A) autoinjector | 1件: Peginterferon beta-1a Peginterferon beta-1a | 1件: Peginterferon beta-1a
Peginterferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 338 | BIIB019 | - | - | - | - | 1件: 13 13 💬
|
| 339 | BIIB033 | - | - | - | - | 1件: 13 13 💬
|
| 340 | BIIB033 (ANTI-lingo) - EV substance code SUB118957 | - | - | - | - | 1件: 13 13 💬
|
| 341 | BIIB041 | - | - | - | - | 1件: 13 13 💬
|
| 342 | BIIB061 | - | - | - | - | 1件: 13 13 💬
|
| 343 | BIIB091 | - | - | - | - | 1件: 13 13 💬
|
| 344 | BIIB133 | - | - | - | - | 1件: 13 13 💬
|
| 345 | Biobanking with genetic analysis | - | - | - | - | 3件: 13 13, 51, 56 💬
|
| 346 | Biological samples | - | - | - | - | 2件: 13 13, 206 💬
|
| 347 | Biospecimen collection | - | - | - | - | 18件: 13 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
|
| 348 | Biotin | 1件: Biotin Biotin | 1件: Biotin
Biotin
💬
| - | - | 3件: 2 2, 8, 13 💬
|
| 349 | Birt 2584 XX | - | - | - | - | 1件: 13 13 💬
|
| 350 | Birt 2584XX | - | - | - | - | 1件: 13 13 💬
|
| 351 | Bisacodyl | 1件: Bisacodyl Bisacodyl | 1件: Bisacodyl
Bisacodyl
💬
| - | - | 2件: 13 13, 97 💬
|
| 352 | Blood sample | - | - | - | - | 28件: 2 2, 3, 8, 13, 34, 46, 49, 51, 53, 61, 65, 66, 67, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 280, 288, 294, 299 💬
|
| 353 | Blood samples | - | - | - | - | 12件: 13 13, 41, 46, 51, 61, 96, 97, 167, 227, 240, 271, 280 💬
|
| 354 | Blood sampling | - | - | - | - | 9件: 13 13, 17, 46, 49, 51, 96, 98, 106, 162 💬
|
| 355 | Blood tests | - | - | - | - | 3件: 13 13, 46, 263 💬
|
| 356 | Bmmnc | - | - | - | - | 1件: 13 13 💬
|
| 357 | BMS-986368 | - | - | - | - | 1件: 13 13 💬
|
| 358 | BMS-986374 | - | - | - | - | 1件: 13 13 💬
|
| 359 | BNT162 | - | - | - | - | 1件: 13 13 💬
|
| 360 | BNT162b2, bivalent | - | - | - | - | 7件: 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 361 | Bodybio balance OIL | - | - | - | - | 1件: 13 13 💬
|
| 362 | Bodybio PC | - | - | - | - | 1件: 13 13 💬
|
| 363 | Bone marrow autologous mesenchymal stem cells transplantation | - | - | - | - | 1件: 13 13 💬
|
| 364 | Borage OIL 20% GLA | 1件: Borage oil Borage oil | - | - | - | 1件: 13 13 💬
|
| 365 | Bortezomib | 2件: Bortezomib Bortezomib,
Bortezomib D-mannitol | 1件: Bortezomib
Bortezomib
💬
| 1件: PSMB5 PSMB5 💬
| 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 16件: 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 172, 222, 228, 256, 288, 331 💬
|
| 366 | Boswelan | - | - | - | - | 1件: 13 13 💬
|
| 367 | Boswellia serrata extract PS0201BO capsules | 1件: Indian frankincense Indian frankincense | - | - | - | 1件: 13 13 💬
|
| 368 | Botox | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 5件: 6 6, 13, 36, 149, 226 💬
|
| 369 | Botox 100 UNT injection | - | - | - | - | 1件: 13 13 💬
|
| 370 | Botulinum toxin | - | - | - | - | 3件: 6 6, 13, 149 💬
|
| 371 | Botulinum toxin A | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 4件: 13 13, 51, 149, 226 💬
|
| 372 | Botulinum toxin A - haemagglutinin complex | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 373 | Botulinum toxin type A | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 11件: 2 2, 5, 6, 7, 13, 15, 17, 47, 113, 149, 171 💬
|
| 374 | Botulinum toxin type A 200U | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 375 | Botulinum toxin type A 300U | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 376 | Bouchard belgian dark chocolate probiotic napolitains, containing bifidobacterium longum | - | - | - | - | 1件: 13 13 💬
|
| 377 | Brimonidine tartrate | 1件: Brimonidine Brimonidine | 2件: Brimonidine tartrate
Brimonidine tartrate
,
Brimonidine
💬
| 3件: ADRA2A ADRA2A,
ADRA2B,
ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 13 13 💬
|
| 378 | Bryostatin 1 | 1件: Bryostatin 1 Bryostatin 1 | - | - | - | 2件: 13 13, 62 💬
|
| 379 | BX-1 | - | - | - | - | 1件: 13 13 💬
|
| 380 | C-11 ER176 radiotracer | - | - | - | - | 1件: 13 13 💬
|
| 381 | C105 | - | - | - | - | 1件: 13 13 💬
|
| 382 | C11 pittsburgh compound B | - | - | - | - | 1件: 13 13 💬
|
| 383 | Caffeine | 1件: Caffeine Caffeine | 3件: Caffeine
Caffeine
,
Caffeine hydrate
,
Caffeine citrate
💬
| 11件: ADORA1 ADORA1,
ADORA2A,
PDE1,
PDE2A,
PDE3A,
PDE3B,
PDE4,
PDE4,
PDE4,
PDE4,
PDE5 💬
| 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 2 2, 6, 13, 21, 46, 96, 97, 265 💬
|
| 384 | Calcio | 1件: Calcium Calcium | - | - | - | 3件: 13 13, 96, 97 💬
|
| 385 | Calcium and vitamin D combination | 1件: Calcium Calcium | - | - | - | 1件: 13 13 💬
|
| 386 | Calcium carbonate | 2件: Calcium Calcium,
Calcium carbonate | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | 7件: 13 13, 19, 46, 75, 96, 235, 299 💬
|
| 387 | Calcium levofolinate | 1件: Calcium Calcium | - | - | - | 1件: 13 13 💬
|
| 388 | Calculus bovis | 1件: Bos taurus gallstone Bos taurus gallstone | - | - | - | 1件: 13 13 💬
|
| 389 | Cannabidiol | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1,
CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 18件: 6 6, 8, 13, 19, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 271 💬
|
| 390 | Cannabidiol / dronabinol capsule 5 MG+2,5 MG | 2件: Cannabidiol Cannabidiol,
Dronabinol | 2件: Dronabinol
Dronabinol
,
Cannabidiol
💬
| 2件: CNR1 CNR1,
CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
| 391 | Cannabidiol capsule 5 MG | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1,
CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
| 392 | Cannabis | 1件: Medical Cannabis Medical Cannabis | 1件: Cannabis
Cannabis
💬
| - | - | 3件: 13 13, 46, 90 💬
|
| 393 | Cannabis, medical | 1件: Medical Cannabis Medical Cannabis | 1件: Cannabis
Cannabis
💬
| - | - | 5件: 2 2, 6, 13, 96, 97 💬
|
| 394 | Cannador | - | - | - | - | 1件: 13 13 💬
|
| 395 | Capacity OF muscular oxygen extraction | - | - | - | - | 1件: 13 13 💬
|
| 396 | Caprylic triglyceride | 1件: Tricaprylin Tricaprylin | 1件: Tricaprilin
Tricaprilin
💬
| - | - | 1件: 13 13 💬
|
| 397 | Carbamazepine | 1件: Carbamazepine Carbamazepine | 1件: Carbamazepine
Carbamazepine
💬
| 5件: SCN1A SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 3件: 6 6, 13, 231 💬
|
| 398 | Carbidopa | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 5件: 6 6, 13, 17, 140, 201 💬
|
| 399 | Carbone vegetale polvere | - | - | - | - | 1件: 13 13 💬
|
| 400 | Cardiopulmonary evaluation | - | - | - | - | 1件: 13 13 💬
|
| 401 | Carmustina | 1件: Carmustine Carmustine | 1件: Carmustine
Carmustine
💬
| - | - | 1件: 13 13 💬
|
| 402 | Carmustine | 1件: Carmustine Carmustine | 1件: Carmustine
Carmustine
💬
| - | - | 5件: 11 11, 13, 14, 28, 60 💬
|
| 403 | Carnosine, capsulle, 2 G/DAY, 8 weeks | 1件: Carnosine Carnosine | - | - | - | 1件: 13 13 💬
|
| 404 | Cawthorne cooksey exercises | - | - | - | - | 1件: 13 13 💬
|
| 405 | CBD | - | - | - | - | 9件: 6 6, 8, 13, 36, 140, 144, 145, 156, 158 💬
|
| 406 | CC-97540 | - | - | - | - | 4件: 11 11, 13, 49, 51 💬
|
| 407 | CCI-779 | - | - | - | - | 2件: 13 13, 46 💬
|
| 408 | CD20/BCMA-directed CAR-T cells | - | - | - | - | 3件: 11 11, 13, 49 💬
|
| 409 | CDP323 | 1件: CDP323 CDP323 | - | - | - | 1件: 13 13 💬
|
| 410 | Celecoxib | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 13件: 2 2, 3, 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
|
| 411 | Cell suspension containing dendritic cells | - | - | - | - | 1件: 13 13 💬
|
| 412 | Cellcept | 1件: Mycophenolate mofetil Mycophenolate mofetil | 2件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| 2件: IMPDH IMPDH,
IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 5件: 11 11, 13, 42, 43, 49 💬
|
| 413 | Cellular therapy with EBV specific autologous CTL infusion | - | - | - | - | 1件: 13 13 💬
|
| 414 | Ceralifimod | 1件: Ceralifimod Ceralifimod | - | - | - | 1件: 13 13 💬
|
| 415 | Ceralifmod | - | - | - | - | 1件: 13 13 💬
|
| 416 | Cerebro-spinal fluid | - | - | - | - | 1件: 13 13 💬
|
| 417 | Ceterizine | - | - | - | - | 1件: 13 13 💬
|
| 418 | Cetirizina mylan generics | 1件: Cetirizine Cetirizine | 2件: Cetirizine hydrochloride
Cetirizine hydrochloride
,
Cetirizine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 419 | Cetirizine | 1件: Cetirizine Cetirizine | 2件: Cetirizine hydrochloride
Cetirizine hydrochloride
,
Cetirizine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 3件: 13 13, 19, 35 💬
|
| 420 | Cetirizine hydrochloride | 1件: Cetirizine Cetirizine | 2件: Cetirizine hydrochloride
Cetirizine hydrochloride
,
Cetirizine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 421 | Cetrizine | - | - | - | - | 1件: 13 13 💬
|
| 422 | CGP 77116 | - | - | - | - | 1件: 13 13 💬
|
| 423 | Charcoal | - | - | - | - | 1件: 13 13 💬
|
| 424 | Cholecalciferol | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 9件: 13 13, 19, 34, 46, 49, 96, 97, 298, 299 💬
|
| 425 | Cholecalciferol, vitamin D3 | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 13 13 💬
|
| 426 | Cholestyramine | 1件: Cholestyramine Cholestyramine | 1件: Cholestyramine resin
Cholestyramine resin
💬
| - | - | 2件: 13 13, 79 💬
|
| 427 | CHR-1103 / GBR500 | - | - | - | - | 1件: 13 13 💬
|
| 428 | Cianocobalamina | 1件: Cyanocobalamin Cyanocobalamin | 5件: Cyanocobalamin
Cyanocobalamin
,
Vitamin B12
,
Cyanocobalamin Co 57
,
Cyanocobalamin Co 58
,
Cyanocobalamin Co 60
💬
| - | - | 1件: 13 13 💬
|
| 429 | CIC using lofric primo | - | - | - | - | 1件: 13 13 💬
|
| 430 | Circadin | 1件: Melatonin Melatonin | 1件: Melatonin
Melatonin
💬
| 2件: MTNR1A MTNR1A,
MTNR1B 💬
| 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 431 | Cisapride | 1件: Cisapride Cisapride | 2件: Cisapride
Cisapride
,
Cisapride
💬
| 3件: HTR2 HTR2,
HTR3,
HTR4 💬
| 8件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 432 | Citalopram | 1件: Citalopram Citalopram | 2件: Citalopram hydrobromide
Citalopram hydrobromide
,
Citalopram
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 5件: 6 6, 13, 46, 98, 127 💬
|
| 433 | Citarabina | 1件: Cytarabine Cytarabine | 2件: Cytarabine
Cytarabine
,
Cytarabine hydrochloride
💬
| - | - | 1件: 13 13 💬
|
| 434 | Citochine ED immunomodulatori | - | - | - | - | 1件: 13 13 💬
|
| 435 | CLA | - | - | - | - | 2件: 13 13, 97 💬
|
| 436 | Cladribina | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 437 | Cladribina oral | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 438 | Cladribine | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 3件: 11 11, 13, 94 💬
|
| 439 | Cladribine 10 MG oral tablet | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 440 | Cladribine 3.5 MG/KG | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 441 | Cladribine 5.25 MG/KG | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 442 | Cladribine oral tablet | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 443 | Cladribine pill | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 444 | Cladribine subcutaneous injection | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 445 | Cladribine tablet | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 446 | Cladribine tablets | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 447 | Classic, progressive endurance training | - | - | - | - | 1件: 13 13 💬
|
| 448 | Clemastine | 1件: Clemastine Clemastine | 2件: Clemastine fumarate
Clemastine fumarate
,
Clemastine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 449 | Clemastine fumarate | 1件: Clemastine Clemastine | 2件: Clemastine fumarate
Clemastine fumarate
,
Clemastine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 450 | Clemastine milstein 1 MG, tabletten | 1件: Clemastine Clemastine | 2件: Clemastine fumarate
Clemastine fumarate
,
Clemastine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 451 | Clinical and neurological evaluation | - | - | - | - | 1件: 13 13 💬
|
| 452 | Clinical assessment | - | - | - | - | 2件: 6 6, 13 💬
|
| 453 | Clinican CBD 10% OIL | - | - | - | - | 1件: 13 13 💬
|
| 454 | Clostridium botulinum toxin type A | 2件: Botulinum toxin type A Botulinum toxin type A,
Clostridium botulinum | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 455 | CLS12311 | - | - | - | - | 1件: 13 13 💬
|
| 456 | CLS12311 high | - | - | - | - | 1件: 13 13 💬
|
| 457 | CLS12311 LOW | - | - | - | - | 1件: 13 13 💬
|
| 458 | CLS12311 medium | - | - | - | - | 1件: 13 13 💬
|
| 459 | CNM-AU8 | 1件: CNM-Au8 CNM-Au8 | - | - | - | 2件: 2 2, 13 💬
|
| 460 | CNP-MS-0601 | - | - | - | - | 1件: 13 13 💬
|
| 461 | Cnto 1275 | - | - | - | - | 2件: 13 13, 96 💬
|
| 462 | CO-14 | - | - | - | - | 1件: 13 13 💬
|
| 463 | Coconut OIL | 2件: Coconut Coconut,
Coconut oil | 1件: Coconut oil
Coconut oil
💬
| - | - | 1件: 13 13 💬
|
| 464 | Coconut OIL and epigallocatechin gallate | 2件: Coconut Coconut,
Coconut oil | 1件: Coconut oil
Coconut oil
💬
| - | - | 1件: 13 13 💬
|
| 465 | Coduse balance training and step square exercises | - | - | - | - | 1件: 13 13 💬
|
| 466 | Coenzyme Q | - | - | - | - | 1件: 13 13 💬
|
| 467 | Colecalciferol | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 5件: 13 13, 46, 96, 97, 228 💬
|
| 468 | Colestiramina | 1件: Cholestyramine Cholestyramine | 1件: Cholestyramine resin
Cholestyramine resin
💬
| - | - | 1件: 13 13 💬
|
| 469 | Comirnaty konzentrat ZUR herstellung einer injektionsdispersion | - | - | - | - | 1件: 13 13 💬
|
| 470 | Complement protein C5 inhibitor | - | - | - | - | 1件: 13 13 💬
|
| 471 | Continued ocrelizumab | - | - | - | - | 1件: 13 13 💬
|
| 472 | Conventional balance training | - | - | - | - | 1件: 13 13 💬
|
| 473 | COP-1/copolymer-1 | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 474 | Copaxone | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 475 | Copaxone - 20 MG/ML soluzione iniettabile 28 siringhe preriempite | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 476 | Copaxone - 20 MG/ML soluzione iniettabile IN siringhe preriempite 30 siringhe | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 477 | Copaxone - 40 MG/ML soluzione iniettabile IN | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 478 | Copaxone - 40 MG/ML soluzione iniettabile IN siringa preriempita 12 siringhe preriempite DA 1 ML CON AGO | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 479 | Copaxone 20 MG | - | - | - | - | 1件: 13 13 💬
|
| 480 | Copaxone 20 MG/ML | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 481 | Copaxone 20 MG/ML solucióN inyectable EN jeringa precargada | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 482 | Copaxone 20 MG/ML solucióN para inyeccióN EN jeringa precargada | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 483 | Copaxone 20 MG/ML solution FOR injection, PRE-filled syringe | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 484 | Copaxone 20 MG/ML, solution FOR injection, PRE-filled syringes | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 485 | Copaxone 20MG/ML solution FOR injection, PRE-filled syringe | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 486 | Copaxone 40 MG/ML | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 487 | Copaxone 40 MG/ML solution FOR injection, PRE-filled syringe | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 488 | Copaxone*SC 28SIR 20MG/ML | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 489 | Copaxone-teva | - | - | - | - | 1件: 13 13 💬
|
| 490 | Copolymer 1 | - | - | - | - | 1件: 13 13 💬
|
| 491 | Core stability | - | - | - | - | 1件: 13 13 💬
|
| 492 | Corticosteroid | - | - | - | - | 7件: 13 13, 66, 84, 96, 97, 113, 222 💬
|
| 493 | Corticosteroids & tancart19/20 | - | - | - | - | 1件: 13 13 💬
|
| 494 | Covid-19 vaccination | - | - | - | - | 1件: 13 13 💬
|
| 495 | Covid-19 vaccine | - | - | - | - | 5件: 13 13, 46, 49, 51, 97 💬
|
| 496 | Covid19 vaccine | - | - | - | - | 1件: 13 13 💬
|
| 497 | Cranberry | 1件: Cranberry Cranberry | - | - | - | 1件: 13 13 💬
|
| 498 | Creatine | 1件: Creatine Creatine | - | - | - | 10件: 1 1, 2, 6, 8, 13, 46, 49, 50, 201, 337 💬
|
| 499 | Cryopreserved myelin-derived peptide-loaded tolerogenic dendritic cells | - | - | - | - | 1件: 13 13 💬
|
| 500 | CS-0777 tablets | - | - | - | - | 1件: 13 13 💬
|
| 501 | CSF sampling | - | - | - | - | 1件: 13 13 💬
|
| 502 | CT-P53 | - | - | - | - | 1件: 13 13 💬
|
| 503 | CT103A cells | 1件: CT103A CT103A | - | - | - | 3件: 11 11, 13, 16 💬
|
| 504 | Curcumin | 1件: Curcumin Curcumin | - | - | - | 10件: 13 13, 34, 46, 67, 74, 94, 96, 97, 139, 299 💬
|
| 505 | CYB704 | - | - | - | - | 1件: 13 13 💬
|
| 506 | Cyclophosfamide | - | - | - | - | 1件: 13 13 💬
|
| 507 | Cyclophosphamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 44件: 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
| 508 | Cyclophosphamide and ATG | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 13 13 💬
|
| 509 | Cyclophosphamide and fludarabine | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 3件: 11 11, 13, 16 💬
|
| 510 | Cyclophosphamide monohydrate | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 4件: 13 13, 60, 96, 256 💬
|
| 511 | Cyclophosphamide/ATG | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 13 13 💬
|
| 512 | Cyclophosphamide/glatiramer acetate | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 13 13 💬
|
| 513 | Cyclophosphamide/rituximab | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 13 13 💬
|
| 514 | Cymbalta | 1件: Duloxetine Duloxetine | 2件: Duloxetine hydrochloride
Duloxetine hydrochloride
,
Duloxetine
💬
| 2件: SLC6A2 SLC6A2,
SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 3件: 6 6, 13, 49 💬
|
| 515 | Cytarabine | 1件: Cytarabine Cytarabine | 2件: Cytarabine
Cytarabine
,
Cytarabine hydrochloride
💬
| - | - | 7件: 11 11, 13, 14, 25, 34, 49, 60 💬
|
| 516 | Cytolytic CD4+ T cells | - | - | - | - | 1件: 13 13 💬
|
| 517 | Cápsulas DE laquinimod 0.6 MG | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 1件: 13 13 💬
|
| 518 | Células madre mesenquimales | - | - | - | - | 1件: 13 13 💬
|
| 519 | D mannose | - | - | - | - | 1件: 13 13 💬
|
| 520 | D-aspartate | - | - | - | - | 1件: 13 13 💬
|
| 521 | D-biotin | - | - | - | - | 3件: 10 10, 13, 20 💬
|
| 522 | D-biotina | - | - | - | - | 1件: 13 13 💬
|
| 523 | DAC HYP | - | - | - | - | 1件: 13 13 💬
|
| 524 | DAC-HYP | - | - | - | - | 1件: 13 13 💬
|
| 525 | Daclizumab | 1件: Daclizumab Daclizumab | 1件: Daclizumab
Daclizumab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 8件: 13 13, 56, 60, 65, 97, 107, 283, 284 💬
|
| 526 | Daclizumab high yield process | 1件: Daclizumab Daclizumab | 1件: Daclizumab
Daclizumab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 💬
|
| 527 | Daclizumab HYP | 1件: Daclizumab Daclizumab | 1件: Daclizumab
Daclizumab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 💬
|
| 528 | Daclizumab HYP (DAC HYP | 1件: Daclizumab Daclizumab | 1件: Daclizumab
Daclizumab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 💬
|
| 529 | Daclizumab HYP (DAC HYP) | 1件: Daclizumab Daclizumab | 1件: Daclizumab
Daclizumab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 💬
|
| 530 | Daclizumab with greek suufix | 1件: Daclizumab Daclizumab | 1件: Daclizumab
Daclizumab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 💬
|
| 531 | Dalfampridine | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 4 4, 13 💬
|
| 532 | Dalfampridine ER | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
| 533 | Dalfampridine ER, 10 MG oral tablet, extended release | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
| 534 | Dalfampridine plus physical therapy | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
| 535 | Dalfampridine-ER 10MG | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
| 536 | Dalfampridine-ER 5MG | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
| 537 | Dantrolene | 1件: Dantrolene Dantrolene | 2件: Dantrolene sodium
Dantrolene sodium
,
Dantrolene
💬
| - | - | 1件: 13 13 💬
|
| 538 | Dapirolizumab pegol | 1件: Dapirolizumab pegol Dapirolizumab pegol | - | - | - | 2件: 13 13, 49 💬
|
| 539 | Daratumumab | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬
| 1件: CD38 CD38 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 7件: 13 13, 28, 46, 48, 49, 60, 63 💬
|
| 540 | Darifenacin | 1件: Darifenacin Darifenacin | 2件: Darifenacin hydrobromide
Darifenacin hydrobromide
,
Darifenacin
💬
| 1件: CHRM3 CHRM3 💬
| 12件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 2件: 13 13, 26 💬
|
| 541 | DC-TAB | - | - | - | - | 1件: 13 13 💬
|
| 542 | Dekristol 20000 IE | - | - | - | - | 1件: 13 13 💬
|
| 543 | Dekristol® 400-tabletten | - | - | - | - | 1件: 13 13 💬
|
| 544 | Delta-9-tetrahydrocannabinol | 1件: Dronabinol Dronabinol | 1件: Dronabinol
Dronabinol
💬
| 2件: CNR1 CNR1,
CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 2件: 13 13, 36 💬
|
| 545 | Demestril septem | - | - | - | - | 1件: 13 13 💬
|
| 546 | Desloratadine given orally | 1件: Desloratadine Desloratadine | 1件: Desloratadine
Desloratadine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 547 | Determination OF calcium intake BY A dietician interview | - | - | - | - | 2件: 13 13, 46 💬
|
| 548 | Dexamethason | - | - | - | - | 4件: 13 13, 28, 46, 331 💬
|
| 549 | Dexamethasone | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 22件: 13 13, 14, 16, 19, 28, 35, 63, 64, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
|
| 550 | Dexamethasone given orally | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 551 | Dexamethasone soduim phosphate | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 552 | Dexchlorpheniramine | 1件: Dexchlorpheniramine Dexchlorpheniramine | 1件: Dexchlorpheniramine
Dexchlorpheniramine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 553 | Dexrazoxane | 1件: Dexrazoxane Dexrazoxane | 2件: Dexrazoxane
Dexrazoxane
,
Dexrazoxane hydrochloride
💬
| - | - | 1件: 13 13 💬
|
| 554 | Dextromethorphan | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 8件: 6 6, 8, 13, 21, 85, 96, 97, 156 💬
|
| 555 | Dextromethorphan hydrobromide | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 13 13, 46 💬
|
| 556 | Dextromethorphan hydrobromide 20 MG and quinidine sulfate 10 MG | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 2 2, 13 💬
|
| 557 | Dextromethorphan hydrobromide 30 MG and quinidine sulfate 10 MG | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 2 2, 13 💬
|
| 558 | Dextromethorphan/quinidine | 2件: Dextromethorphan Dextromethorphan,
Quinidine | 7件: Quinidine gluconate
Quinidine gluconate
,
Quinidine polygalacturonate
,
Dextromethorphan hydrobromide
,
Quinidine sulfate
,
Dextromethorphan
,
Daunorubicin
,
Quinidine
💬
| 11件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬
| 23件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 559 | Dextrometorfano hidrobromuro | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 560 | Dextrometorfano/quinidina | 2件: Dextromethorphan Dextromethorphan,
Quinidine | 7件: Quinidine gluconate
Quinidine gluconate
,
Quinidine polygalacturonate
,
Dextromethorphan hydrobromide
,
Quinidine sulfate
,
Dextromethorphan
,
Daunorubicin
,
Quinidine
💬
| 11件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬
| 23件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 561 | Diazoxide | 1件: Diazoxide Diazoxide | 2件: Diazoxide
Diazoxide
,
Diazoxide choline
💬
| 2件: ABCC8 ABCC8,
KCNJ11 💬
| 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 1件: 13 13 💬
|
| 562 | Dibase | - | - | - | - | 1件: 13 13 💬
|
| 563 | Diclofenac sodium topical GEL | 1件: Diclofenac Diclofenac | 5件: Diclofenac potassium
Diclofenac potassium
,
Diclofenac sodium
,
Diclofenac
,
Diclofenac diethylamine
,
Diclofenac epolamine
💬
| 2件: PTGS1 PTGS1,
PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 💬
|
| 564 | Dimethyl fumarate | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: Dimethyl fumarate
Dimethyl fumarate
💬
| 1件: KLHL19 KLHL19 💬
| 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 5件: 13 13, 20, 51, 86, 296 💬
|
| 565 | Dimethyl fumarate 240 MG | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: Dimethyl fumarate
Dimethyl fumarate
💬
| 1件: KLHL19 KLHL19 💬
| 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 13 13 💬
|
| 566 | Dimetil-fumarato | - | - | - | - | 1件: 13 13 💬
|
| 567 | Dimetilfumarato | - | - | - | - | 1件: 13 13 💬
|
| 568 | Diphenhydramine | 1件: Diphenhydramine Diphenhydramine | 4件: Diphenhydramine
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 10件: 13 13, 19, 49, 51, 70, 86, 96, 222, 256, 300 💬
|
| 569 | Diphenhydramine IV | 1件: Diphenhydramine Diphenhydramine | 4件: Diphenhydramine
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 570 | Diphenydramine | - | - | - | - | 1件: 13 13 💬
|
| 571 | Diphtheria toxoid | 1件: Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) | 1件: Diphtheria toxoid
Diphtheria toxoid
💬
| - | - | 2件: 13 13, 46 💬
|
| 572 | Diroximel fumarate | 1件: Diroximel fumarate Diroximel fumarate | 1件: Diroximel fumarate
Diroximel fumarate
💬
| - | - | 1件: 13 13 💬
|
| 573 | Dirucotide | 1件: Dirucotide Dirucotide | 1件: Dirucotide
Dirucotide
💬
| - | - | 1件: 13 13 💬
|
| 574 | Dirucotide acetate | 1件: Dirucotide Dirucotide | 1件: Dirucotide
Dirucotide
💬
| - | - | 1件: 13 13 💬
|
| 575 | Disability evaluation tests | - | - | - | - | 1件: 13 13 💬
|
| 576 | Discontinuation OF disease modifying therapy | - | - | - | - | 1件: 13 13 💬
|
| 577 | Disease modifying therapy | - | - | - | - | 1件: 13 13 💬
|
| 578 | Divozilimab | 1件: Divozilimab Divozilimab | 1件: Divozilimab
Divozilimab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 13 13, 51 💬
|
| 579 | DMT | - | - | - | - | 1件: 13 13 💬
|
| 580 | DMT category 1 | - | - | - | - | 1件: 13 13 💬
|
| 581 | DMT continuation | - | - | - | - | 1件: 13 13 💬
|
| 582 | DMT withdrawal | - | - | - | - | 1件: 13 13 💬
|
| 583 | Domperidone | 1件: Domperidone Domperidone | 2件: Domperidone
Domperidone
,
Domperidone maleate
💬
| 1件: DRD2 DRD2 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 5件: 6 6, 13, 17, 51, 230 💬
|
| 584 | Donepezil | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 8件: 5 5, 6, 13, 46, 124, 127, 156, 206 💬
|
| 585 | Dosing interruption OF natalizumab | - | - | - | - | 1件: 13 13 💬
|
| 586 | DPA | - | - | - | - | 4件: 2 2, 6, 13, 127 💬
|
| 587 | DPA-714 PET/MRI | - | - | - | - | 1件: 13 13 💬
|
| 588 | DRF | - | - | - | - | 1件: 13 13 💬
|
| 589 | Dronabinol | 1件: Dronabinol Dronabinol | 1件: Dronabinol
Dronabinol
💬
| 2件: CNR1 CNR1,
CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 3件: 2 2, 13, 298 💬
|
| 590 | Dronabinol 25 MG/ML, oral drops | 1件: Dronabinol Dronabinol | 1件: Dronabinol
Dronabinol
💬
| 2件: CNR1 CNR1,
CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
| 591 | Dronabinol capsule 2,5 MG | 1件: Dronabinol Dronabinol | 1件: Dronabinol
Dronabinol
💬
| 2件: CNR1 CNR1,
CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
| 592 | Drug - SHR1459 | - | - | - | - | 1件: 13 13 💬
|
| 593 | Dual task performance | - | - | - | - | 1件: 13 13 💬
|
| 594 | Duloxetine | 1件: Duloxetine Duloxetine | 2件: Duloxetine hydrochloride
Duloxetine hydrochloride
,
Duloxetine
💬
| 2件: SLC6A2 SLC6A2,
SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 13 💬
|
| 595 | DUOC-01 | - | - | - | - | 3件: 13 13, 19, 20 💬
|
| 596 | Dydrogesterone | 1件: Dydrogesterone Dydrogesterone | 1件: Dydrogesterone
Dydrogesterone
💬
| 1件: PGR PGR 💬
| 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 💬
|
| 597 | Dynamic balance training | - | - | - | - | 1件: 13 13 💬
|
| 598 | Dynamic balance walking training | - | - | - | - | 1件: 13 13 💬
|
| 599 | Dynamic contrast-enhanced magnetic resonance imaging | - | - | - | - | 1件: 13 13 💬
|
| 600 | Dysport | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 2件: 13 13, 36 💬
|
| 601 | Dysport*SC IM 2FL 500U | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 602 | Early harvest extra virgin olive OIL | - | - | - | - | 1件: 13 13 💬
|
| 603 | Early highly effective therapies group | - | - | - | - | 1件: 13 13 💬
|
| 604 | Ebixa | 1件: Memantine Memantine | 2件: Memantine hydrochloride
Memantine hydrochloride
,
Memantine
💬
| 5件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 3件: 2 2, 6, 13 💬
|
| 605 | ECP002A | - | - | - | - | 1件: 13 13 💬
|
| 606 | Eculizumab | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 8件: 11 11, 13, 14, 61, 62, 109, 221, 222 💬
|
| 607 | Eculizumab administration | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 13 13 💬
|
| 608 | Efalizumab | 1件: Efalizumab Efalizumab | 1件: Efalizumab
Efalizumab
💬
| 1件: ITGAL ITGAL 💬
| 12件: Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | 9件: 11 11, 13, 37, 46, 53, 61, 95, 96, 221 💬
|
| 609 | Efgartigimod alfa injection | 1件: Efgartigimod alfa Efgartigimod alfa | 1件: Efgartigimod alfa
Efgartigimod alfa
💬
| - | - | 1件: 13 13 💬
|
| 610 | Egcg | 1件: Epigallocatechin gallate Epigallocatechin gallate | - | - | - | 6件: 6 6, 8, 13, 28, 85, 206 💬
|
| 611 | EHP-101 25 MG BID | - | - | - | - | 1件: 13 13 💬
|
| 612 | EHP-101 25 MG OD | - | - | - | - | 1件: 13 13 💬
|
| 613 | EHP-101 50 MG BID | - | - | - | - | 1件: 13 13 💬
|
| 614 | EHP-101 50 MG OD | - | - | - | - | 1件: 13 13 💬
|
| 615 | EK-12 | - | - | - | - | 1件: 13 13 💬
|
| 616 | Elezanumab | 1件: Elezanumab Elezanumab | 1件: Elezanumab
Elezanumab
💬
| 1件: RGMA RGMA 💬
| 2件: Axon guidance Axon guidance, TGF-beta signaling pathway 💬 | 1件: 13 13 💬
|
| 617 | ELND002 | - | - | - | - | 1件: 13 13 💬
|
| 618 | EMD 28162 | - | - | - | - | 1件: 13 13 💬
|
| 619 | Emselex 15 MG retardtabletten | 1件: Darifenacin Darifenacin | 2件: Darifenacin hydrobromide
Darifenacin hydrobromide
,
Darifenacin
💬
| 1件: CHRM3 CHRM3 💬
| 12件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 1件: 13 13 💬
|
| 620 | Emselex 7,5 MG retardtabletten | 1件: Darifenacin Darifenacin | 2件: Darifenacin hydrobromide
Darifenacin hydrobromide
,
Darifenacin
💬
| 1件: CHRM3 CHRM3 💬
| 12件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 1件: 13 13 💬
|
| 621 | Emtricitabine | 1件: Emtricitabine Emtricitabine | 1件: Emtricitabine
Emtricitabine
💬
| - | - | 3件: 13 13, 93, 325 💬
|
| 622 | ENA713 | - | - | - | - | 2件: 6 6, 13 💬
|
| 623 | Enalapril | 1件: Enalapril Enalapril | 2件: Enalapril maleate
Enalapril maleate
,
Enalapril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 6件: 13 13, 66, 113, 210, 222, 279 💬
|
| 624 | Encapsulated baclofen 20 MG | 1件: Baclofen Baclofen | 1件: Baclofen
Baclofen
💬
| 2件: GABBR GABBR,
GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
| 625 | Encapsulated simvastatin tablets | - | - | - | - | 1件: 13 13 💬
|
| 626 | Endoxan | - | - | - | - | 6件: 13 13, 28, 49, 51, 85, 162 💬
|
| 627 | Endoxan - ciclofosfamide | - | - | - | - | 1件: 13 13 💬
|
| 628 | Endoxan baxter | - | - | - | - | 3件: 13 13, 43, 96 💬
|
| 629 | Enspryng | 1件: Satralizumab Satralizumab | 1件: Satralizumab
Satralizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 💬
|
| 630 | Entire-body PET-CT scans | - | - | - | - | 1件: 13 13 💬
|
| 631 | Eparmefolin 30 CPR 0,1/0,5MG | - | - | - | - | 1件: 13 13 💬
|
| 632 | Epigallocatechin | 1件: Epigallocatechin Epigallocatechin | - | - | - | 1件: 13 13 💬
|
| 633 | EPO | - | - | - | - | 1件: 13 13 💬
|
| 634 | Epoetin alfa | 1件: Erythropoietin Erythropoietin | 4件: Epoetin alfa
Epoetin alfa
,
Epoetin epsilon
,
Epoetin theta
,
Epoetin zeta
💬
| 1件: EPOR EPOR 💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 3件: 13 13, 18, 46 💬
|
| 635 | Epoetin beta | 2件: Epoetin beta Epoetin beta,
Erythropoietin | 5件: Epoetin alfa
Epoetin alfa
,
Epoetin beta
,
Epoetin epsilon
,
Epoetin theta
,
Epoetin zeta
💬
| 1件: EPOR EPOR 💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 13 13 💬
|
| 636 | Eritrociti accoppiati A peptidi | - | - | - | - | 1件: 13 13 💬
|
| 637 | Erypo/erypo FS | - | - | - | - | 1件: 13 13 💬
|
| 638 | Erythropoietin | 1件: Erythropoietin Erythropoietin | 4件: Epoetin alfa
Epoetin alfa
,
Epoetin epsilon
,
Epoetin theta
,
Epoetin zeta
💬
| 1件: EPOR EPOR 💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 10件: 2 2, 6, 13, 18, 22, 47, 61, 70, 95, 96 💬
|
| 639 | Escalation therapies group | - | - | - | - | 1件: 13 13 💬
|
| 640 | Escitalopram | 1件: Escitalopram Escitalopram | 2件: Escitalopram oxalate
Escitalopram oxalate
,
Escitalopram
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 3件: 2 2, 6, 13 💬
|
| 641 | Escitalopram oxalate antidepressant | 1件: Escitalopram Escitalopram | 2件: Escitalopram oxalate
Escitalopram oxalate
,
Escitalopram
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 642 | Esomeprazole | 1件: Esomeprazole Esomeprazole | 5件: Esomeprazole magnesium
Esomeprazole magnesium
,
Esomeprazole sodium
,
Esomeprazole
,
Esomeprazole strontium
,
Esomeprazole magnesium dihydrate
💬
| 2件: ATP4A ATP4A,
ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 9件: 6 6, 13, 46, 86, 98, 107, 113, 298, 299 💬
|
| 643 | Essential - hydroxytyrosol | - | - | - | - | 1件: 13 13 💬
|
| 644 | Essential fatty acids | - | - | - | - | 1件: 13 13 💬
|
| 645 | Estradiol | 1件: Estradiol Estradiol | 2件: Estradiol
Estradiol
,
Estradiol hemihydrate
💬
| 2件: ESR1 ESR1,
ESR2 💬
| 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 2件: 13 13, 76 💬
|
| 646 | Estradiol hemihydrate | 1件: Estradiol Estradiol | 2件: Estradiol
Estradiol
,
Estradiol hemihydrate
💬
| 2件: ESR1 ESR1,
ESR2 💬
| 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 13 13 💬
|
| 647 | Estriol | 1件: Estriol Estriol | 2件: Estriol
Estriol
,
Estriol tripropionate
💬
| 2件: ESR1 ESR1,
ESR2 💬
| 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 2件: 13 13, 227 💬
|
| 648 | Estroprogestins | - | - | - | - | 1件: 13 13 💬
|
| 649 | Eszopiclone | 1件: Eszopiclone Eszopiclone | 1件: Eszopiclone
Eszopiclone
💬
| 16件: GABRA GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 3件: 6 6, 13, 46 💬
|
| 650 | Ethinylestradiol | 1件: Ethinylestradiol Ethinylestradiol | 1件: Ethinyl estradiol
Ethinyl estradiol
💬
| 1件: ESR1 ESR1 💬
| 9件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 13 13 💬
|
| 651 | Etifoxine | 1件: Etifoxine Etifoxine | 2件: Etifoxine
Etifoxine
,
Etifoxine hydrochloride
💬
| - | - | 1件: 13 13 💬
|
| 652 | Etims | - | - | - | - | 1件: 13 13 💬
|
| 653 | Etoposide | 1件: Etoposide Etoposide | 2件: Etoposide
Etoposide
,
Etoposide phosphate
💬
| - | - | 12件: 11 11, 13, 14, 26, 28, 34, 54, 60, 65, 85, 164, 331 💬
|
| 654 | EU-ocrevus | - | - | - | - | 1件: 13 13 💬
|
| 655 | EU/1/08/454/001-002, EU/1/08/454/005-007 | - | - | - | - | 1件: 13 13 💬
|
| 656 | EU/1/95/003/005-010 | - | - | - | - | 1件: 13 13 💬
|
| 657 | EU/1/97/033/002 | - | - | - | - | 1件: 13 13 💬
|
| 658 | EU/1/98/063/001-003 | - | - | - | - | 1件: 13 13 💬
|
| 659 | EU/1/98/063/004-006 | - | - | - | - | 1件: 13 13 💬
|
| 660 | Evaluation OF lower extremity muscle strength, physical activity, exercise capacity, balance, quality OF life, and fatigue IN healthy controls | - | - | - | - | 1件: 13 13 💬
|
| 661 | Evaluation OF lower extremity muscle strength, physical activity, exercise capacity, balance, quality OF life, and fatigue IN poms | - | - | - | - | 1件: 13 13 💬
|
| 662 | Evobrutinib | 1件: Evobrutinib Evobrutinib | 1件: Evobrutinib
Evobrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 3件: 13 13, 46, 49 💬
|
| 663 | Evobrutinib 10MG | 1件: Evobrutinib Evobrutinib | 1件: Evobrutinib
Evobrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 1件: 13 13 💬
|
| 664 | Evobrutinib 25MG | 1件: Evobrutinib Evobrutinib | 1件: Evobrutinib
Evobrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 1件: 13 13 💬
|
| 665 | Exelon transdermales pflaster | - | - | - | - | 1件: 13 13 💬
|
| 666 | Exercise intervention | - | - | - | - | 4件: 13 13, 18, 60, 97 💬
|
| 667 | Exergame | - | - | - | - | 2件: 6 6, 13 💬
|
| 668 | Experimental glatiramer acetate | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 669 | Exposure TO methylprednisolone during pregnancy | - | - | - | - | 1件: 13 13 💬
|
| 670 | Exposure TO ONE or more disease-modifying drug(S)(dmds) used TO treat MS | - | - | - | - | 1件: 13 13 💬
|
| 671 | Extavia | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 672 | Extavia (interferon BETA-1B), novartis pharma AG | 2件: Human interferon beta Human interferon beta,
Interferon beta-1b | 2件: Interferon beta-1b
Interferon beta-1b
,
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 673 | Extavia 250 microgram/ML | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 674 | Extavia 250 micrograms/ML | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 675 | Extavia*SC 15FL 250MCG/ML+15SI | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 676 | Extended release fampridine | - | - | - | - | 1件: 13 13 💬
|
| 677 | Extended-release oxycodone | - | - | - | - | 1件: 13 13 💬
|
| 678 | Extended-release quetiapine fumarate | - | - | - | - | 1件: 13 13 💬
|
| 679 | Extracellular vesicles derived from human-induced neural stem cells FOR intrathecal injection | - | - | - | - | 1件: 13 13 💬
|
| 680 | Extracorporeal photopheresis | - | - | - | - | 3件: 13 13, 46, 96 💬
|
| 681 | F-18 3f4AP | - | - | - | - | 1件: 13 13 💬
|
| 682 | Famciclovir | 1件: Famciclovir Famciclovir | 1件: Famciclovir
Famciclovir
💬
| - | - | 2件: 11 11, 13 💬
|
| 683 | Fampridina | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
| 684 | Fampridine | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 13 13, 14 💬
|
| 685 | Fampridine SR | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
| 686 | Fampridine-SR | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
| 687 | Fampyra | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 13 13, 14 💬
|
| 688 | Fampyra 10 MG prolonged-release tablets | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
| 689 | Fampyra 10MG prolonged release tablets | - | - | - | - | 1件: 13 13 💬
|
| 690 | Fatigue | - | - | - | - | 1件: 13 13 💬
|
| 691 | Fear OF falling | - | - | - | - | 1件: 13 13 💬
|
| 692 | Febuxostat | 1件: Febuxostat Febuxostat | 2件: Febuxostat
Febuxostat
,
Febuxostat hydrate
💬
| 1件: XDH XDH 💬
| 4件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | 4件: 2 2, 6, 13, 97 💬
|
| 693 | Fecal microbial transplants | - | - | - | - | 1件: 13 13 💬
|
| 694 | Fecal microbiota | 1件: Fecal microbiota Fecal microbiota | - | - | - | 5件: 13 13, 49, 93, 96, 97 💬
|
| 695 | Fecal microbiota transplantation | 1件: Fecal microbiota Fecal microbiota | - | - | - | 10件: 2 2, 6, 13, 63, 66, 94, 96, 97, 99, 271 💬
|
| 696 | Fecal microbiota transplantation (FMT) OF FMP30 donor stool | 1件: Fecal microbiota Fecal microbiota | - | - | - | 1件: 13 13 💬
|
| 697 | Femoston 1/10 | - | - | - | - | 1件: 13 13 💬
|
| 698 | Femoston 2/10 | - | - | - | - | 1件: 13 13 💬
|
| 699 | Fenebrutinib | 1件: Fenebrutinib Fenebrutinib | 1件: Fenebrutinib
Fenebrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 1件: 13 13 💬
|
| 700 | Feraheme | - | - | - | - | 1件: 13 13 💬
|
| 701 | Ferumoxytol | 1件: Ferumoxytol Ferumoxytol | 1件: Ferumoxytol
Ferumoxytol
💬
| - | - | 2件: 13 13, 226 💬
|
| 702 | Ferumoxytol infusion | 1件: Ferumoxytol Ferumoxytol | 1件: Ferumoxytol
Ferumoxytol
💬
| - | - | 1件: 13 13 💬
|
| 703 | Fexofenadine | 1件: Fexofenadine Fexofenadine | 2件: Fexofenadine hydrochloride
Fexofenadine hydrochloride
,
Fexofenadine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 4件: 6 6, 13, 19, 46 💬
|
| 704 | Filgrastim | 1件: Filgrastim Filgrastim | 1件: Filgrastim
Filgrastim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 29件: 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
|
| 705 | Fingolimob | - | - | - | - | 1件: 13 13 💬
|
| 706 | Fingolimod | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 14, 156 💬
|
| 707 | Fingolimod 0.5 MG | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 708 | Fingolimod 0.5MG | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 709 | Fingolimod 1.25 MG | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 710 | Fingolimod hydrochloride | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 14 💬
|
| 711 | Fingolimodi | - | - | - | - | 1件: 13 13 💬
|
| 712 | Fingolmod | - | - | - | - | 1件: 13 13 💬
|
| 713 | Firategrast | 1件: Firategrast Firategrast | 1件: Firategrast
Firategrast
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 714 | Firategrast 150 MG | 1件: Firategrast Firategrast | 1件: Firategrast
Firategrast
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 715 | Firategrast 300 MG | 1件: Firategrast Firategrast | 1件: Firategrast
Firategrast
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 716 | Firategrast gastro-retentive solution | 1件: Firategrast Firategrast | 1件: Firategrast
Firategrast
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 717 | Firategrast immediate release tablet | 1件: Firategrast Firategrast | 1件: Firategrast
Firategrast
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 718 | Firategrast modified release tablet | 1件: Firategrast Firategrast | 1件: Firategrast
Firategrast
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 719 | First line DMT | - | - | - | - | 1件: 13 13 💬
|
| 720 | Fish OIL | 1件: Fish oil Fish oil | - | - | - | 5件: 13 13, 46, 49, 96, 299 💬
|
| 721 | Fish OIL concentrate | 1件: Fish oil Fish oil | - | - | - | 1件: 13 13 💬
|
| 722 | Fish OIL, rich IN omega-3-acids | 1件: Fish oil Fish oil | - | - | - | 1件: 13 13 💬
|
| 723 | Fish OIL,rich IN omega 3 acids | 1件: Fish oil Fish oil | - | - | - | 1件: 13 13 💬
|
| 724 | Fludara | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 725 | Fludarabine | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 23件: 11 11, 13, 19, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 326 💬
|
| 726 | Fludarabine phosphate FOR injection | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 727 | Flumazenil | 1件: Flumazenil Flumazenil | 1件: Flumazenil
Flumazenil
💬
| 16件: GABRA GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 5件: 6 6, 13, 17, 18, 206 💬
|
| 728 | Fluoxetin hexal | 1件: Fluoxetine Fluoxetine | 2件: Fluoxetine
Fluoxetine
,
Fluoxetine hydrochloride
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 729 | Fluoxetine | 1件: Fluoxetine Fluoxetine | 2件: Fluoxetine
Fluoxetine
,
Fluoxetine hydrochloride
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 3件: 13 13, 17, 86 💬
|
| 730 | Fluoxetine hydrochloride | 1件: Fluoxetine Fluoxetine | 2件: Fluoxetine
Fluoxetine
,
Fluoxetine hydrochloride
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 731 | Flupirtin | - | - | - | - | 1件: 13 13 💬
|
| 732 | Flupirtine | 1件: Flupirtine Flupirtine | 2件: Flupirtine maleate
Flupirtine maleate
,
Flupirtine
💬
| - | - | 1件: 13 13 💬
|
| 733 | Flupirtinmaleat | - | - | - | - | 1件: 13 13 💬
|
| 734 | Flurbiprofen | 1件: Flurbiprofen Flurbiprofen | 2件: Flurbiprofen
Flurbiprofen
,
Flurbiprofen sodium
💬
| 2件: PTGS1 PTGS1,
PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 3件: 13 13, 21, 46 💬
|
| 735 | Foralumab | 1件: Foralumab Foralumab | - | - | - | 2件: 13 13, 96 💬
|
| 736 | Foralumab TZLS-401 100 µG | 1件: Foralumab Foralumab | - | - | - | 1件: 13 13 💬
|
| 737 | Foralumab TZLS-401 50 µG | 1件: Foralumab Foralumab | - | - | - | 1件: 13 13 💬
|
| 738 | Formistin - 10 MG compresse rivestite CON film 20 compresse | - | - | - | - | 1件: 13 13 💬
|
| 739 | Formistin 10 MG | - | - | - | - | 1件: 13 13 💬
|
| 740 | Formulation A | - | - | - | - | 1件: 13 13 💬
|
| 741 | Formulation B | - | - | - | - | 1件: 13 13 💬
|
| 742 | Formulation C | - | - | - | - | 1件: 13 13 💬
|
| 743 | Formulation D | - | - | - | - | 1件: 13 13 💬
|
| 744 | Four square step test | - | - | - | - | 2件: 6 6, 13 💬
|
| 745 | Frexalimab | 1件: Frexalimab Frexalimab | 1件: Frexalimab
Frexalimab
💬
| 1件: TNFSF5 TNFSF5 💬
| 14件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis 💬 | 2件: 13 13, 222 💬
|
| 746 | FTY720 | - | - | - | - | 1件: 13 13 💬
|
| 747 | FTY720D | - | - | - | - | 1件: 13 13 💬
|
| 748 | Full spectrum vitamin | - | - | - | - | 1件: 13 13 💬
|
| 749 | Fully humanized ANTI-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody | - | - | - | - | 1件: 13 13 💬
|
| 750 | Functional balance intervention | - | - | - | - | 1件: 13 13 💬
|
| 751 | Functional mobility | - | - | - | - | 2件: 6 6, 13 💬
|
| 752 | Functional reach test | - | - | - | - | 2件: 6 6, 13 💬
|
| 753 | G-CSF | 1件: Filgrastim Filgrastim | 1件: Filgrastim
Filgrastim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 18件: 2 2, 6, 11, 13, 16, 22, 47, 49, 51, 60, 61, 62, 65, 85, 96, 284, 285, 331 💬
|
| 754 | GA 20 MG/ML | - | - | - | - | 1件: 13 13 💬
|
| 755 | GA 40 MG/ML | - | - | - | - | 1件: 13 13 💬
|
| 756 | GA depot | - | - | - | - | 1件: 13 13 💬
|
| 757 | GA depot 25MG once monthly | - | - | - | - | 1件: 13 13 💬
|
| 758 | GA depot 40 MG | - | - | - | - | 1件: 13 13 💬
|
| 759 | GA depot 40MG once monthly | - | - | - | - | 1件: 13 13 💬
|
| 760 | GA depot 80 MG | - | - | - | - | 1件: 13 13 💬
|
| 761 | Gabapentin | 1件: Gabapentin Gabapentin | 1件: Gabapentin
Gabapentin
💬
| 5件: CACNA2D1 CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬
| 10件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 4件: 6 6, 13, 19, 70 💬
|
| 762 | Gabapentine | 1件: Gabapentin Gabapentin | 1件: Gabapentin
Gabapentin
💬
| 5件: CACNA2D1 CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬
| 10件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 763 | Gabapentine 300MG | 1件: Gabapentin Gabapentin | 1件: Gabapentin
Gabapentin
💬
| 5件: CACNA2D1 CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬
| 10件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 764 | Gadobenate dimeglumine | 1件: Gadobenic acid Gadobenic acid | 2件: Gadobenate dimeglumine
Gadobenate dimeglumine
,
Gadobenic acid
💬
| - | - | 1件: 13 13 💬
|
| 765 | Gadobutrol | 1件: Gadobutrol Gadobutrol | 1件: Gadobutrol
Gadobutrol
💬
| - | - | 4件: 13 13, 22, 46, 226 💬
|
| 766 | Gadolinium-based contrast | 1件: Gadolinium Gadolinium | - | - | - | 1件: 13 13 💬
|
| 767 | Gadopentetate dimeglumine | 1件: Gadopentetic acid Gadopentetic acid | 2件: Gadopentetate dimeglumine
Gadopentetate dimeglumine
,
Gadopentetic acid
💬
| - | - | 2件: 13 13, 34 💬
|
| 768 | Gadoteric acid | 1件: Gadoteric acid Gadoteric acid | 2件: Gadoterate meglumine
Gadoterate meglumine
,
Gadoteric acid
💬
| - | - | 2件: 13 13, 58 💬
|
| 769 | Gadoteridol | 1件: Gadoteridol Gadoteridol | 1件: Gadoteridol
Gadoteridol
💬
| - | - | 1件: 13 13 💬
|
| 770 | Gadovist 1 mmol/ML solucióN inyectable EN jeringa precargada/ cartucho precargado | - | - | - | - | 1件: 13 13 💬
|
| 771 | Gadovist 1.0 mmol/ML injektionslösung | 1件: Gadobutrol Gadobutrol | 1件: Gadobutrol
Gadobutrol
💬
| - | - | 1件: 13 13 💬
|
| 772 | Gamma-tocopherol | 1件: gamma-Tocopherol gamma-Tocopherol | - | - | - | 1件: 13 13 💬
|
| 773 | GBP | - | - | - | - | 1件: 13 13 💬
|
| 774 | GDC-0853 | - | - | - | - | 3件: 13 13, 46, 49 💬
|
| 775 | GDC-0853 RO7010939 | - | - | - | - | 3件: 13 13, 46, 49 💬
|
| 776 | Gemfibrozil | 1件: Gemfibrozil Gemfibrozil | 1件: Gemfibrozil
Gemfibrozil
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 13 💬
|
| 777 | Genotropin | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 5件: 13 13, 77, 107, 187, 193 💬
|
| 778 | Gilenya | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 2 2, 13, 14 💬
|
| 779 | Gilenya - 0.25 MG - capsule rigide - USO orale | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 780 | Gilenya - 0.5 MG - capsule rigide - USO orale | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 781 | Gilenya - 0.5 MG - capsule rigide - USO orale - blister divisibile PER dose unitaria(PVC/pvdc/ALU) scatola DA 7x1 capsule | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 782 | Gilenya - 0.5 MG - capsule rigide - USO orale - blister(PVC/pvdc/ALU) scatola DA 28 capsule | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 783 | Gilenya 0,5 MG hartkapseln | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 784 | Gilenya 0,5MG CPS DUR | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 785 | Gilenya hard capsules | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 786 | Gileyna | - | - | - | - | 1件: 13 13 💬
|
| 787 | Ginkgo biloba | 1件: Ginkgo biloba Ginkgo biloba | 1件: Ginkgo
Ginkgo
💬
| - | - | 3件: 13 13, 18, 47 💬
|
| 788 | Ginseng | 1件: Ginseng Ginseng | 1件: Ginseng
Ginseng
💬
| - | - | 2件: 13 13, 46 💬
|
| 789 | Glatiramer acetate | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 3件: 13 13, 96, 156 💬
|
| 790 | Glatiramer acetate (GA) 40 MG | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 791 | Glatiramer acetate 150MG enteric coated tablets | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 792 | Glatiramer acetate 150MG enteric-coated (gastro-resistant) tablets | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 793 | Glatiramer acetate 20 MG | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 794 | Glatiramer acetate 20 MG, with mitoxantrone | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 795 | Glatiramer acetate 20 MG/0.5 ML | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 796 | Glatiramer acetate 40 MG | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 797 | Glatiramer acetate injection with oral cetirizine hydrochloride | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 798 | Glatiramer acetate with minocycline | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 799 | Glatiramer acetate, IFN-beta 1A (IM), IFN-beta 1A (subcutaneous), and IFN-beta 1B | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 800 | Glatiramer acetate, interferons (intramuscular, subcutaneous, pegylated) teriflunomide, fumarates (dimethyl, diroximel, monomethyl) fingolimod, siponimod, ozanimod, ponesimod | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 801 | Glatiramer acetate, N-acetylcysteine | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 802 | Glatiramer acetato | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 803 | Glatiramero acetato | - | - | - | - | 1件: 13 13 💬
|
| 804 | Glicerol-1,3-didecanoato-2-octadeca-(6Z,9Z,12Z)-trienoato | - | - | - | - | 1件: 13 13 💬
|
| 805 | Glucose | 1件: Dextrose, unspecified form Dextrose, unspecified form | 2件: Dextrose
Dextrose
,
Glucose, liquid
💬
| - | - | 9件: 6 6, 13, 66, 77, 96, 97, 226, 254, 299 💬
|
| 806 | Glutamate and aspartate | - | - | - | - | 1件: 13 13 💬
|
| 807 | Glycerol-1,3-didecanoate-2-octadeca-(6Z,9Z,12Z)-trienoate | 1件: Glycerin Glycerin | 1件: Glycerin
Glycerin
💬
| - | - | 1件: 13 13 💬
|
| 808 | Gnbac1 | - | - | - | - | 1件: 13 13 💬
|
| 809 | Gnbac1 monoclonal antibody | - | - | - | - | 1件: 13 13 💬
|
| 810 | Gold nanocrystals | 1件: Gold Gold | - | - | - | 3件: 2 2, 6, 13 💬
|
| 811 | Granulocyte-colony stimulating factor (G-CSF) and prednisone | - | - | - | - | 1件: 13 13 💬
|
| 812 | Group balance training | - | - | - | - | 1件: 13 13 💬
|
| 813 | GSK1223249 | - | - | - | - | 2件: 2 2, 13 💬
|
| 814 | GSK1841157 | - | - | - | - | 3件: 13 13, 35, 46 💬
|
| 815 | GSK2018682 | - | - | - | - | 1件: 13 13 💬
|
| 816 | GSK2018682 CD2 capsule | - | - | - | - | 1件: 13 13 💬
|
| 817 | GSK2018682 CD3 micronised tablet | - | - | - | - | 1件: 13 13 💬
|
| 818 | GSK2018682 CD3 NON-micronised tablet IN FED state | - | - | - | - | 1件: 13 13 💬
|
| 819 | GSK239512 | - | - | - | - | 1件: 13 13 💬
|
| 820 | GSK2395612 | - | - | - | - | 1件: 13 13 💬
|
| 821 | GSK3888130B | - | - | - | - | 1件: 13 13 💬
|
| 822 | GTR | - | - | - | - | 1件: 13 13 💬
|
| 823 | GTR.ACE | - | - | - | - | 1件: 13 13 💬
|
| 824 | Guanabenz | 1件: Guanabenz Guanabenz | 2件: Guanabenz acetate
Guanabenz acetate
,
Guanabenz
💬
| 3件: ADRA2A ADRA2A,
ADRA2B,
ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 13 13 💬
|
| 825 | GW-1000-02 | - | - | - | - | 1件: 13 13 💬
|
| 826 | Gylenia | - | - | - | - | 1件: 13 13 💬
|
| 827 | Gylenia 0,5 MG | - | - | - | - | 1件: 13 13 💬
|
| 828 | GZ402668 | - | - | - | - | 1件: 13 13 💬
|
| 829 | GZ402673 | - | - | - | - | 1件: 13 13 💬
|
| 830 | H5g1.1-MAB | - | - | - | - | 3件: 13 13, 50, 62 💬
|
| 831 | HB-admscs | 1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | - | - | - | 7件: 2 2, 4, 6, 13, 14, 46, 49 💬
|
| 832 | HBM9161 injection | - | - | - | - | 1件: 13 13 💬
|
| 833 | Helminth OVA | - | - | - | - | 1件: 13 13 💬
|
| 834 | Hematopoetic stem cell infusion | - | - | - | - | 1件: 13 13 💬
|
| 835 | Hematopoietic stem cell therapy | - | - | - | - | 1件: 13 13 💬
|
| 836 | Hematopoietic stem cell transplantation | - | - | - | - | 13件: 11 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
|
| 837 | Heterologous booster | - | - | - | - | 1件: 13 13 💬
|
| 838 | Hiberix | - | - | - | - | 1件: 13 13 💬
|
| 839 | Hidrocloruro DE fingolimod | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 14 💬
|
| 840 | High dose myobloc | - | - | - | - | 1件: 13 13 💬
|
| 841 | High phenolic extra virgin olive OIL | - | - | - | - | 1件: 13 13 💬
|
| 842 | HIGH-dose intravenous methylprednisolone | - | - | - | - | 1件: 13 13 💬
|
| 843 | High/LOW sodium diet | - | - | - | - | 1件: 13 13 💬
|
| 844 | Histamine | 1件: Histamine Histamine | 3件: Histamine dihydrochloride
Histamine dihydrochloride
,
Histamine phosphate
,
Histamine
💬
| 4件: HRH1 HRH1,
HRH2,
HRH3,
HRH4 💬
| 5件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 845 | HMR 1726D | - | - | - | - | 1件: 13 13 💬
|
| 846 | HMR1726 | - | - | - | - | 1件: 13 13 💬
|
| 847 | HMR1726D | - | - | - | - | 1件: 13 13 💬
|
| 848 | Home based balance training | - | - | - | - | 2件: 6 6, 13 💬
|
| 849 | HOME-based balance training | - | - | - | - | 1件: 13 13 💬
|
| 850 | Homologous booster | - | - | - | - | 1件: 13 13 💬
|
| 851 | Hookworm larvae | - | - | - | - | 1件: 13 13 💬
|
| 852 | HP184 | - | - | - | - | 1件: 13 13 💬
|
| 853 | Human ANTI-IL-12 IGG1 MAB | - | - | - | - | 1件: 13 13 💬
|
| 854 | Human ANTI-IL-12 MAB | - | - | - | - | 1件: 13 13 💬
|
| 855 | Human ANTI-lingo-1 monoclonal antibody | - | - | - | - | 1件: 13 13 💬
|
| 856 | Human autologous mesenchymal stem cells | - | - | - | - | 2件: 2 2, 13 💬
|
| 857 | Human interferon beta | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 858 | Human interferon BETA-1A and glatiramer acetate | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 859 | Human leucocyte interferon-alpha | - | - | - | - | 1件: 13 13 💬
|
| 860 | Human monoclonal antibody (cnto 1275) TO interleukin-12p40 | - | - | - | - | 1件: 13 13 💬
|
| 861 | Human neural stem cells | - | - | - | - | 2件: 2 2, 13 💬
|
| 862 | Human normal immunoglobulin | 1件: Human immunoglobulin G Human immunoglobulin G | 1件: Globulin, immune
Globulin, immune
💬
| - | - | 8件: 11 11, 13, 14, 43, 45, 50, 63, 65 💬
|
| 863 | Human recombinant growth hormone | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 2件: 13 13, 299 💬
|
| 864 | Human umbilical cord mesenchymal stem cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 4件: 13 13, 96, 113, 271 💬
|
| 865 | Humax-CD20 | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 13 13, 46 💬
|
| 866 | Hydrochlorothiazide | 1件: Hydrochlorothiazide Hydrochlorothiazide | 1件: Hydrochlorothiazide
Hydrochlorothiazide
💬
| 1件: SLC12A3 SLC12A3 💬
| 1件: Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action 💬 | 4件: 13 13, 67, 225, 235 💬
|
| 867 | Hydrogen peroxide | 2件: Hydrogen Hydrogen,
Hydrogen peroxide | 1件: Hydrogen peroxide
Hydrogen peroxide
💬
| - | - | 1件: 13 13 💬
|
| 868 | Hydroxychloroquine | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 26件: 6 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 💬
|
| 869 | Hydroxychloroquine pill | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 1件: 13 13 💬
|
| 870 | Hydroxychloroquine sulfate | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 4件: 13 13, 46, 53, 66 💬
|
| 871 | Hydroxyurea | 1件: Hydroxyurea Hydroxyurea | 1件: Hydroxyurea
Hydroxyurea
💬
| 1件: RRM2 RRM2 💬
| 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬 | 10件: 3 3, 13, 19, 20, 46, 65, 85, 86, 107, 284 💬
|
| 872 | Hyperimmune caprine serum against HIV lysate | - | - | - | - | 1件: 13 13 💬
|
| 873 | Ibudilast | 1件: Ibudilast Ibudilast | 1件: Ibudilast
Ibudilast
💬
| 8件: CYSLTR1 CYSLTR1,
PDE3A,
PDE3B,
PDE4,
PDE4,
PDE4,
PDE4,
PTGIR 💬
| 15件: Apelin signaling pathway Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 2 2, 13 💬
|
| 874 | Ibuprofen | 1件: Ibuprofen Ibuprofen | 5件: Ibuprofen
Ibuprofen
,
Ibuprofen aluminum
,
Ibuprofen lysine
,
Ibuprofen sodium
,
Ibuprofen sodium
💬
| 2件: PTGS1 PTGS1,
PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 6件: 13 13, 46, 65, 113, 271, 299 💬
|
| 875 | Ibuprofen sandoz 400 MG filmtabletten | 1件: Ibuprofen Ibuprofen | 5件: Ibuprofen
Ibuprofen
,
Ibuprofen aluminum
,
Ibuprofen lysine
,
Ibuprofen sodium
,
Ibuprofen sodium
💬
| 2件: PTGS1 PTGS1,
PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 💬
|
| 876 | ICP-022 | - | - | - | - | 3件: 13 13, 46, 49 💬
|
| 877 | Idebenone | 1件: Idebenone Idebenone | 1件: Idebenone
Idebenone
💬
| - | - | 7件: 6 6, 8, 13, 18, 21, 113, 302 💬
|
| 878 | Idmt | - | - | - | - | 1件: 13 13 💬
|
| 879 | IDP-023 | - | - | - | - | 1件: 13 13 💬
|
| 880 | IFA incomplete freund'S adjuvant | - | - | - | - | 1件: 13 13 💬
|
| 881 | Ifenprodil | 1件: Ifenprodil Ifenprodil | 2件: Ifenprodil tartrate
Ifenprodil tartrate
,
Ifenprodil
💬
| 3件: ADRA1A ADRA1A,
ADRA1B,
ADRA1D 💬
| 9件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 13 13 💬
|
| 882 | IFN beta 1A 44 MCG TIW | - | - | - | - | 1件: 13 13 💬
|
| 883 | IFN BETA-1A | - | - | - | - | 1件: 13 13 💬
|
| 884 | IFN ß-1A | - | - | - | - | 1件: 13 13 💬
|
| 885 | IL2 | - | - | - | - | 1件: 13 13 💬
|
| 886 | IM90838 | - | - | - | - | 3件: 13 13, 96, 97 💬
|
| 887 | Imatinib mesilate | 1件: Imatinib Imatinib | 2件: Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| 3件: ABL1 ABL1,
KIT,
PDGFRA 💬
| 31件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 3件: 13 13, 86, 88 💬
|
| 888 | Imatinib mesylate | 1件: Imatinib Imatinib | 2件: Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| 3件: ABL1 ABL1,
KIT,
PDGFRA 💬
| 31件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 5件: 13 13, 28, 34, 51, 86 💬
|
| 889 | IMC-002 | - | - | - | - | 1件: 13 13 💬
|
| 890 | IMCY-0141 | 1件: IMCY-0141 IMCY-0141 | - | - | - | 1件: 13 13 💬
|
| 891 | Immune globulin | - | - | - | - | 3件: 11 11, 13, 14 💬
|
| 892 | Immune globulin IV [human], 10% caprylate/chromatography purified | - | - | - | - | 1件: 13 13 💬
|
| 893 | Immunoadsorption | - | - | - | - | 2件: 13 13, 14 💬
|
| 894 | Immunoglobulin | - | - | - | - | 3件: 13 13, 14, 63 💬
|
| 895 | Immunoglobulin G | - | - | - | - | 9件: 2 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
|
| 896 | Immunosuppressive agents | - | - | - | - | 4件: 13 13, 50, 96, 220 💬
|
| 897 | IMS001 | - | - | - | - | 1件: 13 13 💬
|
| 898 | IMU-838 | - | - | - | - | 3件: 13 13, 96, 97 💬
|
| 899 | IMU-838 tablets | - | - | - | - | 1件: 13 13 💬
|
| 900 | IMU-838-RC | - | - | - | - | 1件: 13 13 💬
|
| 901 | Imurel | - | - | - | - | 7件: 13 13, 44, 45, 46, 54, 96, 97 💬
|
| 902 | Incabotulinumtoxina | - | - | - | - | 1件: 13 13 💬
|
| 903 | Incobotulinum toxin A | - | - | - | - | 3件: 2 2, 6, 13 💬
|
| 904 | Incontinence severity | - | - | - | - | 1件: 13 13 💬
|
| 905 | Indapamide pill | 1件: Indapamide Indapamide | 1件: Indapamide
Indapamide
💬
| 1件: SLC12A3 SLC12A3 💬
| 1件: Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action 💬 | 1件: 13 13 💬
|
| 906 | Inebilizumab | 1件: Inebilizumab Inebilizumab | 1件: Inebilizumab
Inebilizumab
💬
| 1件: CD19 CD19 💬
| 5件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | 6件: 11 11, 13, 46, 49, 51, 300 💬
|
| 907 | INF BETA-1A | - | - | - | - | 1件: 13 13 💬
|
| 908 | Influenza vaccine | - | - | - | - | 6件: 11 11, 13, 46, 51, 84, 97 💬
|
| 909 | Inhaled cannabis | - | - | - | - | 1件: 13 13 💬
|
| 910 | Injectable MS DMT | - | - | - | - | 1件: 13 13 💬
|
| 911 | Injection OF autologous bone marrow derived mesenchymal stem cells | - | - | - | - | 1件: 13 13 💬
|
| 912 | Injection OF cell free media | - | - | - | - | 1件: 13 13 💬
|
| 913 | INN colecalciferol | - | - | - | - | 1件: 13 13 💬
|
| 914 | Inosine | 1件: Inosine Inosine | 1件: Inosine
Inosine
💬
| - | - | 4件: 2 2, 6, 13, 122 💬
|
| 915 | Inspiratory muscle training | - | - | - | - | 1件: 13 13 💬
|
| 916 | Insulin | - | - | - | - | 6件: 6 6, 13, 46, 75, 77, 299 💬
|
| 917 | INT131 | - | - | - | - | 1件: 13 13 💬
|
| 918 | Inteferone BETA-1A | - | - | - | - | 1件: 13 13 💬
|
| 919 | Interferon beta | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 3件: 13 13, 20, 50 💬
|
| 920 | Interferon beta - 1A | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 921 | Interferon beta -1B | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 922 | Interferon beta 1 | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 923 | Interferon beta 1-A | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 924 | Interferon beta 1A | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 925 | Interferon beta 1A 30 UG IM once weekly | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 926 | Interferon beta 1A pegilado | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 927 | Interferon beta 1A, oral doxycycline | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 928 | Interferon beta 1B | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 929 | Interferon beta therapy | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 930 | Interferon beta treatment TO ADD-ON atorvastatin treatment | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 931 | Interferon beta type 1A | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 932 | Interferon BETA-1 A | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 933 | Interferon BETA-1A | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 3件: 13 13, 96, 97 💬
|
| 934 | Interferon BETA-1A (rebif®) alone | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 935 | Interferon BETA-1A FBS-free/HSA free, RNF | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 936 | Interferon BETA-1A FBS-free/HSA-free | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 937 | Interferon BETA-1A FBS-free/HSA-free, RNF | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 938 | Interferon BETA-1A HSA+ biosimilar | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 939 | Interferon BETA-1A HSA-free biosimilar | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 940 | Interferon BETA-1A original | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 941 | Interferon BETA-1A prefilled syringe | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 942 | Interferon BETA-1B | 2件: Human interferon beta Human interferon beta,
Interferon beta-1b | 2件: Interferon beta-1b
Interferon beta-1b
,
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 943 | Interferon BETA-1B and tacrolimus | 2件: Human interferon beta Human interferon beta,
Interferon beta-1b | 2件: Interferon beta-1b
Interferon beta-1b
,
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 944 | Interferon BETA-1B group | 2件: Human interferon beta Human interferon beta,
Interferon beta-1b | 2件: Interferon beta-1b
Interferon beta-1b
,
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 945 | Interferon BETA-1B, FRP about 6 weeks after randomization | 2件: Human interferon beta Human interferon beta,
Interferon beta-1b | 2件: Interferon beta-1b
Interferon beta-1b
,
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 946 | Interferon BETA-1B, FRP within 15 days after randomization | 2件: Human interferon beta Human interferon beta,
Interferon beta-1b | 2件: Interferon beta-1b
Interferon beta-1b
,
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 947 | Interferon BETA-1B/atorvastatin group | 2件: Human interferon beta Human interferon beta,
Interferon beta-1b | 2件: Interferon beta-1b
Interferon beta-1b
,
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 948 | Interferon BETA1A | - | - | - | - | 1件: 13 13 💬
|
| 949 | Interferon or glatiramer acetate | - | - | - | - | 1件: 13 13 💬
|
| 950 | Interferon ß-1A | - | - | - | - | 1件: 13 13 💬
|
| 951 | Interferon ß-1A 30 µG | - | - | - | - | 1件: 13 13 💬
|
| 952 | Interferon ß-1B | - | - | - | - | 1件: 13 13 💬
|
| 953 | Interferon ß1 | - | - | - | - | 1件: 13 13 💬
|
| 954 | Interferon-beta | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 955 | Interferon-beta 1A | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 956 | Interferon-beta 1A FBS-free/HSA free, RNF | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 957 | Interferon-beta 1A FBS-free/HSA-free, RNF | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 958 | Interferon-beta 1B | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 959 | Interferon-beta and human leukocyte interferon-A | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 960 | Interferon-BETA-1A | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 961 | Interferon-BETA-1A (avonex) plus methylprednisolone | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 962 | Interferon-BETA-1A FBS-free/HSA free, RNF | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 963 | Interferon-BETA-1A FBS-free/HSA-free | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 964 | Interferon-BETA-1B | 2件: Human interferon beta Human interferon beta,
Interferon beta-1b | 2件: Interferon beta-1b
Interferon beta-1b
,
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 965 | Interferon-BETA1 | - | - | - | - | 1件: 13 13 💬
|
| 966 | Interferon-ß-1 | - | - | - | - | 1件: 13 13 💬
|
| 967 | Interferon-ß-1A | - | - | - | - | 1件: 13 13 💬
|
| 968 | Interferon-ß-1B | - | - | - | - | 1件: 13 13 💬
|
| 969 | Interferone | - | - | - | - | 1件: 13 13 💬
|
| 970 | Interferone beta 1A | - | - | - | - | 1件: 13 13 💬
|
| 971 | Interferone beta 1B | - | - | - | - | 1件: 13 13 💬
|
| 972 | Interferone BETA-1A | - | - | - | - | 1件: 13 13 💬
|
| 973 | Interferone BETA-1B | - | - | - | - | 1件: 13 13 💬
|
| 974 | Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab | - | - | - | - | 1件: 13 13 💬
|
| 975 | InterferóN beta 1A pegilado | - | - | - | - | 1件: 13 13 💬
|
| 976 | InterferóN BETA-1A pegilado | - | - | - | - | 1件: 13 13 💬
|
| 977 | Interleukin-2 | 1件: Human interleukin-2 Human interleukin-2 | - | - | - | 9件: 2 2, 13, 49, 50, 55, 65, 96, 97, 162 💬
|
| 978 | Intradetrusor injection OF botulinum toxin-A | - | - | - | - | 1件: 13 13 💬
|
| 979 | Intranasal foralumab solution | - | - | - | - | 1件: 13 13 💬
|
| 980 | Intratect | - | - | - | - | 4件: 13 13, 14, 35, 65 💬
|
| 981 | Intrathecal administration OF autologous MSC-NP | - | - | - | - | 1件: 13 13 💬
|
| 982 | Intrathecal methotrexate | - | - | - | - | 1件: 13 13 💬
|
| 983 | Intrathecal MSC-NP injection | - | - | - | - | 1件: 13 13 💬
|
| 984 | Intrathecal saline injection | - | - | - | - | 1件: 13 13 💬
|
| 985 | Intravenous (IV) infusions | - | - | - | - | 2件: 13 13, 97 💬
|
| 986 | Intravenous glucocorticoids | - | - | - | - | 1件: 13 13 💬
|
| 987 | Intravenous immunoglobulin | - | - | - | - | 8件: 13 13, 14, 35, 38, 39, 49, 51, 309 💬
|
| 988 | Intravenous injection OF mesenchymal stem cells | - | - | - | - | 1件: 13 13 💬
|
| 989 | Intravenous methylprednisolone | - | - | - | - | 3件: 13 13, 97, 145 💬
|
| 990 | Intravenous methylprednisolone (ivmp) and efgartigimod | - | - | - | - | 1件: 13 13 💬
|
| 991 | Intravenous steroid | - | - | - | - | 1件: 13 13 💬
|
| 992 | IPX056 | - | - | - | - | 1件: 13 13 💬
|
| 993 | IPX056 10 MG | - | - | - | - | 1件: 13 13 💬
|
| 994 | IPX056 20 MG | - | - | - | - | 1件: 13 13 💬
|
| 995 | IPX056 30 MG | - | - | - | - | 1件: 13 13 💬
|
| 996 | IPX056 35 MG | - | - | - | - | 1件: 13 13 💬
|
| 997 | IPX056 40 MG | - | - | - | - | 1件: 13 13 💬
|
| 998 | IPX056-10 MG | - | - | - | - | 1件: 13 13 💬
|
| 999 | IPX056-20 MG | - | - | - | - | 1件: 13 13 💬
|
| 1000 | IPX056-25 MG | - | - | - | - | 1件: 13 13 💬
|
| 1001 | IPX056-30 MG | - | - | - | - | 1件: 13 13 💬
|
| 1002 | IPX056-35 MG | - | - | - | - | 1件: 13 13 💬
|
| 1003 | IPX056-40 MG | - | - | - | - | 1件: 13 13 💬
|
| 1004 | IR902 | - | - | - | - | 1件: 13 13 💬
|
| 1005 | Irradiation | - | - | - | - | 1件: 13 13 💬
|
| 1006 | Isentress | 1件: Raltegravir Raltegravir | 2件: Raltegravir
Raltegravir
,
Raltegravir potassium
💬
| - | - | 1件: 13 13 💬
|
| 1007 | Isoxsuprine hydrochloride | 1件: Isoxsuprine Isoxsuprine | 2件: Isoxsuprine hydrochloride
Isoxsuprine hydrochloride
,
Isoxsuprine
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 13 13 💬
|
| 1008 | IV methylprednisolone | - | - | - | - | 1件: 13 13 💬
|
| 1009 | IV methylprednisolone administration | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 1010 | Ivig | - | - | - | - | 8件: 11 11, 13, 14, 35, 51, 63, 65, 172 💬
|
| 1011 | Ivmp | - | - | - | - | 1件: 13 13 💬
|
| 1012 | Ixazomib (ninlaro®) capsules | 1件: Ixazomib Ixazomib | 2件: Ixazomib
Ixazomib
,
Ixazomib citrate
💬
| 1件: PSMB5 PSMB5 💬
| 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
| 1013 | JM-4 | - | - | - | - | 1件: 13 13 💬
|
| 1014 | JNJ-67896153/ACT-128800 | - | - | - | - | 1件: 13 13 💬
|
| 1015 | JYP0061 | - | - | - | - | 1件: 13 13 💬
|
| 1016 | Kemstro | - | - | - | - | 1件: 13 13 💬
|
| 1017 | Kepivance | 1件: Palifermin Palifermin | 1件: Palifermin
Palifermin
💬
| 1件: FGFR2 FGFR2 💬
| 12件: Calcium signaling pathway Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬 | 1件: 13 13 💬
|
| 1018 | Keppra | 1件: Levetiracetam Levetiracetam | 1件: Levetiracetam
Levetiracetam
💬
| 1件: SV2 SV2 💬
| 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 1件: 13 13 💬
|
| 1019 | Keppra 250MG | 1件: Levetiracetam Levetiracetam | 1件: Levetiracetam
Levetiracetam
💬
| 1件: SV2 SV2 💬
| 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 1件: 13 13 💬
|
| 1020 | Keppra 500MG | 1件: Levetiracetam Levetiracetam | 1件: Levetiracetam
Levetiracetam
💬
| 1件: SV2 SV2 💬
| 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 1件: 13 13 💬
|
| 1021 | Kesimpta | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1022 | Kesimpta 20 MG injektionslösung IM fertigpen | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1023 | Kesimpta 20 MG solution FOR injection IN PRE-filled PEN | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1024 | Ketamine | 1件: Ketamine Ketamine | 2件: Ketamine hydrochloride
Ketamine hydrochloride
,
Ketamine
💬
| 5件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 6件: 6 6, 13, 70, 113, 156, 215 💬
|
| 1025 | Ketoconazole | 1件: Ketoconazole Ketoconazole | 1件: Ketoconazole
Ketoconazole
💬
| - | - | 2件: 13 13, 75 💬
|
| 1026 | Ketogenic diet | - | - | - | - | 9件: 13 13, 19, 21, 49, 67, 77, 127, 145, 148 💬
|
| 1027 | Ketoprofen | 1件: Ketoprofen Ketoprofen | 3件: Ketoprofen
Ketoprofen
,
Ketoprofen lysine
,
Ketoprofen sodium
💬
| 2件: PTGS1 PTGS1,
PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 13 13, 46 💬
|
| 1028 | Keyhole limpet hemocyanin | 1件: Keyhole limpet hemocyanin Keyhole limpet hemocyanin | - | - | - | 2件: 13 13, 46 💬
|
| 1029 | Keyhole limpet hemocyanin (KLH) NEO-antigen | 1件: Keyhole limpet hemocyanin Keyhole limpet hemocyanin | - | - | - | 1件: 13 13 💬
|
| 1030 | Kirunal fish OIL | - | - | - | - | 1件: 13 13 💬
|
| 1031 | KLH | - | - | - | - | 2件: 13 13, 65 💬
|
| 1032 | KYV-101 | - | - | - | - | 4件: 11 11, 13, 50, 51 💬
|
| 1033 | KYV-101 (biological) - 0.33 ×10^8 cells | - | - | - | - | 1件: 13 13 💬
|
| 1034 | KYV-101 (biological) - 1 ×10^8 cells | - | - | - | - | 1件: 13 13 💬
|
| 1035 | KYV-101 ANTI-CD19 CAR-T cell therapy | - | - | - | - | 1件: 13 13 💬
|
| 1036 | L acetyl carnitine | - | - | - | - | 1件: 13 13 💬
|
| 1037 | L-000124467 | - | - | - | - | 1件: 13 13 💬
|
| 1038 | L-carnitine | 1件: Levocarnitine Levocarnitine | 2件: Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
💬
| - | - | 5件: 13 13, 46, 86, 96, 240 💬
|
| 1039 | L-histidine | - | - | - | - | 1件: 13 13 💬
|
| 1040 | L01bb04 | - | - | - | - | 1件: 13 13 💬
|
| 1041 | L03 AB | - | - | - | - | 1件: 13 13 💬
|
| 1042 | L03 AB 08 | - | - | - | - | 1件: 13 13 💬
|
| 1043 | L03 AB07 | - | - | - | - | 1件: 13 13 💬
|
| 1044 | L03ab13 | - | - | - | - | 1件: 13 13 💬
|
| 1045 | L04aa04 - immunoglobulina antitimocitaria (DI coniglio) immunoglobulina DI coniglio antitimociti umani thymoglobuline | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | 1件: Anti-human thymocyte immunoglobulin, rabbit
Anti-human thymocyte immunoglobulin, rabbit
💬
| 11件: CD2 CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬
| 31件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 1件: 13 13 💬
|
| 1046 | L04aa31 | - | - | - | - | 1件: 13 13 💬
|
| 1047 | Laboratory biomarker analysis | - | - | - | - | 22件: 11 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
|
| 1048 | Lactose monohydrate | 1件: Lactose Lactose | 2件: Anhydrous lactose
Anhydrous lactose
,
Lactose
💬
| - | - | 1件: 13 13 💬
|
| 1049 | Lactulose | 1件: Lactulose Lactulose | 1件: Lactulose
Lactulose
💬
| - | - | 3件: 6 6, 13, 97 💬
|
| 1050 | Lamotrigine | 1件: Lamotrigine Lamotrigine | 1件: Lamotrigine
Lamotrigine
💬
| 5件: SCN1A SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 5件: 13 13, 34, 113, 114, 144 💬
|
| 1051 | Lamotrigine extended release tablets | 1件: Lamotrigine Lamotrigine | 1件: Lamotrigine
Lamotrigine
💬
| 5件: SCN1A SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 13 13 💬
|
| 1052 | Laquinimod | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 4件: 8 8, 13, 49, 96 💬
|
| 1053 | Laquinimod 0.3 | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 1件: 13 13 💬
|
| 1054 | Laquinimod 0.6 | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 1件: 13 13 💬
|
| 1055 | Laquinimod 1.2 | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 1件: 13 13 💬
|
| 1056 | Laquinimod capsulas 0.6 MG | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 1件: 13 13 💬
|
| 1057 | Laquinimod capsules 0.3 MG | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 1件: 13 13 💬
|
| 1058 | Laquinimod capsules 0.6 MG | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 1件: 13 13 💬
|
| 1059 | Laquinimod tablets 0.3 MG | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 1件: 13 13 💬
|
| 1060 | Lavender OIL | 1件: Lavender oil Lavender oil | 1件: Lavender oil
Lavender oil
💬
| - | - | 1件: 13 13 💬
|
| 1061 | LCAR-AIO T cells | - | - | - | - | 3件: 11 11, 13, 49 💬
|
| 1062 | Learning | - | - | - | - | 1件: 13 13 💬
|
| 1063 | Lemtrada | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 2件: 13 13, 65 💬
|
| 1064 | Lemtrada 12 MG konzentrat ZUR herstellung einer infusionslösung | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 13 13 💬
|
| 1065 | Lenograstim | 1件: Lenograstim Lenograstim | 1件: Lenograstim
Lenograstim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 8件: 2 2, 13, 16, 18, 19, 57, 65, 97 💬
|
| 1066 | Levetiracetam | 1件: Levetiracetam Levetiracetam | 1件: Levetiracetam
Levetiracetam
💬
| 1件: SV2 SV2 💬
| 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 7件: 2 2, 4, 6, 13, 34, 149, 307 💬
|
| 1067 | Levitra | 1件: Vardenafil Vardenafil | 2件: Vardenafil
Vardenafil
,
Vardenafil hydrochloride
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 13 13, 86 💬
|
| 1068 | Levocarnil | - | - | - | - | 1件: 13 13 💬
|
| 1069 | Levofolene 4 MG 30 CPR | 1件: Levoleucovorin Levoleucovorin | 3件: Levoleucovorin calcium
Levoleucovorin calcium
,
Sodium levofolinate
,
Calcium levofolinate hydrate
💬
| - | - | 1件: 13 13 💬
|
| 1070 | Levonorgestrel | 1件: Levonorgestrel Levonorgestrel | 1件: Levonorgestrel
Levonorgestrel
💬
| 1件: PGR PGR 💬
| 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 💬
|
| 1071 | LFB-R603 | - | - | - | - | 1件: 13 13 💬
|
| 1072 | LFB-R603, TGTX1101 | - | - | - | - | 1件: 13 13 💬
|
| 1073 | Liberation therapy | - | - | - | - | 1件: 13 13 💬
|
| 1074 | Lidocaine | 1件: Lidocaine Lidocaine | 3件: Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| 5件: SCN1A SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 10件: 6 6, 13, 22, 46, 86, 107, 168, 226, 231, 256 💬
|
| 1075 | Linoleic acid | 1件: Linoleic acid Linoleic acid | - | - | - | 1件: 13 13 💬
|
| 1076 | Linoleic acid/oleic acid | 1件: Linoleic acid Linoleic acid | - | - | - | 1件: 13 13 💬
|
| 1077 | Liofen XL | - | - | - | - | 1件: 13 13 💬
|
| 1078 | Liothyronine | 1件: Liothyronine Liothyronine | 2件: Liothyronine sodium
Liothyronine sodium
,
Liothyronine
💬
| 2件: THRA THRA,
THRB 💬
| 3件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | 1件: 13 13 💬
|
| 1079 | Liothyronine sodium | 1件: Liothyronine Liothyronine | 2件: Liothyronine sodium
Liothyronine sodium
,
Liothyronine
💬
| 2件: THRA THRA,
THRB 💬
| 3件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | 1件: 13 13 💬
|
| 1080 | Lipoic acid | 1件: Lipoic acid Lipoic acid | 1件: Thioctic acid
Thioctic acid
💬
| - | - | 3件: 13 13, 14, 20 💬
|
| 1081 | Lipoic acid (LA) with fish OIL and LA without fish OIL | 1件: Lipoic acid Lipoic acid | 1件: Thioctic acid
Thioctic acid
💬
| - | - | 1件: 13 13 💬
|
| 1082 | Lipoic acid and omega-3 fatty acids | 1件: Lipoic acid Lipoic acid | 1件: Thioctic acid
Thioctic acid
💬
| - | - | 1件: 13 13 💬
|
| 1083 | Liraglutide | 1件: Liraglutide Liraglutide | 1件: Liraglutide
Liraglutide
💬
| 1件: GLP1R GLP1R 💬
| 4件: Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 5件: 6 6, 13, 75, 77, 193 💬
|
| 1084 | Lisdexamfetamine sulfate | 1件: Lisdexamfetamine Lisdexamfetamine | 2件: Lisdexamfetamine dimesylate
Lisdexamfetamine dimesylate
,
Lisdexamfetamine
💬
| 2件: SLC6A2 SLC6A2,
SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 1085 | Listed FOR each disorder below, UP TO three drugs PER disorder (TOO many characters TO list IN this field | - | - | - | - | 1件: 13 13 💬
|
| 1086 | Lithium carbonate | 2件: Lithium carbonate Lithium carbonate,
Lithium citrate | 2件: Lithium carbonate
Lithium carbonate
,
Lithium citrate
💬
| - | - | 5件: 2 2, 13, 17, 18, 127 💬
|
| 1087 | Live hookworm larvae | - | - | - | - | 1件: 13 13 💬
|
| 1088 | Live necator americanus larvae | - | - | - | - | 1件: 13 13 💬
|
| 1089 | Lodosyn | - | - | - | - | 1件: 13 13 💬
|
| 1090 | Lokomat training | - | - | - | - | 1件: 13 13 💬
|
| 1091 | Loperamide | 1件: Loperamide Loperamide | 2件: Loperamide hydrochloride
Loperamide hydrochloride
,
Loperamide
💬
| 3件: OPRD1 OPRD1,
OPRK1,
OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 13 13, 97 💬
|
| 1092 | Loratadine | 1件: Loratadine Loratadine | 1件: Loratadine
Loratadine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 5件: 13 13, 19, 46, 89, 98 💬
|
| 1093 | LOU064 | - | - | - | - | 2件: 13 13, 53 💬
|
| 1094 | LOU064c1 | - | - | - | - | 1件: 13 13 💬
|
| 1095 | LOW dose ARM receiving neutral OIL and 400 IU/G OF vitamin D every second DAY | - | - | - | - | 1件: 13 13 💬
|
| 1096 | LOW dose cannabis | 1件: Medical Cannabis Medical Cannabis | 1件: Cannabis
Cannabis
💬
| - | - | 1件: 13 13 💬
|
| 1097 | LOW dose myobloc | - | - | - | - | 1件: 13 13 💬
|
| 1098 | LOW immunogenic interferon-BETA-1A | - | - | - | - | 1件: 13 13 💬
|
| 1099 | LP-168 tablet | - | - | - | - | 1件: 13 13 💬
|
| 1100 | LPX-TI641 | - | - | - | - | 2件: 13 13, 46 💬
|
| 1101 | LU AG06466 | - | - | - | - | 1件: 13 13 💬
|
| 1102 | Lubiprostone | 1件: Lubiprostone Lubiprostone | 1件: Lubiprostone
Lubiprostone
💬
| 1件: CLCN2 CLCN2 💬
| 1件: Mineral absorption Mineral absorption 💬 | 5件: 6 6, 13, 97, 290, 299 💬
|
| 1103 | Lumbar puncture | - | - | - | - | 6件: 6 6, 13, 19, 96, 97, 127 💬
|
| 1104 | Lutein | 1件: Lutein Lutein | - | - | - | 2件: 13 13, 90 💬
|
| 1105 | Lutenyl | - | - | - | - | 1件: 13 13 💬
|
| 1106 | LY2127399 | - | - | - | - | 3件: 13 13, 46, 49 💬
|
| 1107 | LY248686 | - | - | - | - | 1件: 13 13 💬
|
| 1108 | LY3541860 | - | - | - | - | 2件: 13 13, 46 💬
|
| 1109 | M2951 | - | - | - | - | 3件: 13 13, 46, 49 💬
|
| 1110 | MAB therapy | - | - | - | - | 1件: 13 13 💬
|
| 1111 | Mabcampath | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 3件: 13 13, 60, 65 💬
|
| 1112 | Mabcampath 10 MG/ML concentrado para solucióN para perfusióN | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 13 13 💬
|
| 1113 | Mabcampath-1H | - | - | - | - | 1件: 13 13 💬
|
| 1114 | Mabthera | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 17件: 11 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 61, 63, 64, 65, 83, 162, 222 💬
|
| 1115 | Mabthera or biosimilar rituximab product | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1116 | Magnesium | 1件: Magnesium Magnesium | - | - | - | 4件: 13 13, 46, 235, 298 💬
|
| 1117 | Magnetic resonance imaging | - | - | - | - | 11件: 13 13, 19, 22, 28, 34, 46, 65, 205, 285, 299, 344 💬
|
| 1118 | Maltodextrin | 1件: Maltodextrin Maltodextrin | 1件: Maltodextrin
Maltodextrin
💬
| - | - | 4件: 6 6, 13, 96, 97 💬
|
| 1119 | Maltodextrin fiber supplement | 1件: Maltodextrin Maltodextrin | 1件: Maltodextrin
Maltodextrin
💬
| - | - | 1件: 13 13 💬
|
| 1120 | Mangafodipir | 1件: Mangafodipir Mangafodipir | 2件: Mangafodipir trisodium
Mangafodipir trisodium
,
Mangafodipir
💬
| - | - | 1件: 13 13 💬
|
| 1121 | Mannitol | 1件: Mannitol Mannitol | 1件: Mannitol
Mannitol
💬
| - | - | 6件: 6 6, 13, 60, 96, 113, 299 💬
|
| 1122 | Mantadan*20CPR 100MG | - | - | - | - | 1件: 13 13 💬
|
| 1123 | Masitinb mesylate | - | - | - | - | 1件: 13 13 💬
|
| 1124 | Masitinib | 1件: Masitinib Masitinib | 1件: Masitinib
Masitinib
💬
| 1件: KIT KIT 💬
| 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 3件: 2 2, 13, 46 💬
|
| 1125 | Masitinib 100 MG | 1件: Masitinib Masitinib | 1件: Masitinib
Masitinib
💬
| 1件: KIT KIT 💬
| 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 13 13 💬
|
| 1126 | Masitinib 200 MG | 1件: Masitinib Masitinib | 1件: Masitinib
Masitinib
💬
| 1件: KIT KIT 💬
| 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 13 13 💬
|
| 1127 | Masitinib mesilate | 1件: Masitinib Masitinib | 1件: Masitinib
Masitinib
💬
| 1件: KIT KIT 💬
| 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 2件: 2 2, 13 💬
|
| 1128 | Masitinib mesilato | 1件: Masitinib Masitinib | 1件: Masitinib
Masitinib
💬
| 1件: KIT KIT 💬
| 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 13 13 💬
|
| 1129 | Masitinib mesylate | 1件: Masitinib Masitinib | 1件: Masitinib
Masitinib
💬
| 1件: KIT KIT 💬
| 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 6件: 2 2, 5, 6, 13, 46, 96 💬
|
| 1130 | Mastinib | - | - | - | - | 1件: 13 13 💬
|
| 1131 | Mavenclad | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 1132 | Mavenclad - 10 MG - compressa - USO orale - blister (AL/AL) - 6 compresse | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 1133 | Mavenclad 10 MG tablets | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 1134 | Mavenclad 10MG TBL NOB | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 1135 | Mavenclad 6CPR 10 MG | - | - | - | - | 1件: 13 13 💬
|
| 1136 | Mavenclad 6CPR 10MG | - | - | - | - | 1件: 13 13 💬
|
| 1137 | Mavenclad tabletter 10 MG | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 1138 | Mayzent | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1139 | Mayzent 0,25 MG compresse rivestite CON film | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1140 | Mayzent 0,25 MG filmtabletten | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1141 | Mayzent 0.25 MG FI | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1142 | Mayzent 2 MG compresse rivestite CON film | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1143 | Mayzent 2 MG FILM-coated tablets | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1144 | Mayzent 2 MG filmtabletten | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1145 | MBP peptide | - | - | - | - | 1件: 13 13 💬
|
| 1146 | MBP8298 | - | - | - | - | 1件: 13 13 💬
|
| 1147 | MBP8298 synthetic peptide | - | - | - | - | 1件: 13 13 💬
|
| 1148 | MD1003 | - | - | - | - | 5件: 2 2, 10, 13, 14, 20 💬
|
| 1149 | MD1003 100MG capsule | - | - | - | - | 1件: 13 13 💬
|
| 1150 | MEDI-551 | - | - | - | - | 2件: 13 13, 51 💬
|
| 1151 | MEDI-551 100 MG-IV | - | - | - | - | 1件: 13 13 💬
|
| 1152 | MEDI-551 30 MG-IV | - | - | - | - | 1件: 13 13 💬
|
| 1153 | MEDI-551 300 MG-SC | - | - | - | - | 1件: 13 13 💬
|
| 1154 | MEDI-551 60 MG-SC | - | - | - | - | 1件: 13 13 💬
|
| 1155 | MEDI-551 600 MG-IV | - | - | - | - | 1件: 13 13 💬
|
| 1156 | Medical marijuana | - | - | - | - | 1件: 13 13 💬
|
| 1157 | Medication diary | - | - | - | - | 1件: 13 13 💬
|
| 1158 | Meditation | - | - | - | - | 1件: 13 13 💬
|
| 1159 | Mediterranean diet | - | - | - | - | 6件: 13 13, 77, 96, 97, 265, 299 💬
|
| 1160 | Medrol | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 13 13, 46, 222 💬
|
| 1161 | Megadose oral methylprednisolone | - | - | - | - | 1件: 13 13 💬
|
| 1162 | Melatonin | 1件: Melatonin Melatonin | 1件: Melatonin
Melatonin
💬
| 2件: MTNR1A MTNR1A,
MTNR1B 💬
| 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 16件: 2 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 202 💬
|
| 1163 | Melphalan | 1件: Melphalan Melphalan | 2件: Melphalan
Melphalan
,
Melphalan hydrochloride
💬
| - | - | 19件: 11 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
|
| 1164 | Memantine | 1件: Memantine Memantine | 2件: Memantine hydrochloride
Memantine hydrochloride
,
Memantine
💬
| 5件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 8件: 2 2, 6, 8, 13, 49, 127, 205, 206 💬
|
| 1165 | Menitorix | - | - | - | - | 1件: 13 13 💬
|
| 1166 | Menveo | - | - | - | - | 4件: 11 11, 13, 62, 222 💬
|
| 1167 | Mesenchymal stem cells | - | - | - | - | 17件: 2 2, 6, 13, 20, 46, 49, 50, 51, 60, 96, 97, 107, 222, 271, 274, 298, 299 💬
|
| 1168 | Mesenchymal stem/stromal cells | - | - | - | - | 1件: 13 13 💬
|
| 1169 | Mesna | - | - | - | - | 11件: 11 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬
|
| 1170 | Metabolic fatigue | - | - | - | - | 1件: 13 13 💬
|
| 1171 | Metex | - | - | - | - | 2件: 13 13, 46 💬
|
| 1172 | Metformin | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA PRKAA,
PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 23件: 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 84, 86, 97, 113, 127, 206, 218, 225, 265, 285, 298 💬
|
| 1173 | Metformin 1000 MG oral tablet | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA PRKAA,
PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 13 13 💬
|
| 1174 | Metformin 500 MG oral tablet, UP TO 4 tablets A DAY | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA PRKAA,
PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 13 13 💬
|
| 1175 | Metformin and clemastine IN combination | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA PRKAA,
PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 13 13 💬
|
| 1176 | Metformin hydrochloride 850 MG oral tablet | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA PRKAA,
PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 13 13 💬
|
| 1177 | Methelphenidate | - | - | - | - | 1件: 13 13 💬
|
| 1178 | Methotrexat | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR,
DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 3件: 13 13, 46, 96 💬
|
| 1179 | Methotrexate | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR,
DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 37件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
| 1180 | Methyl B12 | - | - | - | - | 1件: 13 13 💬
|
| 1181 | Methyl folate | - | - | - | - | 1件: 13 13 💬
|
| 1182 | Methyl prednisolonate | - | - | - | - | 1件: 13 13 💬
|
| 1183 | Methyloprednisolone | - | - | - | - | 1件: 13 13 💬
|
| 1184 | Methylphenidate | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2,
SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 5件: 6 6, 13, 34, 84, 113 💬
|
| 1185 | Methylphenidate hydrochloride | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2,
SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 2件: 6 6, 13 💬
|
| 1186 | Methylphenidate modified release | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2,
SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 1187 | Methylphenidate modified release 20 MG | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2,
SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 1188 | Methylphenidate modified release 30 MG | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2,
SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 1189 | Methylphenidate modified release 40 MG | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2,
SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 1190 | Methylprednisolon-21-hydrogensuccinat, natriumsalz | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 1191 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 45件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
| 1192 | Methylprednisolone 1250 MG/24H X3 days | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 1193 | Methylprednisolone hemisuccinate | 2件: Methylprednisolone Methylprednisolone,
Methylprednisolone hemisuccinate | 4件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone sodium succinate
,
Methylprednisolone acetate
,
Methylprednisolone hemisuccinate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 85 💬
|
| 1194 | Methylprednisolone IV | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 1195 | Methylprednisolone PO | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 1196 | Methylprednisolone sodium hemisuccinate | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 13 13, 85, 97 💬
|
| 1197 | Methylprednisolone sodium succinate | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 6件: 13 13, 46, 49, 50, 51, 211 💬
|
| 1198 | Methylprednisolone succinate | 2件: Methylprednisolone Methylprednisolone,
Methylprednisolone hemisuccinate | 4件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone sodium succinate
,
Methylprednisolone acetate
,
Methylprednisolone hemisuccinate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 66 💬
|
| 1199 | Metilprednisolone sodio succinato | - | - | - | - | 4件: 13 13, 14, 56, 66 💬
|
| 1200 | Microgynon | - | - | - | - | 2件: 13 13, 51 💬
|
| 1201 | Micropirin | - | - | - | - | 1件: 13 13 💬
|
| 1202 | Midazolam | 1件: Midazolam Midazolam | 3件: Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| 16件: GABRA GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 12件: 2 2, 3, 6, 13, 46, 67, 96, 97, 231, 272, 298, 299 💬
|
| 1203 | MIL62 | - | - | - | - | 3件: 13 13, 49, 222 💬
|
| 1204 | Mild dose cannabis | 1件: Medical Cannabis Medical Cannabis | 1件: Cannabis
Cannabis
💬
| - | - | 1件: 13 13 💬
|
| 1205 | Minocycline | 1件: Minocycline Minocycline | 2件: Minocycline hydrochloride
Minocycline hydrochloride
,
Minocycline
💬
| - | - | 14件: 2 2, 6, 8, 13, 46, 85, 90, 94, 97, 162, 201, 206, 280, 299 💬
|
| 1206 | Minocycline 100 MG FILM-coated tablets | 1件: Minocycline Minocycline | 2件: Minocycline hydrochloride
Minocycline hydrochloride
,
Minocycline
💬
| - | - | 1件: 13 13 💬
|
| 1207 | Minocycline 100MG | 1件: Minocycline Minocycline | 2件: Minocycline hydrochloride
Minocycline hydrochloride
,
Minocycline
💬
| - | - | 1件: 13 13 💬
|
| 1208 | Minocycline hydrochloride | 1件: Minocycline Minocycline | 2件: Minocycline hydrochloride
Minocycline hydrochloride
,
Minocycline
💬
| - | - | 4件: 13 13, 201, 206, 299 💬
|
| 1209 | Mirabegron | 1件: Mirabegron Mirabegron | 1件: Mirabegron
Mirabegron
💬
| 1件: ADRB3 ADRB3 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway 💬 | 4件: 6 6, 13, 53, 226 💬
|
| 1210 | Mirna | - | - | - | - | 1件: 13 13 💬
|
| 1211 | MIS416 | - | - | - | - | 1件: 13 13 💬
|
| 1212 | Mitoquinone | 1件: Mitoquinone Mitoquinone | - | - | - | 1件: 13 13 💬
|
| 1213 | Mitoxantrone | 1件: Mitoxantrone Mitoxantrone | 2件: Mitoxantrone hydrochloride
Mitoxantrone hydrochloride
,
Mitoxantrone
💬
| - | - | 1件: 13 13 💬
|
| 1214 | Mitoxantrone - immunomodulator | 1件: Mitoxantrone Mitoxantrone | 2件: Mitoxantrone hydrochloride
Mitoxantrone hydrochloride
,
Mitoxantrone
💬
| - | - | 1件: 13 13 💬
|
| 1215 | Mitoxantrone hydrochloride liposome injection | 1件: Mitoxantrone Mitoxantrone | 2件: Mitoxantrone hydrochloride
Mitoxantrone hydrochloride
,
Mitoxantrone
💬
| - | - | 1件: 13 13 💬
|
| 1216 | MK0812 | - | - | - | - | 1件: 13 13 💬
|
| 1217 | MLN1202 | - | - | - | - | 1件: 13 13 💬
|
| 1218 | MMF | - | - | - | - | 15件: 13 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 84, 107, 222, 224, 226 💬
|
| 1219 | Modafinil | 1件: Modafinil Modafinil | 1件: Modafinil
Modafinil
💬
| - | - | 4件: 6 6, 13, 49, 93 💬
|
| 1220 | Modafinil generis 100 MG | 1件: Modafinil Modafinil | 1件: Modafinil
Modafinil
💬
| - | - | 1件: 13 13 💬
|
| 1221 | Moderna MRNA-1273, bivalent | - | - | - | - | 7件: 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 1222 | Modified paleolithic diet | - | - | - | - | 1件: 13 13 💬
|
| 1223 | Modified paleolithic elimination diet | - | - | - | - | 1件: 13 13 💬
|
| 1224 | MOG peptide | - | - | - | - | 1件: 13 13 💬
|
| 1225 | Monoclonal antibody M-T412 | - | - | - | - | 1件: 13 13 💬
|
| 1226 | Monomethyl fumarate | 1件: Monomethyl fumarate Monomethyl fumarate | 1件: Monomethyl fumarate
Monomethyl fumarate
💬
| - | - | 1件: 13 13 💬
|
| 1227 | Monomethyl fumarate 190 MG | 1件: Monomethyl fumarate Monomethyl fumarate | 1件: Monomethyl fumarate
Monomethyl fumarate
💬
| - | - | 1件: 13 13 💬
|
| 1228 | Monovalent [B.1.351] COV2 pres DTM-AS03 | - | - | - | - | 7件: 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 1229 | Montelukast | 1件: Montelukast Montelukast | 2件: Montelukast sodium
Montelukast sodium
,
Montelukast
💬
| 1件: CYSLTR1 CYSLTR1 💬
| 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 9件: 6 6, 13, 19, 46, 61, 63, 85, 98, 228 💬
|
| 1230 | MOR103 | - | - | - | - | 2件: 13 13, 46 💬
|
| 1231 | Most recent vaccine TO seasonal influenza | - | - | - | - | 1件: 13 13 💬
|
| 1232 | Motivational interviewing | - | - | - | - | 1件: 13 13 💬
|
| 1233 | Motor imagery AS compared TO physical practice FOR balance tasks | - | - | - | - | 1件: 13 13 💬
|
| 1234 | MPA | - | - | - | - | 8件: 13 13, 35, 46, 49, 50, 51, 60, 107 💬
|
| 1235 | MRI brain and cervical spine | - | - | - | - | 1件: 13 13 💬
|
| 1236 | MRI contrast-enhancing agents | - | - | - | - | 1件: 13 13 💬
|
| 1237 | MRI contrast-enhancing preparations | - | - | - | - | 1件: 13 13 💬
|
| 1238 | Mrna covid-19 vaccine | - | - | - | - | 1件: 13 13 💬
|
| 1239 | MRNA-1195 | - | - | - | - | 1件: 13 13 💬
|
| 1240 | MRNA-1273 | - | - | - | - | 7件: 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 1241 | MSC2015 | - | - | - | - | 1件: 13 13 💬
|
| 1242 | MSC2304479A | - | - | - | - | 1件: 13 13 💬
|
| 1243 | MSC2304480A | - | - | - | - | 1件: 13 13 💬
|
| 1244 | MSC2304481A | - | - | - | - | 1件: 13 13 💬
|
| 1245 | MSC2304482A | - | - | - | - | 1件: 13 13 💬
|
| 1246 | MSC2358825A | - | - | - | - | 1件: 13 13 💬
|
| 1247 | MSC2364447C | - | - | - | - | 2件: 13 13, 49 💬
|
| 1248 | MSC2491529A | - | - | - | - | 1件: 13 13 💬
|
| 1249 | Mscs | - | - | - | - | 2件: 13 13, 228 💬
|
| 1250 | MT-1303 | - | - | - | - | 3件: 13 13, 96, 97 💬
|
| 1251 | MT-1303-forma | - | - | - | - | 1件: 13 13 💬
|
| 1252 | MT-1303-formb | - | - | - | - | 1件: 13 13 💬
|
| 1253 | MT-1303-high | - | - | - | - | 1件: 13 13 💬
|
| 1254 | MT-1303-LOW | - | - | - | - | 1件: 13 13 💬
|
| 1255 | MT-1303-middle | - | - | - | - | 1件: 13 13 💬
|
| 1256 | MTR-601 | - | - | - | - | 1件: 13 13 💬
|
| 1257 | MTX | - | - | - | - | 14件: 13 13, 35, 40, 46, 49, 50, 51, 54, 55, 60, 84, 96, 107, 162 💬
|
| 1258 | Multiferon | - | - | - | - | 1件: 13 13 💬
|
| 1259 | Mutagrip | - | - | - | - | 2件: 11 11, 13 💬
|
| 1260 | Mybetaapp | - | - | - | - | 1件: 13 13 💬
|
| 1261 | Mycophenolate mofetil | 2件: Mycophenolate mofetil Mycophenolate mofetil,
Mycophenolic acid | 4件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH IMPDH,
IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 32件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 46, 49, 51, 53, 60, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
|
| 1262 | Mycophenolate mofetil, MMF | 2件: Mycophenolate mofetil Mycophenolate mofetil,
Mycophenolic acid | 4件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH IMPDH,
IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 1件: 13 13 💬
|
| 1263 | Myelin | 1件: Myelin basic protein Myelin basic protein | - | - | - | 1件: 13 13 💬
|
| 1264 | Myeloablative regimen | - | - | - | - | 1件: 13 13 💬
|
| 1265 | Méthylprednisolone mylan | - | - | - | - | 1件: 13 13 💬
|
| 1266 | N acetylcysteine | - | - | - | - | 1件: 13 13 💬
|
| 1267 | N-acetyl cysteine | - | - | - | - | 6件: 13 13, 34, 85, 88, 296, 310 💬
|
| 1268 | N-acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: Acetylcysteine
Acetylcysteine
💬
| - | - | 14件: 6 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 296, 299, 337 💬
|
| 1269 | N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine | - | - | - | - | 1件: 13 13 💬
|
| 1270 | N. meningitidis group W135 oligosaccharide conjugated CRM197 | - | - | - | - | 1件: 13 13 💬
|
| 1271 | N02bg10 | - | - | - | - | 1件: 13 13 💬
|
| 1272 | N03ax12 | - | - | - | - | 1件: 13 13 💬
|
| 1273 | N06dx01 | - | - | - | - | 1件: 13 13 💬
|
| 1274 | NA18F | - | - | - | - | 1件: 13 13 💬
|
| 1275 | Nabilone | 1件: Nabilone Nabilone | 1件: Nabilone
Nabilone
💬
| 2件: CNR1 CNR1,
CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 4件: 6 6, 13, 97, 127 💬
|
| 1276 | Nabiximols | 1件: Nabiximols Nabiximols | 1件: Nabiximols
Nabiximols
💬
| - | - | 1件: 13 13 💬
|
| 1277 | Nabiximols - sativex | 3件: Cannabidiol Cannabidiol,
Dronabinol,
Nabiximols | 3件: Dronabinol
Dronabinol
,
Nabiximols
,
Cannabidiol
💬
| 2件: CNR1 CNR1,
CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
| 1278 | Naltrexone | 1件: Naltrexone Naltrexone | 2件: Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| 3件: OPRD1 OPRD1,
OPRK1,
OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 6 6, 10, 13, 96, 226 💬
|
| 1279 | Namisol | - | - | - | - | 2件: 13 13, 298 💬
|
| 1280 | Nanocort | - | - | - | - | 3件: 13 13, 46, 97 💬
|
| 1281 | Nanocurcumin | - | - | - | - | 2件: 13 13, 271 💬
|
| 1282 | Naproxen | 1件: Naproxen Naproxen | 2件: Naproxen
Naproxen
,
Naproxen sodium
💬
| 2件: PTGS1 PTGS1,
PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 4件: 13 13, 46, 107, 271 💬
|
| 1283 | Natalizumab | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 5件: 13 13, 15, 25, 46, 96 💬
|
| 1284 | Natalizumab 300 MG IN 15 ML injection | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 1285 | Natalizumab discontinuation | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 1286 | Natalizumab FOR IV infusion | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 1287 | Natalizumab FOR subcutaneous injection | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 1288 | Natalizumab IV | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 1289 | Natalizumab SC | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 1290 | Natalizumab treatment | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 1291 | Natalizumab/natalizumab-sztn, alemtuzumab, ocrelizumab, rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, cladribine, ofatumumab, ublituximab-xiiy, ocrelizumab and hyaluronidase-ocsq | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 1292 | NBI-5788 | - | - | - | - | 1件: 13 13 💬
|
| 1293 | Nebido | - | - | - | - | 1件: 13 13 💬
|
| 1294 | Nebido® testosterone undecanoate 1000 MG/4 ML solution FOR injection | - | - | - | - | 1件: 13 13 💬
|
| 1295 | Neorecormon | 2件: Epoetin beta Epoetin beta,
Erythropoietin | 5件: Epoetin alfa
Epoetin alfa
,
Epoetin beta
,
Epoetin epsilon
,
Epoetin theta
,
Epoetin zeta
💬
| 1件: EPOR EPOR 💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 2件: 13 13, 18 💬
|
| 1296 | Neramexane mesylate | 1件: Neramexane Neramexane | - | - | - | 1件: 13 13 💬
|
| 1297 | Nerispirdine | 1件: Nerispirdine Nerispirdine | - | - | - | 1件: 13 13 💬
|
| 1298 | Nerispirdine hydrochloride | 1件: Nerispirdine Nerispirdine | - | - | - | 1件: 13 13 💬
|
| 1299 | Neupogen | 1件: Filgrastim Filgrastim | 1件: Filgrastim
Filgrastim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 4件: 13 13, 28, 51, 285 💬
|
| 1300 | Neuromuscular electrical stimulation delivered using THE electrical therapy device empi 300 PV | - | - | - | - | 1件: 13 13 💬
|
| 1301 | Neuromuscular evaluation | - | - | - | - | 1件: 13 13 💬
|
| 1302 | Neurontin | 1件: Gabapentin Gabapentin | 1件: Gabapentin
Gabapentin
💬
| 5件: CACNA2D1 CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬
| 10件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 1303 | Neurontin 300 MG hard capsule | 1件: Gabapentin Gabapentin | 1件: Gabapentin
Gabapentin
💬
| 5件: CACNA2D1 CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬
| 10件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 1304 | Neurovax | 1件: NeuroVax NeuroVax | - | - | - | 1件: 13 13 💬
|
| 1305 | Neurovax 300UG/ML dose FOR IM injection | 1件: NeuroVax NeuroVax | - | - | - | 1件: 13 13 💬
|
| 1306 | NEW formulation OF rebif - human interferon BETA-1A | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1307 | NG01 - autologous bone marrow derived human stromal cells | - | - | - | - | 1件: 13 13 💬
|
| 1308 | Niacinamide | 1件: Nicotinamide Nicotinamide | 1件: Niacinamide
Niacinamide
💬
| - | - | 3件: 6 6, 13, 67 💬
|
| 1309 | Nicotinamid riboside | - | - | - | - | 1件: 13 13 💬
|
| 1310 | Nicotine and cotinine serum levels | 1件: Nicotine Nicotine | 2件: Nicotine
Nicotine
,
Nicotine bitartrate
💬
| 16件: CHRNA1 CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
| 9件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | 1件: 13 13 💬
|
| 1311 | Nicotine dependence | 1件: Nicotine Nicotine | 2件: Nicotine
Nicotine
,
Nicotine bitartrate
💬
| 16件: CHRNA1 CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬
| 9件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | 1件: 13 13 💬
|
| 1312 | Nintendo WII FIT balance board | - | - | - | - | 1件: 13 13 💬
|
| 1313 | Nintendo WII FIT balance exercises | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 13 13 💬
|
| 1314 | Nirs after bosentan administration | - | - | - | - | 1件: 13 13 💬
|
| 1315 | Nirs baseline | - | - | - | - | 1件: 13 13 💬
|
| 1316 | Nitrofurantoin | 1件: Nitrofurantoin Nitrofurantoin | 1件: Nitrofurantoin
Nitrofurantoin
💬
| - | - | 1件: 13 13 💬
|
| 1317 | Nivolumab | 1件: Nivolumab Nivolumab | 1件: Nivolumab
Nivolumab
💬
| 1件: PDCD1 PDCD1 💬
| 3件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | 12件: 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
|
| 1318 | NO treatment ARM | - | - | - | - | 1件: 13 13 💬
|
| 1319 | Nomegestrol | 1件: Nomegestrol Nomegestrol | 1件: Nomegestrol
Nomegestrol
💬
| 1件: PGR PGR 💬
| 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 💬
|
| 1320 | Nomegestrol acetate | 2件: Nomegestrol Nomegestrol,
Nomegestrol acetate | 2件: Nomegestrol
Nomegestrol
,
Nomegestrol acetate
💬
| 1件: PGR PGR 💬
| 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 💬
|
| 1321 | NON disponibile | - | - | - | - | 2件: 13 13, 201 💬
|
| 1322 | NON-pegylated interferon | - | - | - | - | 1件: 13 13 💬
|
| 1323 | Norethindrone | 1件: Norethisterone Norethisterone | 2件: Norethindrone
Norethindrone
,
Norethindrone acetate
💬
| 1件: PGR PGR 💬
| 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 4件: 13 13, 46, 49, 299 💬
|
| 1324 | Normal saline | - | - | - | - | 20件: 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 97, 210, 211, 222, 226, 276, 280, 296, 299 💬
|
| 1325 | Normal saline FOR injection | - | - | - | - | 2件: 13 13, 84 💬
|
| 1326 | NOT applicable | - | - | - | - | 1件: 13 13 💬
|
| 1327 | Novantrone*INF 2MG/ML 5ML | 1件: Mitoxantrone Mitoxantrone | 2件: Mitoxantrone hydrochloride
Mitoxantrone hydrochloride
,
Mitoxantrone
💬
| - | - | 1件: 13 13 💬
|
| 1328 | Novartis pharmaceuticals corporation | - | - | - | - | 1件: 13 13 💬
|
| 1329 | Novatrex | - | - | - | - | 1件: 13 13 💬
|
| 1330 | NPB-01 | - | - | - | - | 3件: 13 13, 14, 162 💬
|
| 1331 | NT-KO-003 | - | - | - | - | 1件: 13 13 💬
|
| 1332 | NU100 | - | - | - | - | 1件: 13 13 💬
|
| 1333 | NVF233 | - | - | - | - | 1件: 13 13 💬
|
| 1334 | Obexelimab | 1件: Obexelimab Obexelimab | 1件: Obexelimab
Obexelimab
💬
| 1件: CD19 CD19 💬
| 5件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | 4件: 13 13, 49, 61, 300 💬
|
| 1335 | Observation OF ocrelizumab AS treatment IN rrms patients | - | - | - | - | 1件: 13 13 💬
|
| 1336 | Observational control | - | - | - | - | 1件: 13 13 💬
|
| 1337 | OCH-NCNP1 | - | - | - | - | 1件: 13 13 💬
|
| 1338 | Oclelizumab | - | - | - | - | 1件: 13 13 💬
|
| 1339 | OCR | - | - | - | - | 1件: 13 13 💬
|
| 1340 | Ocrelizumab | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 4件: 11 11, 13, 46, 49 💬
|
| 1341 | Ocrelizumab 300 MG | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1342 | Ocrelizumab 300MG | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1343 | Ocrelizumab 300MG/10 ML | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1344 | Ocrelizumab 300MG/10ML | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1345 | Ocrelizumab 600 MG | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1346 | Ocrelizumab AT home | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1347 | Ocrelizumab dose 1 | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1348 | Ocrelizumab dose 2 and dose 3 | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1349 | Ocrelizumab IV | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1350 | Ocrelizumab SC | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1351 | Ocrevus | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1352 | Ocrevus 300 MG, solution à diluer pour perfusion | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1353 | Ocrevus-EU | - | - | - | - | 1件: 13 13 💬
|
| 1354 | Ocrevus-US | - | - | - | - | 1件: 13 13 💬
|
| 1355 | Ocrrelizumab 300 MG | - | - | - | - | 1件: 13 13 💬
|
| 1356 | Octagam | 1件: Human immunoglobulin G Human immunoglobulin G | 1件: Globulin, immune
Globulin, immune
💬
| - | - | 2件: 13 13, 65 💬
|
| 1357 | Octagam 50 MG/ML | 1件: Human immunoglobulin G Human immunoglobulin G | 1件: Globulin, immune
Globulin, immune
💬
| - | - | 1件: 13 13 💬
|
| 1358 | Ocufolin | - | - | - | - | 1件: 13 13 💬
|
| 1359 | Ofatumumab | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 4件: 11 11, 13, 35, 46 💬
|
| 1360 | Ofatumumab 100 | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1361 | Ofatumumab 300 | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1362 | Ofatumumab 30MG | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1363 | Ofatumumab 3MG | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1364 | Ofatumumab 60MG | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1365 | Ofatumumab 700 | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1366 | Ofatumumab approved dose | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1367 | Ofatumumab NEW dose | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1368 | Ofatumumab subcutaneous injection | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 13 13, 35 💬
|
| 1369 | Ofatumumab with AI | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1370 | Ofatumumab with PRF | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1371 | Ofatunumab | - | - | - | - | 1件: 13 13 💬
|
| 1372 | Oleovit D3 14.400 IU/ML oral drops, solution | - | - | - | - | 1件: 13 13 💬
|
| 1373 | Olesoxime | 1件: Olesoxime Olesoxime | 1件: Olesoxime
Olesoxime
💬
| - | - | 3件: 2 2, 3, 13 💬
|
| 1374 | OMB157 | - | - | - | - | 1件: 13 13 💬
|
| 1375 | OMB157G | - | - | - | - | 1件: 13 13 💬
|
| 1376 | Omega 3 fatty acids | 1件: Omega-3 fatty acids Omega-3 fatty acids | - | - | - | 1件: 13 13 💬
|
| 1377 | Omega-3 fatty acids | 1件: Omega-3 fatty acids Omega-3 fatty acids | - | - | - | 2件: 13 13, 79 💬
|
| 1378 | Omeprazole | 1件: Omeprazole Omeprazole | 3件: Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| 2件: ATP4A ATP4A,
ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 12件: 6 6, 13, 21, 46, 85, 90, 96, 97, 98, 271, 282, 298 💬
|
| 1379 | Onabotulinumtoxina | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 2件: 6 6, 13 💬
|
| 1380 | ONE-LEG stance test | - | - | - | - | 1件: 13 13 💬
|
| 1381 | ONO-4641 | - | - | - | - | 1件: 13 13 💬
|
| 1382 | ONO-4641/ MSC2430913A | - | - | - | - | 1件: 13 13 💬
|
| 1383 | ONO-4641/MSC2430913A | - | - | - | - | 1件: 13 13 💬
|
| 1384 | Opicinumab | 1件: Opicinumab Opicinumab | 1件: Opicinumab
Opicinumab
💬
| - | - | 1件: 13 13 💬
|
| 1385 | Oral corticosteroids | - | - | - | - | 4件: 13 13, 46, 97, 251 💬
|
| 1386 | Oral glucocorticoids | - | - | - | - | 1件: 13 13 💬
|
| 1387 | Oral glucose tolerance test | - | - | - | - | 6件: 6 6, 13, 77, 160, 195, 299 💬
|
| 1388 | Oral immunosuppressant | - | - | - | - | 1件: 13 13 💬
|
| 1389 | Oral methylprednisolone 625 MG/24H X3 days | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 1390 | Oral THC | - | - | - | - | 1件: 13 13 💬
|
| 1391 | ORCA-Q | - | - | - | - | 1件: 13 13 💬
|
| 1392 | Orelabrutinib | 1件: Orelabrutinib Orelabrutinib | 1件: Orelabrutinib
Orelabrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 4件: 13 13, 49, 61, 63 💬
|
| 1393 | ORY2001 | - | - | - | - | 1件: 13 13 💬
|
| 1394 | OS440 | - | - | - | - | 1件: 13 13 💬
|
| 1395 | Other analgesics and antipyretics | - | - | - | - | 1件: 13 13 💬
|
| 1396 | Other disease modifying therapies | - | - | - | - | 1件: 13 13 💬
|
| 1397 | Other disease-modifying therapy | - | - | - | - | 1件: 13 13 💬
|
| 1398 | Other H1 antagonist | - | - | - | - | 1件: 13 13 💬
|
| 1399 | Other nervous system drugs | - | - | - | - | 2件: 6 6, 13 💬
|
| 1400 | Ovastat 1000 | 1件: Treosulfan Treosulfan | 1件: Treosulfan
Treosulfan
💬
| - | - | 2件: 13 13, 65 💬
|
| 1401 | Ovastat 5000 | 1件: Treosulfan Treosulfan | 1件: Treosulfan
Treosulfan
💬
| - | - | 2件: 13 13, 65 💬
|
| 1402 | Oxcarbazepine | 1件: Oxcarbazepine Oxcarbazepine | 1件: Oxcarbazepine
Oxcarbazepine
💬
| 5件: SCN1A SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 13 13 💬
|
| 1403 | Oxiklorin | - | - | - | - | 2件: 13 13, 46 💬
|
| 1404 | Oxine | 1件: Oxyquinoline Oxyquinoline | 2件: Oxyquinoline sulfate
Oxyquinoline sulfate
,
Oxyquinoline
💬
| - | - | 2件: 13 13, 51 💬
|
| 1405 | Oxybutynin hydrochloride | 1件: Oxybutynin Oxybutynin | 2件: Oxybutynin
Oxybutynin
,
Oxybutynin chloride
💬
| 5件: CHRM1 CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
| 14件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 2件: 6 6, 13 💬
|
| 1406 | Ozanimod | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 96, 97 💬
|
| 1407 | Ozanimod 0.5 MG | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1408 | Ozanimod 1 MG | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1409 | Ozanimod cloridrato | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1410 | Ozanimod HCI | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1411 | Ozanimod HCL | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 96, 97 💬
|
| 1412 | Ozanimod hydrochloride | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 96, 97 💬
|
| 1413 | Ozanimod oral capsule | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 97 💬
|
| 1414 | Pain | - | - | - | - | 1件: 13 13 💬
|
| 1415 | Palifermin | 1件: Palifermin Palifermin | 1件: Palifermin
Palifermin
💬
| 1件: FGFR2 FGFR2 💬
| 12件: Calcium signaling pathway Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬 | 6件: 13 13, 36, 38, 39, 65, 96 💬
|
| 1416 | Pantoprazole | 1件: Pantoprazole Pantoprazole | 2件: Pantoprazole sodium
Pantoprazole sodium
,
Pantoprazole
💬
| 2件: ATP4A ATP4A,
ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 2件: 13 13, 65 💬
|
| 1417 | Paracetamol | 1件: Acetaminophen Acetaminophen | 1件: Acetaminophen
Acetaminophen
💬
| 2件: PTGS1 PTGS1,
PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 4件: 3 3, 6, 13, 46 💬
|
| 1418 | Paracetamolo 500 MG | - | - | - | - | 1件: 13 13 💬
|
| 1419 | Paroxetine | 1件: Paroxetine Paroxetine | 4件: Paroxetine hydrochloride hemihydrate
Paroxetine hydrochloride hemihydrate
,
Paroxetine
,
Paroxetine hydrochloride
,
Paroxetine mesylate
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 6 6, 13, 46, 85 💬
|
| 1420 | Part A: 100 MG/ML GSK2618960 | - | - | - | - | 1件: 13 13 💬
|
| 1421 | Part B: dose OF GSK2618960 decided from part A | - | - | - | - | 1件: 13 13 💬
|
| 1422 | Part C: dose OF GSK2618960 decided from part A and B | - | - | - | - | 1件: 13 13 💬
|
| 1423 | PB006 | - | - | - | - | 1件: 13 13 💬
|
| 1424 | PCV | - | - | - | - | 1件: 13 13 💬
|
| 1425 | Peak | - | - | - | - | 1件: 13 13 💬
|
| 1426 | Peanut butter | 1件: Peanut Peanut | - | - | - | 1件: 13 13 💬
|
| 1427 | PEG | - | - | - | - | 8件: 6 6, 13, 41, 46, 76, 97, 246, 337 💬
|
| 1428 | PEG-liposomal prednisolone sodium phosphate | 2件: Phosphate ion Phosphate ion,
Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 97 💬
|
| 1429 | Peginterferon BETA-1A | 1件: Peginterferon beta-1a Peginterferon beta-1a | 1件: Peginterferon beta-1a
Peginterferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1430 | Peginterferone beta 1A | - | - | - | - | 1件: 13 13 💬
|
| 1431 | Peginterferone BETA-1A | - | - | - | - | 1件: 13 13 💬
|
| 1432 | Peginterferone lambda-1A | - | - | - | - | 1件: 13 13 💬
|
| 1433 | Pegylated intereron BETA-1A | - | - | - | - | 1件: 13 13 💬
|
| 1434 | Pegylated interferon BETA-1A | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1435 | Pending | - | - | - | - | 7件: 6 6, 13, 19, 96, 97, 113, 302 💬
|
| 1436 | Peptid coupled RED blood cells | - | - | - | - | 1件: 13 13 💬
|
| 1437 | Peptide coupled RED blood cells | - | - | - | - | 1件: 13 13 💬
|
| 1438 | Perfusion OF treatment ocrelizumab | - | - | - | - | 1件: 13 13 💬
|
| 1439 | Perfusion OF treatment rituximab | - | - | - | - | 1件: 13 13 💬
|
| 1440 | Periodized exercise training | - | - | - | - | 1件: 13 13 💬
|
| 1441 | Peripheral blood stem cell transplantation | - | - | - | - | 12件: 11 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 💬
|
| 1442 | Peripheral blood withdrawal | - | - | - | - | 1件: 13 13 💬
|
| 1443 | Personalized extended interval dosing OF natalizumab | - | - | - | - | 1件: 13 13 💬
|
| 1444 | PET with 11C-flumazenil | - | - | - | - | 1件: 13 13 💬
|
| 1445 | PET with [11C]flumazenil | - | - | - | - | 1件: 13 13 💬
|
| 1446 | PET/CT scan | - | - | - | - | 2件: 13 13, 67 💬
|
| 1447 | PF-06342674 0.25 MG/KG | - | - | - | - | 1件: 13 13 💬
|
| 1448 | PF-06342674 1.5 MG/KG | - | - | - | - | 1件: 13 13 💬
|
| 1449 | PF-06342674 6.0 MG/KG | - | - | - | - | 1件: 13 13 💬
|
| 1450 | Phase 2 | - | - | - | - | 1件: 13 13 💬
|
| 1451 | Phase 3 | - | - | - | - | 1件: 13 13 💬
|
| 1452 | Phenylcyclopropylamine derivatives and dual LSD1/MAO-B (lysine-specific demethylase 1 and monoamine oxidase-B) inhibitor | - | - | - | - | 1件: 13 13 💬
|
| 1453 | Phenytoin | 1件: Phenytoin Phenytoin | 2件: Phenytoin
Phenytoin
,
Phenytoin sodium
💬
| 5件: SCN1A SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 13 13 💬
|
| 1454 | Phosphate | 1件: Phosphate ion Phosphate ion | - | - | - | 13件: 3 3, 11, 13, 46, 65, 70, 75, 90, 235, 238, 256, 286, 288 💬
|
| 1455 | PI-2301 | - | - | - | - | 1件: 13 13 💬
|
| 1456 | Pioglitazone | 1件: Pioglitazone Pioglitazone | 2件: Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 16件: 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 220, 229, 265, 298, 299 💬
|
| 1457 | PIPE-307 | - | - | - | - | 1件: 13 13 💬
|
| 1458 | PIPE-307 dose A | - | - | - | - | 1件: 13 13 💬
|
| 1459 | PIPE-307 dose B | - | - | - | - | 1件: 13 13 💬
|
| 1460 | PIPE-791 | - | - | - | - | 2件: 13 13, 85 💬
|
| 1461 | Pirfenidone | 1件: Pirfenidone Pirfenidone | 1件: Pirfenidone
Pirfenidone
💬
| 6件: CCL2 CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬
| 83件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
| 1462 | Pirtobrutinib | 1件: Pirtobrutinib Pirtobrutinib | 1件: Pirtobrutinib
Pirtobrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 1件: 13 13 💬
|
| 1463 | Pixantrone | 1件: Pixantrone Pixantrone | 2件: Pixantrone
Pixantrone
,
Pixantrone dimaleate
💬
| - | - | 2件: 11 11, 13 💬
|
| 1464 | PL 04515/0127 | - | - | - | - | 1件: 13 13 💬
|
| 1465 | PL 12762/0049 | - | - | - | - | 1件: 13 13 💬
|
| 1466 | Plasma exchange | - | - | - | - | 7件: 13 13, 43, 44, 64, 95, 171, 222 💬
|
| 1467 | Plasticity-based computerized cognitive remediation program | - | - | - | - | 1件: 13 13 💬
|
| 1468 | Platelet transfusion | - | - | - | - | 1件: 13 13 💬
|
| 1469 | Platform | - | - | - | - | 1件: 13 13 💬
|
| 1470 | Pledigry | - | - | - | - | 1件: 13 13 💬
|
| 1471 | Plegridy | 1件: Peginterferon beta-1a Peginterferon beta-1a | 1件: Peginterferon beta-1a
Peginterferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1472 | Plegridy (peginterferon BETA-1A), biogen idec LTD | 1件: Peginterferon beta-1a Peginterferon beta-1a | 1件: Peginterferon beta-1a
Peginterferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1473 | Plegridy - 125 MCG - soluzione iniettabile - USO sottocutaneo - penna preriempita - 0,5 ML - 6 penne preriempite | - | - | - | - | 1件: 13 13 💬
|
| 1474 | Plegridy 125 micrograms | 1件: Peginterferon beta-1a Peginterferon beta-1a | 1件: Peginterferon beta-1a
Peginterferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1475 | Plegridy 63 micrograms | 1件: Peginterferon beta-1a Peginterferon beta-1a | 1件: Peginterferon beta-1a
Peginterferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1476 | Pleneva TM BGC20-0134 | - | - | - | - | 1件: 13 13 💬
|
| 1477 | Plovamer acetate | - | - | - | - | 1件: 13 13 💬
|
| 1478 | Plovamer acetate 10 MG | - | - | - | - | 1件: 13 13 💬
|
| 1479 | Plovamer acetate 20 MG | - | - | - | - | 1件: 13 13 💬
|
| 1480 | Plovamer acetate 3 MG | - | - | - | - | 1件: 13 13 💬
|
| 1481 | PLP peptide | - | - | - | - | 1件: 13 13 💬
|
| 1482 | Pneumococcal polysaccharide vaccine | - | - | - | - | 2件: 13 13, 46 💬
|
| 1483 | Pneumovax II | - | - | - | - | 1件: 13 13 💬
|
| 1484 | PNF | - | - | - | - | 1件: 13 13 💬
|
| 1485 | PNU-215062 sodium salt | - | - | - | - | 1件: 13 13 💬
|
| 1486 | Polyphenon E | 1件: Sinecatechins Sinecatechins | 1件: Sinecatechins
Sinecatechins
💬
| - | - | 3件: 13 13, 36, 97 💬
|
| 1487 | Ponesimod | 1件: Ponesimod Ponesimod | 1件: Ponesimod
Ponesimod
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1488 | Ponesimod 10 MG | 1件: Ponesimod Ponesimod | 1件: Ponesimod
Ponesimod
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1489 | Ponesimod 20 MG | 1件: Ponesimod Ponesimod | 1件: Ponesimod
Ponesimod
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1490 | Ponesimod 40 MG | 1件: Ponesimod Ponesimod | 1件: Ponesimod
Ponesimod
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1491 | Ponvory | 1件: Ponesimod Ponesimod | 1件: Ponesimod
Ponesimod
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1492 | Position sense | - | - | - | - | 1件: 13 13 💬
|
| 1493 | Pravastatin | 1件: Pravastatin Pravastatin | 2件: Pravastatin sodium
Pravastatin sodium
,
Pravastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 10件: 13 13, 46, 49, 67, 79, 96, 164, 210, 265, 333 💬
|
| 1494 | PRD806998 | - | - | - | - | 1件: 13 13 💬
|
| 1495 | Prebiotics and probiotics supplementation | - | - | - | - | 1件: 13 13 💬
|
| 1496 | Prednisolone | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 38件: 3 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
|
| 1497 | Prednisone | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 54件: 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
|
| 1498 | Pregabalin | 1件: Pregabalin Pregabalin | 1件: Pregabalin
Pregabalin
💬
| 4件: CACNA2D1 CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬
| 7件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | 5件: 13 13, 36, 46, 70, 298 💬
|
| 1499 | Prepulsid | - | - | - | - | 1件: 13 13 💬
|
| 1500 | Prevenar 13 | - | - | - | - | 4件: 13 13, 46, 96, 97 💬
|
| 1501 | PRN2246 | - | - | - | - | 2件: 11 11, 13 💬
|
| 1502 | Procedure/surgery: implant procedure | - | - | - | - | 1件: 13 13 💬
|
| 1503 | Progressive exercise | - | - | - | - | 1件: 13 13 💬
|
| 1504 | Prolonged-release fampridine | - | - | - | - | 1件: 13 13 💬
|
| 1505 | Propensity score | - | - | - | - | 1件: 13 13 💬
|
| 1506 | Propionic acid 1000 MG capsule | 1件: Propanoic acid Propanoic acid | 3件: Propionic acid
Propionic acid
,
Sodium propionate
,
Sodium propionate
💬
| - | - | 1件: 13 13 💬
|
| 1507 | Protein A immunoadsorption | - | - | - | - | 1件: 13 13 💬
|
| 1508 | Provigil | 1件: Modafinil Modafinil | 1件: Modafinil
Modafinil
💬
| - | - | 1件: 13 13 💬
|
| 1509 | Prucalopride | 1件: Prucalopride Prucalopride | 2件: Prucalopride
Prucalopride
,
Prucalopride succinate
💬
| 1件: HTR4 HTR4 💬
| 5件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | 2件: 13 13, 96 💬
|
| 1510 | Psilocybin therapy | 1件: Psilocybin Psilocybin | 1件: Psilocybin
Psilocybin
💬
| 1件: HTR2 HTR2 💬
| 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 3件: 2 2, 6, 13 💬
|
| 1511 | PSP | - | - | - | - | 1件: 13 13 💬
|
| 1512 | PTL201 | - | - | - | - | 1件: 13 13 💬
|
| 1513 | Qalcimum questionnaire | - | - | - | - | 2件: 13 13, 46 💬
|
| 1514 | Quadrivalent influenza vaccine | - | - | - | - | 1件: 13 13 💬
|
| 1515 | Quality OF life | - | - | - | - | 1件: 13 13 💬
|
| 1516 | Quality OF life questionnaires | - | - | - | - | 2件: 13 13, 234 💬
|
| 1517 | Questionnaires | - | - | - | - | 7件: 3 3, 6, 13, 28, 41, 49, 96 💬
|
| 1518 | Quinidina sulfato | 1件: Quinidine Quinidine | 4件: Quinidine gluconate
Quinidine gluconate
,
Quinidine polygalacturonate
,
Quinidine sulfate
,
Quinidine
💬
| 5件: SCN1A SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 13 13 💬
|
| 1519 | Quinidine sulfate | 1件: Quinidine Quinidine | 4件: Quinidine gluconate
Quinidine gluconate
,
Quinidine polygalacturonate
,
Quinidine sulfate
,
Quinidine
💬
| 5件: SCN1A SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 13 13 💬
|
| 1520 | R lipoic acid | 1件: Lipoic acid Lipoic acid | 1件: Thioctic acid
Thioctic acid
💬
| - | - | 1件: 13 13 💬
|
| 1521 | RA15804589, C19061501-F, DNL788, DN2489, DN0002489 | - | - | - | - | 2件: 2 2, 13 💬
|
| 1522 | Rabbit | 1件: Rabbit Rabbit | - | - | - | 5件: 11 11, 13, 60, 96, 285 💬
|
| 1523 | Rabbit ANTI-human thymocyte immunoglobulin | 2件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit),
Rabbit | 1件: Anti-human thymocyte immunoglobulin, rabbit
Anti-human thymocyte immunoglobulin, rabbit
💬
| 11件: CD2 CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬
| 31件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 2件: 13 13, 96 💬
|
| 1524 | Rabbit human T lymphocyte immunoglobulin | 1件: Rabbit Rabbit | - | - | - | 2件: 13 13, 60 💬
|
| 1525 | Radiation therapy | - | - | - | - | 6件: 13 13, 34, 60, 65, 284, 285 💬
|
| 1526 | Radiotracer [11C]-CS1p1 | - | - | - | - | 1件: 13 13 💬
|
| 1527 | Radiotracer [11C]-DPA-713 | - | - | - | - | 1件: 13 13 💬
|
| 1528 | Radiotracer [12F]-FDG | - | - | - | - | 1件: 13 13 💬
|
| 1529 | Ralenova | - | - | - | - | 1件: 13 13 💬
|
| 1530 | Raltegravir | 1件: Raltegravir Raltegravir | 2件: Raltegravir
Raltegravir
,
Raltegravir potassium
💬
| - | - | 4件: 13 13, 26, 93, 265 💬
|
| 1531 | Ramatroban | 1件: Ramatroban Ramatroban | 1件: Ramatroban
Ramatroban
💬
| 2件: PTGDR PTGDR,
TBXA2R 💬
| 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬 | 1件: 13 13 💬
|
| 1532 | Ranitidine | 1件: Ranitidine Ranitidine | 3件: Ranitidine
Ranitidine
,
Ranitidine hydrochloride
,
Ranitidine bismuth citrate
💬
| 1件: HRH2 HRH2 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 65 💬
|
| 1533 | Raptiva 100 MG/ML powder and solvent FOR solution FOR injection | 1件: Efalizumab Efalizumab | 1件: Efalizumab
Efalizumab
💬
| 1件: ITGAL ITGAL 💬
| 12件: Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | 8件: 11 11, 13, 46, 53, 61, 95, 96, 221 💬
|
| 1534 | Ratg | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | 1件: Anti-human thymocyte immunoglobulin, rabbit
Anti-human thymocyte immunoglobulin, rabbit
💬
| 11件: CD2 CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬
| 31件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 4件: 13 13, 51, 60, 285 💬
|
| 1535 | Ravulizumab | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件: 2 2, 11, 13, 50, 62, 66, 109 💬
|
| 1536 | RC18 160 MG | - | - | - | - | 2件: 13 13, 53 💬
|
| 1537 | RC18 160MG | - | - | - | - | 3件: 11 11, 13, 66 💬
|
| 1538 | RC18 240MG | - | - | - | - | 2件: 13 13, 66 💬
|
| 1539 | RD06-05 cart cell injection | - | - | - | - | 2件: 13 13, 51 💬
|
| 1540 | Rebif | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1541 | Rebif (interferon BETA-1A), merck serono europe LTD | 2件: Human interferon beta Human interferon beta,
Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1542 | Rebif 22 | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1543 | Rebif 22 micrograms | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1544 | Rebif 22 Y 44 MCG | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1545 | Rebif 44 | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1546 | Rebif 44 microgrammi/0.5ML soluzione iniettabile IN cartuccia | - | - | - | - | 1件: 13 13 💬
|
| 1547 | Rebif 44 microgramos solucióN inyectable | - | - | - | - | 1件: 13 13 💬
|
| 1548 | Rebif 44 microgramos solucióN inyectable EN jeringa precargada | - | - | - | - | 1件: 13 13 💬
|
| 1549 | Rebif 44 micrograms | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1550 | Rebif 44 micrograms solution FOR injection | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1551 | Rebif 44 micrograms solution FOR injection IN PRE-filled syringe | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1552 | Rebif 44 µG | - | - | - | - | 1件: 13 13 💬
|
| 1553 | Rebif 8,8 µG, rebif 22µG | - | - | - | - | 1件: 13 13 💬
|
| 1554 | Rebif 8.8 micrograms and 22 micrograms solution FOR injection IN PRE-filled syringe initiation pack | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1555 | Rebif NEW formulation + ibuprofen PRN | - | - | - | - | 1件: 13 13 💬
|
| 1556 | Rebif NEW formulation + prophylactic ibuprofen | - | - | - | - | 1件: 13 13 💬
|
| 1557 | Rebif NEW formulation 44MCG multidose cartridge | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1558 | Rebif NEW formulation NON titrated | - | - | - | - | 1件: 13 13 💬
|
| 1559 | Rebif NEW formulation titrated | - | - | - | - | 1件: 13 13 💬
|
| 1560 | Rebif SC 12SIR 12000000ui44MCG | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1561 | Rebif SC 12SIR 6000000UI 22MCG | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1562 | Rebif*SC 12SIR 12000000ui44MCG | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1563 | Rebif*SC 12SIR 6000000UI 22MCG | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1564 | Rebif® NEW formulation | - | - | - | - | 1件: 13 13 💬
|
| 1565 | Rebif® NEW formulation (RNF) using rebismarttm | - | - | - | - | 1件: 13 13 💬
|
| 1566 | Recombinant human alpha B-crystallin | - | - | - | - | 1件: 13 13 💬
|
| 1567 | Recombinant human erythropoietin | 1件: Erythropoietin Erythropoietin | 4件: Epoetin alfa
Epoetin alfa
,
Epoetin epsilon
,
Epoetin theta
,
Epoetin zeta
💬
| 1件: EPOR EPOR 💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 13 13 💬
|
| 1568 | Recombinant human IFN beta | - | - | - | - | 1件: 13 13 💬
|
| 1569 | Recombinant human interferon beta | 1件: Human interferon beta Human interferon beta | 1件: Interferon beta
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1570 | Recombinant humanized ANTI-alpha 4 integrin antibody | - | - | - | - | 1件: 13 13 💬
|
| 1571 | Recombinant humanized ANTI-CD20 monoclonal antibody | - | - | - | - | 1件: 13 13 💬
|
| 1572 | Recombinant interferon BE | - | - | - | - | 1件: 13 13 💬
|
| 1573 | Recombinant interferon BETA-1B | 2件: Human interferon beta Human interferon beta,
Interferon beta-1b | 2件: Interferon beta-1b
Interferon beta-1b
,
Interferon beta
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1574 | Recombinant neisseria meningitidis group B nhba fusion protein | - | - | - | - | 2件: 11 11, 13 💬
|
| 1575 | Recombinant zoster vaccine | - | - | - | - | 2件: 13 13, 49 💬
|
| 1576 | Remibrutinib | 1件: Remibrutinib Remibrutinib | 1件: Remibrutinib
Remibrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 3件: 11 11, 13, 53 💬
|
| 1577 | Remibrutinib oral treatment | 1件: Remibrutinib Remibrutinib | 1件: Remibrutinib
Remibrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 1件: 13 13 💬
|
| 1578 | Repository corticotropin injection | 1件: Corticotropin Corticotropin | 2件: Corticotropin
Corticotropin
,
Corticotropin, repository
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 5件: 2 2, 13, 46, 84, 222 💬
|
| 1579 | Revaxis | - | - | - | - | 1件: 13 13 💬
|
| 1580 | REX robotic assisted balance exercises | - | - | - | - | 1件: 13 13 💬
|
| 1581 | RHB-104 | - | - | - | - | 2件: 13 13, 96 💬
|
| 1582 | Rhepo | - | - | - | - | 1件: 13 13 💬
|
| 1583 | Rhifn BETA-1B | - | - | - | - | 1件: 13 13 💬
|
| 1584 | Rhigm22 | - | - | - | - | 1件: 13 13 💬
|
| 1585 | Rhumab 2h7 | 1件: Ocrelizumab Ocrelizumab | 1件: Ocrelizumab
Ocrelizumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 3件: 13 13, 46, 49 💬
|
| 1586 | Rhumab TO IL-17A IGG1-K-class | - | - | - | - | 1件: 13 13 💬
|
| 1587 | Rhuph20 | - | - | - | - | 2件: 13 13, 14 💬
|
| 1588 | Riboflavin | 1件: Riboflavin Riboflavin | 1件: Riboflavin
Riboflavin
💬
| - | - | 7件: 13 13, 38, 46, 97, 162, 168, 265 💬
|
| 1589 | Rifampicin | 1件: Rifampin Rifampin | 2件: Rifampin
Rifampin
,
Rifampicin sodium
💬
| - | - | 8件: 6 6, 13, 17, 46, 93, 97, 299, 338 💬
|
| 1590 | Rifampin | 1件: Rifampin Rifampin | 2件: Rifampin
Rifampin
,
Rifampicin sodium
💬
| - | - | 4件: 13 13, 84, 86, 299 💬
|
| 1591 | Rilutek | 1件: Riluzole Riluzole | 1件: Riluzole
Riluzole
💬
| 14件: GRIA1 GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
| 24件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 3件: 2 2, 13, 203 💬
|
| 1592 | Riluzole | 1件: Riluzole Riluzole | 1件: Riluzole
Riluzole
💬
| 14件: GRIA1 GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
| 24件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 8件: 2 2, 3, 5, 8, 13, 17, 203, 206 💬
|
| 1593 | RIPK1 inhibitor | - | - | - | - | 1件: 13 13 💬
|
| 1594 | Ritalin | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2,
SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 2件: 6 6, 13 💬
|
| 1595 | Ritalin LA 20MG capsules | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2,
SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 1596 | Ritalin LA 30MG capsules | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2,
SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 1597 | Ritalin LA 40MG capsules | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2,
SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 1598 | Rituximab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 52件: 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 1599 | Rituximab infusion | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 13 13, 222 💬
|
| 1600 | Rituximab IT | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1601 | Rituximab IV | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1602 | Rituximab konsentrat TIL infusjonsvaeske oppløsning 10 MG/ML | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1603 | Rivastigmin | - | - | - | - | 1件: 13 13 💬
|
| 1604 | Rivastigmine transdermal patch | 1件: Rivastigmine Rivastigmine | 2件: Rivastigmine tartrate
Rivastigmine tartrate
,
Rivastigmine
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 2件: 6 6, 13 💬
|
| 1605 | Rixathon | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 3件: 13 13, 46, 49 💬
|
| 1606 | RNF | - | - | - | - | 1件: 13 13 💬
|
| 1607 | RNS60 | - | - | - | - | 2件: 2 2, 13 💬
|
| 1608 | RNS60 125 ML | - | - | - | - | 1件: 13 13 💬
|
| 1609 | RNS60 250 ML | - | - | - | - | 1件: 13 13 💬
|
| 1610 | RO 496-4913/F03 | - | - | - | - | 2件: 13 13, 46 💬
|
| 1611 | RO 496-4913/F07 | - | - | - | - | 1件: 13 13 💬
|
| 1612 | RO 533-3787/F01- 06 | - | - | - | - | 1件: 13 13 💬
|
| 1613 | RO0506997 | - | - | - | - | 2件: 13 13, 46 💬
|
| 1614 | RO4964913 | - | - | - | - | 1件: 13 13 💬
|
| 1615 | RO4964913 F07 | - | - | - | - | 1件: 13 13 💬
|
| 1616 | RO4964913/F03 | - | - | - | - | 1件: 13 13 💬
|
| 1617 | RO4964913/F07 | - | - | - | - | 1件: 13 13 💬
|
| 1618 | RO4964913/F07-01 | - | - | - | - | 1件: 13 13 💬
|
| 1619 | RO5333787 | - | - | - | - | 2件: 11 11, 13 💬
|
| 1620 | RO7010939 | - | - | - | - | 1件: 13 13 💬
|
| 1621 | RO7121932 - MAD | - | - | - | - | 1件: 13 13 💬
|
| 1622 | RO7121932 IV - SAD | - | - | - | - | 1件: 13 13 💬
|
| 1623 | RO7121932 SC - SAD | - | - | - | - | 1件: 13 13 💬
|
| 1624 | Rolipram | 1件: Rolipram Rolipram | 1件: Rolipram
Rolipram
💬
| 4件: PDE4 PDE4,
PDE4,
PDE4,
PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 2件: 8 8, 13 💬
|
| 1625 | RPC-1063 | - | - | - | - | 1件: 13 13 💬
|
| 1626 | RPC1063 | - | - | - | - | 3件: 13 13, 96, 97 💬
|
| 1627 | RTL1000 | 1件: RTL-1000 RTL-1000 | - | - | - | 1件: 13 13 💬
|
| 1628 | RTX | - | - | - | - | 3件: 13 13, 65, 222 💬
|
| 1629 | Ruxience | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1630 | Ruxolitinib | 1件: Ruxolitinib Ruxolitinib | 2件: Ruxolitinib
Ruxolitinib
,
Ruxolitinib phosphate
💬
| 2件: JAK1 JAK1,
JAK2 💬
| 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 5件: 13 13, 15, 60, 65, 228 💬
|
| 1631 | RVP-001 | - | - | - | - | 1件: 13 13 💬
|
| 1632 | RYAH-medtech inhaler | - | - | - | - | 5件: 2 2, 6, 13, 96, 97 💬
|
| 1633 | S-warfarin | 1件: (S)-Warfarin (S)-Warfarin | - | - | - | 1件: 13 13 💬
|
| 1634 | SA237 | - | - | - | - | 1件: 13 13 💬
|
| 1635 | Saline | 1件: Sodium chloride Sodium chloride | 1件: Sodium chloride
Sodium chloride
💬
| - | - | 19件: 2 2, 6, 13, 17, 18, 46, 53, 67, 77, 86, 96, 97, 98, 168, 256, 271, 274, 299, 301 💬
|
| 1636 | Sapelizumab | 1件: Satralizumab Satralizumab | 1件: Satralizumab
Satralizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 💬
|
| 1637 | SAR339658 | - | - | - | - | 2件: 13 13, 97 💬
|
| 1638 | SAR441344 | - | - | - | - | 3件: 13 13, 49, 53 💬
|
| 1639 | SAR441344 IV | - | - | - | - | 2件: 13 13, 49 💬
|
| 1640 | SAR441344 SC | - | - | - | - | 2件: 13 13, 49 💬
|
| 1641 | SAR442168 | - | - | - | - | 2件: 11 11, 13 💬
|
| 1642 | SAR443820 | - | - | - | - | 2件: 2 2, 13 💬
|
| 1643 | SARS-COV-2 mrna vaccine | 2件: CVnCoV CVnCoV,
SARS-CoV-2 mRNA vaccine | - | - | - | 1件: 13 13 💬
|
| 1644 | Sativex | 2件: Cannabidiol Cannabidiol,
Dronabinol | 2件: Dronabinol
Dronabinol
,
Cannabidiol
💬
| 2件: CNR1 CNR1,
CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 2件: 2 2, 13 💬
|
| 1645 | Sativex - spray PER mucosa orale 3 flaconi nebulizzatori CON pompa dosatrice DA 10 ML - 90 erogazioni | - | - | - | - | 1件: 13 13 💬
|
| 1646 | Sativex 2,7MG/2,5 MG solucion para pulverizacion bucal | 2件: Cannabidiol Cannabidiol,
Dronabinol | 2件: Dronabinol
Dronabinol
,
Cannabidiol
💬
| 2件: CNR1 CNR1,
CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
| 1647 | Sativex oromucosal spray | 2件: Cannabidiol Cannabidiol,
Dronabinol | 2件: Dronabinol
Dronabinol
,
Cannabidiol
💬
| 2件: CNR1 CNR1,
CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
| 1648 | Satralizumab | 1件: Satralizumab Satralizumab | 1件: Satralizumab
Satralizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 4件: 11 11, 13, 86, 113 💬
|
| 1649 | Satralizumab 120 MG | 1件: Satralizumab Satralizumab | 1件: Satralizumab
Satralizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 💬
|
| 1650 | SB-683699 | - | - | - | - | 1件: 13 13 💬
|
| 1651 | SB683699 | - | - | - | - | 1件: 13 13 💬
|
| 1652 | SC interferon BETA-1A | - | - | - | - | 1件: 13 13 💬
|
| 1653 | SC interferon BETA-1B | - | - | - | - | 1件: 13 13 💬
|
| 1654 | SC peginterferon BETA-1A | - | - | - | - | 1件: 13 13 💬
|
| 1655 | Sclerolym | - | - | - | - | 1件: 13 13 💬
|
| 1656 | SCM-010 | - | - | - | - | 1件: 13 13 💬
|
| 1657 | Seasonal influenza vaccine | - | - | - | - | 2件: 13 13, 46 💬
|
| 1658 | Seasonal quadrivalent influenza vaccine | - | - | - | - | 1件: 13 13 💬
|
| 1659 | Second-generation fumaric acid | - | - | - | - | 1件: 13 13 💬
|
| 1660 | Secukinumab | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 8件: 13 13, 37, 41, 46, 107, 160, 269, 271 💬
|
| 1661 | Select dmts other than ozanimod | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1662 | Selenium | 1件: Selenium Selenium | - | - | - | 4件: 13 13, 96, 278, 298 💬
|
| 1663 | Self massage | - | - | - | - | 1件: 13 13 💬
|
| 1664 | Sendoxan | - | - | - | - | 2件: 13 13, 43 💬
|
| 1665 | Sendoxane | - | - | - | - | 1件: 13 13 💬
|
| 1666 | Serum containing avonex | - | - | - | - | 1件: 13 13 💬
|
| 1667 | Serum free avonex | - | - | - | - | 1件: 13 13 💬
|
| 1668 | SF-12 questionnaire | - | - | - | - | 3件: 13 13, 51, 56 💬
|
| 1669 | SH U 555 C | - | - | - | - | 1件: 13 13 💬
|
| 1670 | Short-course ocrelizumab | - | - | - | - | 1件: 13 13 💬
|
| 1671 | Silodyx | - | - | - | - | 1件: 13 13 💬
|
| 1672 | Simethicone | 1件: Simethicone Simethicone | 1件: Simethicone
Simethicone
💬
| - | - | 2件: 13 13, 96 💬
|
| 1673 | Simvahexal® 40 MG filmtabletten | - | - | - | - | 1件: 13 13 💬
|
| 1674 | Simvastatin | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 19件: 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 158, 160, 195, 265, 288, 298, 299, 310 💬
|
| 1675 | Simvastatin 40 MG FILM-coated tablets | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬
|
| 1676 | Simvastatin alternova | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬
|
| 1677 | Simvastatin IN relapsing remitting multiple sclerosis | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬
|
| 1678 | Simvastatina sandoz 40 MG comprimidos recubiertos CON PELícula EFG | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬
|
| 1679 | Simvastatine | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 3件: 6 6, 13, 288 💬
|
| 1680 | Simvastatine sandoz 40 MG filmomhulde tabletten | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬
|
| 1681 | Simvastatine sandoz 40MG deelbare filmomhulde tabletten | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬
|
| 1682 | Single-USE autoinjector | - | - | - | - | 1件: 13 13 💬
|
| 1683 | Single-USE autoinjector with A prefilled liquid avonex syringe | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1,
IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
| 1684 | Sinvastatina sandoz 40 MG comprimidos revestidos POR PELícula | - | - | - | - | 1件: 13 13 💬
|
| 1685 | Siponimob | - | - | - | - | 1件: 13 13 💬
|
| 1686 | Siponimod | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 50 💬
|
| 1687 | Siponimod 0,25 MG | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1688 | Siponimod 0.25 MG tablet | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 50 💬
|
| 1689 | Siponimod 0.5 MG tablet | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 50 💬
|
| 1690 | Siponimod 1 MG | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1691 | Siponimod 1 MG tablet | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 50 💬
|
| 1692 | Siponimod 2 MG | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1693 | Siponimod 2 MG tablet | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 50 💬
|
| 1694 | Siponimod fumarato | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1695 | Siponimod fumaric acid | 1件: Siponimod Siponimod | 2件: Siponimod fumarate
Siponimod fumarate
,
Siponimod
💬
| 2件: S1PR1 S1PR1,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1696 | Sirolimus | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 39件: 6 6, 13, 15, 19, 21, 34, 35, 36, 46, 48, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 97, 98, 137, 157, 158, 192, 222, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
| 1697 | Sivatin 40 MG FILM-coated tablets | - | - | - | - | 1件: 13 13 💬
|
| 1698 | Sivelestat | 1件: Sivelestat Sivelestat | 1件: Sivelestat
Sivelestat
💬
| 1件: ELANE ELANE 💬
| 3件: Neutrophil extracellular trap formation Neutrophil extracellular trap formation, Systemic lupus erythematosus, Transcriptional misregulation in cancer 💬 | 3件: 13 13, 85, 96 💬
|
| 1699 | Sleep assessment | - | - | - | - | 1件: 13 13 💬
|
| 1700 | Sleep quality and physical activity | - | - | - | - | 1件: 13 13 💬
|
| 1701 | Smderpept | - | - | - | - | 1件: 13 13 💬
|
| 1702 | Smoked cannabis | - | - | - | - | 1件: 13 13 💬
|
| 1703 | Smoking | - | - | - | - | 1件: 13 13 💬
|
| 1704 | Sodium chlorid | - | - | - | - | 1件: 13 13 💬
|
| 1705 | Sodium chloride | 1件: Sodium chloride Sodium chloride | 1件: Sodium chloride
Sodium chloride
💬
| - | - | 20件: 2 2, 11, 13, 14, 34, 41, 46, 51, 53, 60, 67, 70, 96, 97, 193, 214, 215, 227, 288, 299 💬
|
| 1706 | Sodium chloride solution | 1件: Sodium chloride Sodium chloride | 1件: Sodium chloride
Sodium chloride
💬
| - | - | 4件: 11 11, 13, 51, 228 💬
|
| 1707 | Solifenacin succinate | 1件: Solifenacin Solifenacin | 2件: Solifenacin succinate
Solifenacin succinate
,
Solifenacin
💬
| 1件: CHRM3 CHRM3 💬
| 12件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 1件: 13 13 💬
|
| 1708 | Soliris | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 6件: 11 11, 13, 14, 62, 109, 222 💬
|
| 1709 | Solriamfetol | 1件: Solriamfetol Solriamfetol | 2件: Solriamfetol
Solriamfetol
,
Solriamfetol hydrochloride
💬
| 2件: SLC6A2 SLC6A2,
SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
| 1710 | Solu medrol - 125 MG/2 ML polvere E solvente PER soluzione iniettabile 1 flacone A doppia camera DA 125 MG/2 ML | - | - | - | - | 2件: 13 13, 14 💬
|
| 1711 | SOLU-medrol | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 4件: 13 13, 51, 97, 211 💬
|
| 1712 | SOLU-moderin 1 G | - | - | - | - | 1件: 13 13 💬
|
| 1713 | Solumedrol | - | - | - | - | 3件: 13 13, 46, 107 💬
|
| 1714 | Solumedrol IM 125MG/2ML | - | - | - | - | 1件: 13 13 💬
|
| 1715 | Somatorelin | 1件: Somatorelin Somatorelin | 1件: Somatorelin
Somatorelin
💬
| 1件: GHRHR GHRHR 💬
| 3件: Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
| 1716 | Sparc0921 | - | - | - | - | 1件: 13 13 💬
|
| 1717 | Specifically design 6 month resistance training program | - | - | - | - | 1件: 13 13 💬
|
| 1718 | Spikevax | - | - | - | - | 1件: 13 13 💬
|
| 1719 | Spinning GRP | - | - | - | - | 1件: 13 13 💬
|
| 1720 | Spiropent | - | - | - | - | 2件: 6 6, 13 💬
|
| 1721 | SR-fampridine | - | - | - | - | 1件: 13 13 💬
|
| 1722 | Standard gadolinium contrast | - | - | - | - | 1件: 13 13 💬
|
| 1723 | Standard interval dosing | - | - | - | - | 1件: 13 13 💬
|
| 1724 | Standard lymphodepletion regimen | - | - | - | - | 3件: 11 11, 13, 51 💬
|
| 1725 | Standard MS DMT | - | - | - | - | 1件: 13 13 💬
|
| 1726 | Standard MS dmts | - | - | - | - | 1件: 13 13 💬
|
| 1727 | Standard treatment with A conventional drug | - | - | - | - | 1件: 13 13 💬
|
| 1728 | Standard-OF-care | - | - | - | - | 2件: 13 13, 86 💬
|
| 1729 | Standardized cannabis extract | - | - | - | - | 1件: 13 13 💬
|
| 1730 | Static balance test | - | - | - | - | 1件: 13 13 💬
|
| 1731 | Statin | - | - | - | - | 1件: 13 13 💬
|
| 1732 | Stem cell transplantation | - | - | - | - | 13件: 13 13, 19, 20, 46, 51, 60, 62, 65, 90, 125, 164, 234, 326 💬
|
| 1733 | Step tracking | - | - | - | - | 1件: 13 13 💬
|
| 1734 | Strength training | - | - | - | - | 1件: 13 13 💬
|
| 1735 | Stretching | - | - | - | - | 2件: 6 6, 13 💬
|
| 1736 | Stroop test | - | - | - | - | 1件: 13 13 💬
|
| 1737 | Study drug | - | - | - | - | 2件: 6 6, 13 💬
|
| 1738 | SUB0750MIG | - | - | - | - | 1件: 13 13 💬
|
| 1739 | SUB175614 | - | - | - | - | 1件: 13 13 💬
|
| 1740 | SUB22282 | - | - | - | - | 1件: 13 13 💬
|
| 1741 | Sublingual tizanidine 12 MG | - | - | - | - | 1件: 13 13 💬
|
| 1742 | Sunphenon | - | - | - | - | 1件: 13 13 💬
|
| 1743 | Sunphenon egcg | - | - | - | - | 3件: 13 13, 17, 113 💬
|
| 1744 | Sunphenon egcg TM | - | - | - | - | 1件: 13 13 💬
|
| 1745 | Supervised physical therapy | - | - | - | - | 1件: 13 13 💬
|
| 1746 | Suspension media | - | - | - | - | 1件: 13 13 💬
|
| 1747 | Sustained-release oral dalfampridine | - | - | - | - | 1件: 13 13 💬
|
| 1748 | Suvorexant | 1件: Suvorexant Suvorexant | 1件: Suvorexant
Suvorexant
💬
| 2件: HCRTR1 HCRTR1,
HCRTR2 💬
| 2件: Hormone signaling Hormone signaling, Neuroactive ligand-receptor interaction 💬 | 3件: 5 5, 6, 13 💬
|
| 1749 | Syngeneic bone marrow transplantation | - | - | - | - | 3件: 11 11, 13, 14 💬
|
| 1750 | T cell vaccination | - | - | - | - | 1件: 13 13 💬
|
| 1751 | T-cell vaccination | - | - | - | - | 1件: 13 13 💬
|
| 1752 | Tachipirina - 500 MG compresse20 compresse | - | - | - | - | 1件: 13 13 💬
|
| 1753 | TACI-FC5 | 1件: Atacicept Atacicept | 1件: Atacicept
Atacicept
💬
| 2件: TNFSF13 TNFSF13,
TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 3件: 13 13, 46, 49 💬
|
| 1754 | Tamsulosin | 1件: Tamsulosin Tamsulosin | 2件: Tamsulosin hydrochloride
Tamsulosin hydrochloride
,
Tamsulosin
💬
| 3件: ADRA1A ADRA1A,
ADRA1B,
ADRA1D 💬
| 9件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 13 13 💬
|
| 1755 | Tanakan | 1件: Ginkgo biloba Ginkgo biloba | 1件: Ginkgo
Ginkgo
💬
| - | - | 1件: 13 13 💬
|
| 1756 | Tarenflurbil | 1件: Tarenflurbil Tarenflurbil | 1件: Tarenflurbil
Tarenflurbil
💬
| 4件: APH1 APH1,
NCSTN,
PSEN1,
PSENEN 💬
| 6件: Alzheimer disease Alzheimer disease, Human papillomavirus infection, Neurotrophin signaling pathway, Notch signaling pathway, Pathways of neurodegeneration - multiple diseases, Wnt signaling pathway 💬 | 1件: 13 13 💬
|
| 1757 | Targretin | 1件: Bexarotene Bexarotene | 1件: Bexarotene
Bexarotene
💬
| 3件: RXRA RXRA,
RXRB,
RXRG 💬
| 18件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Efferocytosis, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬 | 1件: 13 13 💬
|
| 1758 | Taurine | 1件: Taurine Taurine | 1件: Taurine
Taurine
💬
| - | - | 4件: 13 13, 21, 201, 337 💬
|
| 1759 | TCD after bosentan administration | - | - | - | - | 1件: 13 13 💬
|
| 1760 | TCD baseline | - | - | - | - | 1件: 13 13 💬
|
| 1761 | Tcelna | - | - | - | - | 1件: 13 13 💬
|
| 1762 | Tecfidera | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: Dimethyl fumarate
Dimethyl fumarate
💬
| 1件: KLHL19 KLHL19 💬
| 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 13 13 💬
|
| 1763 | Tecfidera - 240 MG - capsula rigida gastroresistente - USO orale - blister (PVC/PE/PVDC-PVC alluminio) - 56 capsule | - | - | - | - | 1件: 13 13 💬
|
| 1764 | Tecfidera 240MG CPS ETD | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: Dimethyl fumarate
Dimethyl fumarate
💬
| 1件: KLHL19 KLHL19 💬
| 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 13 13 💬
|
| 1765 | Tecfidera® 120 MG | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: Dimethyl fumarate
Dimethyl fumarate
💬
| 1件: KLHL19 KLHL19 💬
| 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 13 13 💬
|
| 1766 | Tecfidera® 120MG magensaftresistente hartkapseln | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: Dimethyl fumarate
Dimethyl fumarate
💬
| 1件: KLHL19 KLHL19 💬
| 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 13 13 💬
|
| 1767 | Tecfidera® 240 MG | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: Dimethyl fumarate
Dimethyl fumarate
💬
| 1件: KLHL19 KLHL19 💬
| 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 13 13 💬
|
| 1768 | Tecfidera® 240MG magensaftresistente hartkapseln | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: Dimethyl fumarate
Dimethyl fumarate
💬
| 1件: KLHL19 KLHL19 💬
| 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 13 13 💬
|
| 1769 | Telephone-based cognitive behavioral therapy | - | - | - | - | 1件: 13 13 💬
|
| 1770 | Telitacicept | 1件: Telitacicept Telitacicept | - | - | - | 11件: 11 11, 13, 46, 48, 49, 51, 53, 63, 66, 222, 300 💬
|
| 1771 | Temelimab | 1件: Temelimab Temelimab | - | - | - | 1件: 13 13 💬
|
| 1772 | Temsirolimus tablets | 1件: Temsirolimus Temsirolimus | 1件: Temsirolimus
Temsirolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 13 13 💬
|
| 1773 | Tenofovir | 1件: Tenofovir Tenofovir | 1件: Tenofovir
Tenofovir
💬
| - | - | 3件: 13 13, 265, 325 💬
|
| 1774 | Tenofovir alafenamide | 2件: Tenofovir Tenofovir,
Tenofovir alafenamide | 3件: Tenofovir
Tenofovir
,
Tenofovir alafenamide
,
Tenofovir alafenamide fumarate
💬
| - | - | 2件: 2 2, 13 💬
|
| 1775 | Teriflunomide | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 4件: 13 13, 25, 26, 63 💬
|
| 1776 | Teriflunomide 14 MG | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 1777 | Teriflunomide capsule | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 1778 | Teriflunomide HMR1726 | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
| 1779 | Testing OF autonomous nervous system function | - | - | - | - | 1件: 13 13 💬
|
| 1780 | Testosterone | 1件: Testosterone Testosterone | 1件: Testosterone
Testosterone
💬
| 1件: AR AR 💬
| 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 6件: 1 1, 2, 3, 13, 76, 113 💬
|
| 1781 | Testosterone undecanoate | 2件: Testosterone Testosterone,
Testosterone undecanoate | 2件: Testosterone
Testosterone
,
Testosterone undecanoate
💬
| 1件: AR AR 💬
| 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 2件: 13 13, 60 💬
|
| 1782 | Tetanus diphtheria toxoids vaccine | - | - | - | - | 1件: 13 13 💬
|
| 1783 | Tetanus toxoid | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) | 2件: Tetanus toxoid adsorbed
Tetanus toxoid adsorbed
,
Tetanus toxoid
💬
| - | - | 3件: 13 13, 14, 46 💬
|
| 1784 | Tetanus toxoid vaccine | 1件: Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) | 2件: Tetanus toxoid adsorbed
Tetanus toxoid adsorbed
,
Tetanus toxoid
💬
| - | - | 1件: 13 13 💬
|
| 1785 | Tetanus, diphtheria, and acellular pertussis vaccine | - | - | - | - | 1件: 13 13 💬
|
| 1786 | Tetracycline | 1件: Tetracycline Tetracycline | 2件: Tetracycline
Tetracycline
,
Tetracycline hydrochloride
💬
| - | - | 5件: 13 13, 46, 53, 66, 97 💬
|
| 1787 | Tetracycline - statin - antimycotic | 1件: Tetracycline Tetracycline | 2件: Tetracycline
Tetracycline
,
Tetracycline hydrochloride
💬
| - | - | 1件: 13 13 💬
|
| 1788 | Tetrahydrocannabinol | 1件: Dronabinol Dronabinol | 1件: Dronabinol
Dronabinol
💬
| 2件: CNR1 CNR1,
CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 3件: 8 8, 13, 298 💬
|
| 1789 | TG-1101 | - | - | - | - | 1件: 13 13 💬
|
| 1790 | THC | - | - | - | - | 3件: 8 8, 13, 36 💬
|
| 1791 | Thiamine | 1件: Thiamine Thiamine | 3件: Thiamine hydrochloride
Thiamine hydrochloride
,
Thiamine mononitrate
,
Thiamine
💬
| - | - | 3件: 13 13, 93, 265 💬
|
| 1792 | Thioplex | - | - | - | - | 1件: 13 13 💬
|
| 1793 | Thiotepa | 1件: Thiotepa Thiotepa | 1件: Thiotepa
Thiotepa
💬
| - | - | 11件: 13 13, 28, 46, 51, 60, 65, 85, 96, 107, 284, 285 💬
|
| 1794 | Thymoglobuline | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | 1件: Anti-human thymocyte immunoglobulin, rabbit
Anti-human thymocyte immunoglobulin, rabbit
💬
| 11件: CD2 CD2,
CD3D,
CD3E,
CD3G,
CD4,
CD5,
CD7,
CD8A,
CD8B,
IL2RA,
ITGAL 💬
| 31件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 5件: 13 13, 36, 51, 60, 96 💬
|
| 1795 | Thymol | 1件: Thymol Thymol | 1件: Thymol
Thymol
💬
| - | - | 1件: 13 13 💬
|
| 1796 | Time restricted olive OIL based (troo) ketogenic diet | - | - | - | - | 1件: 13 13 💬
|
| 1797 | Timed UP AN GO test | - | - | - | - | 1件: 13 13 💬
|
| 1798 | Tissue selective estrogen complex | - | - | - | - | 1件: 13 13 💬
|
| 1799 | Tizanidine | 1件: Tizanidine Tizanidine | 2件: Tizanidine hydrochloride
Tizanidine hydrochloride
,
Tizanidine
💬
| 3件: ADRA2A ADRA2A,
ADRA2B,
ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 13 13 💬
|
| 1800 | Tizanidine hydrochloride capsule | 1件: Tizanidine Tizanidine | 2件: Tizanidine hydrochloride
Tizanidine hydrochloride
,
Tizanidine
💬
| 3件: ADRA2A ADRA2A,
ADRA2B,
ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 13 13 💬
|
| 1801 | TMP001 | - | - | - | - | 1件: 13 13 💬
|
| 1802 | Tocilizumab | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 24件: 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
|
| 1803 | Tocilizumab injection | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 11 11, 13 💬
|
| 1804 | Toldc - intradermal | - | - | - | - | 1件: 13 13 💬
|
| 1805 | Toldc - intranodal | - | - | - | - | 1件: 13 13 💬
|
| 1806 | Tolebrutinib | 1件: Tolebrutinib Tolebrutinib | 1件: Tolebrutinib
Tolebrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 2件: 11 11, 13 💬
|
| 1807 | Tolebrutinib 120MG | 1件: Tolebrutinib Tolebrutinib | 1件: Tolebrutinib
Tolebrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 1件: 13 13 💬
|
| 1808 | Tolebrutinib 60MG | 1件: Tolebrutinib Tolebrutinib | 1件: Tolebrutinib
Tolebrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 1件: 13 13 💬
|
| 1809 | Tolerogenic dendritic cells loaded with myelin peptides | - | - | - | - | 1件: 13 13 💬
|
| 1810 | Tolerogenic fibroblasts | - | - | - | - | 1件: 13 13 💬
|
| 1811 | Tolperisone HC1 | 1件: Tolperisone Tolperisone | 2件: Tolperisone hydrochloride
Tolperisone hydrochloride
,
Tolperisone
💬
| - | - | 1件: 13 13 💬
|
| 1812 | Tolperisone HCL | 1件: Tolperisone Tolperisone | 2件: Tolperisone hydrochloride
Tolperisone hydrochloride
,
Tolperisone
💬
| - | - | 1件: 13 13 💬
|
| 1813 | Tolpersan | - | - | - | - | 1件: 13 13 💬
|
| 1814 | Tolposan | - | - | - | - | 1件: 13 13 💬
|
| 1815 | Topical preparation H ARM | - | - | - | - | 1件: 13 13 💬
|
| 1816 | Torvast*10CPR 10MG | - | - | - | - | 1件: 13 13 💬
|
| 1817 | Tovaxin | - | - | - | - | 1件: 13 13 💬
|
| 1818 | Tovaxin autologous T cell vaccine | - | - | - | - | 1件: 13 13 💬
|
| 1819 | Tracleer | 1件: Bosentan Bosentan | 2件: Bosentan
Bosentan
,
Bosentan
💬
| 2件: EDNRA EDNRA,
EDNRB 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 13 13, 51, 84, 85, 86, 88, 210, 211 💬
|
| 1820 | Traditional balance exercises | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 13 13 💬
|
| 1821 | Training groupe | - | - | - | - | 1件: 13 13 💬
|
| 1822 | Trancopal dolo | - | - | - | - | 1件: 13 13 💬
|
| 1823 | Transcranial magnetic stimulation | - | - | - | - | 3件: 6 6, 13, 77 💬
|
| 1824 | Trap myelin test | - | - | - | - | 1件: 13 13 💬
|
| 1825 | Treatment withdrawal | - | - | - | - | 1件: 13 13 💬
|
| 1826 | Treosulfan | 1件: Treosulfan Treosulfan | 1件: Treosulfan
Treosulfan
💬
| - | - | 6件: 13 13, 19, 62, 65, 284, 286 💬
|
| 1827 | Trichuris suis eggs | - | - | - | - | 3件: 13 13, 96, 97 💬
|
| 1828 | Trichuris suis OVA | - | - | - | - | 4件: 13 13, 46, 96, 97 💬
|
| 1829 | Trichuris suis OVA (eggs), embryonated, viable | - | - | - | - | 1件: 13 13 💬
|
| 1830 | Trileptal | 1件: Oxcarbazepine Oxcarbazepine | 1件: Oxcarbazepine
Oxcarbazepine
💬
| 5件: SCN1A SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 13 13 💬
|
| 1831 | Trivalent seasonal influenza vaccine | - | - | - | - | 1件: 13 13 💬
|
| 1832 | Trulicity 0,75 MG injekcný roztok naplnený V injekcnom pere | - | - | - | - | 1件: 13 13 💬
|
| 1833 | Trunk impairment | - | - | - | - | 1件: 13 13 💬
|
| 1834 | Trunk position sense | - | - | - | - | 1件: 13 13 💬
|
| 1835 | TSO | - | - | - | - | 3件: 13 13, 46, 97 💬
|
| 1836 | TT vaccine | - | - | - | - | 1件: 13 13 💬
|
| 1837 | TV-5010 | - | - | - | - | 1件: 13 13 💬
|
| 1838 | TV-5600 | - | - | - | - | 3件: 8 8, 13, 96 💬
|
| 1839 | Tylenol pill | - | - | - | - | 1件: 13 13 💬
|
| 1840 | Tysabri | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 3件: 13 13, 25, 63 💬
|
| 1841 | Tysabri 300 MG concentrado para solucióN para perfusióN | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 1842 | Tysabri 300 MG concentrate FOR solution FOR infusion | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 1843 | Tysabri 300 MG solution à diluer pour perfusion | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 💬
|
| 1844 | Tysabri and avonex | - | - | - | - | 1件: 13 13 💬
|
| 1845 | Tysabri injectable product | - | - | - | - | 1件: 13 13 💬
|
| 1846 | Tysabri*IV 1FL 300MG 15ML | - | - | - | - | 1件: 13 13 💬
|
| 1847 | Ublituximab | 1件: Ublituximab Ublituximab | 1件: Ublituximab
Ublituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
| 1848 | Ubltuximab | - | - | - | - | 1件: 13 13 💬
|
| 1849 | Ucar T-cell | - | - | - | - | 3件: 11 11, 13, 51 💬
|
| 1850 | UCB L059 | - | - | - | - | 1件: 13 13 💬
|
| 1851 | UK: sativex oromucosal spray | 2件: Cannabidiol Cannabidiol,
Dronabinol | 2件: Dronabinol
Dronabinol
,
Cannabidiol
💬
| 2件: CNR1 CNR1,
CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
| 1852 | Ultomiris | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件: 2 2, 11, 13, 50, 62, 66, 109 💬
|
| 1853 | Ultrasmall particles OF iron oxide | - | - | - | - | 1件: 13 13 💬
|
| 1854 | Ultromiris | - | - | - | - | 1件: 13 13 💬
|
| 1855 | Umbilical cord derived mesenchymal stem cells | - | - | - | - | 1件: 13 13 💬
|
| 1856 | Umbilical cord mesenchymal stem cells | - | - | - | - | 5件: 13 13, 46, 57, 97, 113 💬
|
| 1857 | Uncoupled rbcs | - | - | - | - | 1件: 13 13 💬
|
| 1858 | Undifferentiated autologous mesenchymal stem cells | - | - | - | - | 1件: 13 13 💬
|
| 1859 | Universal bcma CAR-T | - | - | - | - | 2件: 11 11, 13 💬
|
| 1860 | Universal BCMA-CD19 cart | - | - | - | - | 1件: 13 13 💬
|
| 1861 | Universal CD19 CAR-T | - | - | - | - | 2件: 11 11, 13 💬
|
| 1862 | Untreated TO atorvastatin treatment | - | - | - | - | 1件: 13 13 💬
|
| 1863 | Uplizna | 1件: Inebilizumab Inebilizumab | 1件: Inebilizumab
Inebilizumab
💬
| 1件: CD19 CD19 💬
| 5件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | 3件: 11 11, 13, 300 💬
|
| 1864 | Urbason 40 MG | - | - | - | - | 1件: 13 13 💬
|
| 1865 | Urbason 40 MG comprimidos | - | - | - | - | 1件: 13 13 💬
|
| 1866 | Urbason forte | - | - | - | - | 1件: 13 13 💬
|
| 1867 | Urbason solubile forte 1000MG | - | - | - | - | 1件: 13 13 💬
|
| 1868 | Urbason® solubile forte 1000 MG | - | - | - | - | 1件: 13 13 💬
|
| 1869 | Urine samples | - | - | - | - | 1件: 13 13 💬
|
| 1870 | US-ocrevus | - | - | - | - | 1件: 13 13 💬
|
| 1871 | Uspio MRI - gadolinium MRI | - | - | - | - | 1件: 13 13 💬
|
| 1872 | Usual diet with dietary guidelines FOR americans diet information | - | - | - | - | 1件: 13 13 💬
|
| 1873 | Usual DMT continuation | - | - | - | - | 1件: 13 13 💬
|
| 1874 | Uvedose | - | - | - | - | 2件: 13 13, 46 💬
|
| 1875 | Uvedose 100 000 UI, solution buvable EN ampoule | - | - | - | - | 1件: 13 13 💬
|
| 1876 | V08ca02 | - | - | - | - | 1件: 13 13 💬
|
| 1877 | V08ca09 | - | - | - | - | 1件: 13 13 💬
|
| 1878 | Vaginal estriol | - | - | - | - | 1件: 13 13 💬
|
| 1879 | Vancomycin | 1件: Vancomycin Vancomycin | 2件: Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | 8件: 13 13, 46, 70, 94, 96, 97, 296, 299 💬
|
| 1880 | Vardenafil | 1件: Vardenafil Vardenafil | 2件: Vardenafil
Vardenafil
,
Vardenafil hydrochloride
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 3件: 13 13, 86, 299 💬
|
| 1881 | Vardenafilo hidrocloruro | 1件: Vardenafil Vardenafil | 2件: Vardenafil
Vardenafil
,
Vardenafil hydrochloride
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 13 13 💬
|
| 1882 | Vatelizumab | 1件: Vatelizumab Vatelizumab | - | - | - | 2件: 13 13, 97 💬
|
| 1883 | VAY736 | - | - | - | - | 9件: 13 13, 35, 46, 49, 53, 61, 63, 85, 95 💬
|
| 1884 | VB13s1 | - | - | - | - | 1件: 13 13 💬
|
| 1885 | VB5s2 | - | - | - | - | 1件: 13 13 💬
|
| 1886 | VB6s5 | - | - | - | - | 1件: 13 13 💬
|
| 1887 | Vehicle GEL | - | - | - | - | 2件: 13 13, 34 💬
|
| 1888 | Venlafaxin hexal | - | - | - | - | 1件: 13 13 💬
|
| 1889 | Venlafaxine | 1件: Venlafaxine Venlafaxine | 3件: Venlafaxine hydrochloride
Venlafaxine hydrochloride
,
Venlafaxine
,
Venlafaxine besylate monohydrate
💬
| 2件: SLC6A2 SLC6A2,
SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 3件: 6 6, 13, 97 💬
|
| 1890 | Venlafaxine hydrochloride | 1件: Venlafaxine Venlafaxine | 3件: Venlafaxine hydrochloride
Venlafaxine hydrochloride
,
Venlafaxine
,
Venlafaxine besylate monohydrate
💬
| 2件: SLC6A2 SLC6A2,
SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 13 13, 46 💬
|
| 1891 | Verum ARM receiving vitamin D OIL | - | - | - | - | 1件: 13 13 💬
|
| 1892 | Vesicare 10MG tablet | - | - | - | - | 1件: 13 13 💬
|
| 1893 | Vestibular habituation exercises | - | - | - | - | 1件: 13 13 💬
|
| 1894 | Vestibular rehabilitation: balance and EYE movement exercises | - | - | - | - | 1件: 13 13 💬
|
| 1895 | VIB0551 | - | - | - | - | 1件: 13 13 💬
|
| 1896 | Video game therapy | - | - | - | - | 1件: 13 13 💬
|
| 1897 | Vidofludimus calcium | 1件: Vidofludimus Vidofludimus | 2件: Vidofludimus
Vidofludimus
,
Vidofludimus calcium
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 4件: 13 13, 94, 96, 97 💬
|
| 1898 | Vigantol | - | - | - | - | 2件: 13 13, 65 💬
|
| 1899 | Vigantol OEL | - | - | - | - | 1件: 13 13 💬
|
| 1900 | Vigantol OIL | - | - | - | - | 1件: 13 13 💬
|
| 1901 | Vigantol® OIL | - | - | - | - | 1件: 13 13 💬
|
| 1902 | Vigantol® ÖL 20.000 I.E./ML | - | - | - | - | 1件: 13 13 💬
|
| 1903 | Virtual reality group | - | - | - | - | 1件: 13 13 💬
|
| 1904 | Vitamin A | 1件: Vitamin A Vitamin A | 2件: Vitamin A oil
Vitamin A oil
,
Vitamin A
💬
| 2件: RARA RARA,
RARB 💬
| 8件: Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 3件: 13 13, 53, 90 💬
|
| 1905 | Vitamin D | 1件: Vitamin D Vitamin D | - | - | - | 20件: 6 6, 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 299 💬
|
| 1906 | Vitamin D3 | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 11件: 6 6, 13, 20, 46, 49, 51, 53, 65, 96, 97, 299 💬
|
| 1907 | Vitamin K | 1件: Phylloquinone Phylloquinone | 1件: Phytonadione
Phytonadione
💬
| - | - | 3件: 13 13, 46, 97 💬
|
| 1908 | Vitamin K cream | 1件: Phylloquinone Phylloquinone | 1件: Phytonadione
Phytonadione
💬
| - | - | 1件: 13 13 💬
|
| 1909 | Vitamina D3 kern pharma soluciÓN oleosa | - | - | - | - | 1件: 13 13 💬
|
| 1910 | VSN16R | - | - | - | - | 1件: 13 13 💬
|
| 1911 | VSN16R 100MG | - | - | - | - | 1件: 13 13 💬
|
| 1912 | VX15/2503 | - | - | - | - | 2件: 8 8, 13 💬
|
| 1913 | Warm compress prior TO injection OF glatiramer acetate | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
| 1914 | Water | 1件: Water Water | 1件: Water
Water
💬
| - | - | 25件: 2 2, 5, 6, 13, 17, 19, 22, 46, 51, 53, 56, 57, 63, 64, 66, 67, 85, 96, 97, 206, 226, 230, 274, 278, 299 💬
|
| 1915 | Water tracking | 1件: Water Water | 1件: Water
Water
💬
| - | - | 1件: 13 13 💬
|
| 1916 | WAY-130799 | - | - | - | - | 1件: 13 13 💬
|
| 1917 | Withdrawal OF dalfampridine-ER 10MG | - | - | - | - | 1件: 13 13 💬
|
| 1918 | Wristband physical activity monitor | - | - | - | - | 1件: 13 13 💬
|
| 1919 | XBD173 | - | - | - | - | 1件: 13 13 💬
|
| 1920 | XCEL-MC-alpha | - | - | - | - | 1件: 13 13 💬
|
| 1921 | Xeomin | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 7件: 5 5, 6, 7, 13, 15, 17, 113 💬
|
| 1922 | Xyosted 75 milligram (MG) IN 0.5 ML AUTO-injector | - | - | - | - | 1件: 13 13 💬
|
| 1923 | Zanubrutinib | 1件: Zanubrutinib Zanubrutinib | 1件: Zanubrutinib
Zanubrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 5件: 13 13, 61, 63, 222, 331 💬
|
| 1924 | Zenapax | - | - | - | - | 1件: 13 13 💬
|
| 1925 | Zeposia | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1926 | Zeposia 0,92 MG capsule rigide | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 💬
|
| 1927 | Zeposia® indicated FOR THE treatment OF: relapsing forms OF multiple sclerosis, and active ulcerative colitis IN adults | - | - | - | - | 2件: 13 13, 97 💬
|
| 1928 | Zinbryta | 1件: Daclizumab Daclizumab | 1件: Daclizumab
Daclizumab
💬
| 1件: IL2RA IL2RA 💬
| 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 💬
|
| 1929 | ZK 157046 | - | - | - | - | 1件: 13 13 💬
|
| 1930 | ZOL446H | - | - | - | - | 1件: 13 13 💬
|
| 1931 | Zoledronic acid | 1件: Zoledronic acid Zoledronic acid | 5件: Zoledronic acid
Zoledronic acid
,
Zoledronate disodium
,
Zoledronate trisodium
,
Zoledronic acid
,
Zoledronic acid hemipentahydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 13件: 6 6, 13, 46, 75, 77, 93, 95, 96, 97, 270, 274, 299, 333 💬
|
| 1932 | Zoledronic acid monohydrate | 1件: Zoledronic acid Zoledronic acid | 5件: Zoledronic acid
Zoledronic acid
,
Zoledronate disodium
,
Zoledronate trisodium
,
Zoledronic acid
,
Zoledronic acid hemipentahydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬
|
